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ABSTRACT 
Staphylococcus aureus is one of the major reasons for infectious mortality and morbidity. 
Due to extensive use of antibiotics, S. aureus has acquired resistance to almost all 
antibiotics. FmtA is one of the additional factors for methicillin resistance in S. aureus 
which interacts with wall teichoic acid (WTA) and localizes in the cell division septum. 
Previous studies showed that FmtA has very weak D-Ala-D-Ala carboxypeptidase 
(Cpase) activity. In lieu of these findings, we hypothesized that FmtA may require WTA 
as an activator ligand or protein-protein interactions to become fully functional as Cpase 
in the division septum. Here we show that WTA is not an activator ligand for Cpase 
activity of FmtA, but FmtA has an esterase activity on WTA. FmtA can remove D-Ala 
from D-alanyl ester in WTA. Additionally, we show serine and lysine from sequence 
motif Ser127-X-X-Lys130 (conserved among penicillin binding proteins (PBPs), β-
lactamase and family VIII esterase) of FmtA are involved in this catalytic activity. 
Mutation studies suggest that both Ser-X-X-Lys motif in FmtA, located at the position 
S63 and S127 are involved in catalysis. Our results suggest that FmtA’s esterase 
enzymatic activity depends on both enzyme and substrate concentrations and high 
concentration of substrate (10 mg/mL WTA) can inhibit the reaction. Beside WTA, FmtA 
can also remove D-Ala from lipoteichoic acid (LTA). Results from in-vivo studies of 
WTA from fmtA deletion and fmtA-CM (conditionally over expressed) in S. aureus were 
in agreement with in-vitro esterase activity. In conclusion, WTA is not an activator ligand 
 
ii 
for FmtA and that FmtA shows esterase activity towards D-alanyl ester of WTA and 
LTA. Both SXXK motifs in FmtA are involved in catalysis and Serine and lysine from 
SXXK motif are important for esterase catalysis. To date, biological function of most 
esterase is unknown. To our knowledge, this is the first study to report esterase from S. 
aureus that has sequence similarity to PBPs and β-lactamase and very selective to its 
biological substrate WTA and LTA compare to synthetic substrate.  
 
iii 
ACKNOWLEDGMENTS 
 First of all, I would like to thank almighty Allah for giving me the strength and 
knowledge. I am using this opportunity to express my gratitude to everyone who 
supported me throughout the Masters Degree program at York University.  I am thankful 
to my supervisor Dr.Golemi-Kotra for giving me the opportunity to work in her 
laboratory. It would not have been possible without her kind support, aspiring guidance, 
invaluably constructive criticism and friendly advice during the research project work.  
I express my warm thanks to Dr. Atul Kumar, Kevin Patel, Michael Fridman and 
Zhiefeng Yang for their support and guidance during my training. I would also like to 
thank specially Preet Gill and Martin Romero for providing me moral support.  I would 
also like to acknowledge the crucial role of Dr. Harward Hunter, who gave the 
permission to use NMR 700 with the necessary technical supports. 
It would be incomplete without mentioning the people who always supported me in every 
circumstance in my life. Thanks to my parents, my brother and sisters, without your 
supports from UK and Bangladesh this thesis would not have been accomplished. Finally, 
I would like to finish with the quote of Albert Einstein 
 
“Imagination is more important than knowledge. For knowledge is limited to all we now 
know and understand, while imagination embraces the entire world, and all there ever 
will be to know and understand.”    
 
iv 
TABLE OF CONTENTS 
Abstract.......................................................................................................... ii 
Acknowledgments ........................................................................................ iv 
Table of contents ............................................................................................ v 
List of tables ................................................................................................. ix 
List of figures .................................................................................................. x 
List of abbreviations .................................................................................. xiii 
 
Chapter one: Introduction 
1.1 Staphylococcus aureus .......................................................................................... 1 
1.2 Antibiotics and Multi drug resistance ................................................................. 1 
1.3 The cell wall ........................................................................................................... 4 
1.3.1 Peptidoglycan ................................................................................................... 5 
1.3.2 Penicillin binding proteins ............................................................................... 8 
1.3.3 Penicillin-recognizing enzymes ....................................................................... 9 
1.3.4 Teichoic acids ................................................................................................ 16 
1.4 Methicillin resistance S aureus (MRSA) ........................................................... 21 
1.5 Factors affecting methicillinresistance level ..................................................... 25 
1.5.1 FmtA (a factor which affects methicillin resistance and autolysis in presence 
of Triton X-100) ......................................................................................................... 25 
1.6 Aims of this work ................................................................................................ 27 
References......................................................................................................................28 
 
Chapter two: Interactions of FmtA Δ27 with wall teichoic acid (WTA) 
2.1 Introduction......................................................................................................... 35 
2.2 Materials and Methods ....................................................................................... 38 
2.2.1 Materials and chemicals ................................................................................. 38 
2.2.2 Expression and purifications of FmtAΔ27 wild type and mutant proteins ...... 38 
2.2.3 Construction of fmtA conditional mutant and fmtA Deletion strains ............ 40 
2.2.4 Isolations of wall teichoic acid ....................................................................... 40 
2.2.5 DD-Carboxypeptidase assay .......................................................................... 41 
 
v 
2.2.6 Nuclear Magnetic Resonance Spectroscopy (NMR) Experiments ................ 42 
2.2.7 Enzymatic activity of FmtAΔ27 by NMR ........................................................ 42 
2.2.8 Investigation of the substrate specificity of FmtAΔ27 by NMR ...................... 43 
2.2.9 Enzymatic activity of FmtAΔ27 by continuous spectrophotometric assay ........ 43 
2.2.10  Determination of whole-cell surface charge .................................................. 44 
2.2.11  Phosphate assay ............................................................................................. 44 
2.3 Results .................................................................................................................. 45 
2.3.1 Activity of FmtAΔ27 WT against PG analogue (L-Lys-D-Ala-D-Ala) and WTA 
by DD-Carboxypeptidase assays ............................................................................... 45 
2.3.2 Investigation of esterase activity of FmtAΔ27 on WTA by NMR ................... 51 
2.3.3 Investigating the specificity of D-esterase activity of FmtAΔ27 by NMR ......... 52  
2.3.4 screening for esterase activity of FmtAΔ27 by continous spectrophotometric 
assay using samll molecules  ..................................................................................... 54 
2.3.5 Assesment of esterase activity of  by FmtAΔ27 NMR ..................................... 56 
2.3.6 Active site of FmtAΔ27 WT for esterase activity (SXXK motif) .................... 59 
2.3.7 Esterase and protease inhibitors on the activity of FmtAΔ27  ......................... 61 
2.3.8 Analysis of D-Ala modification of WTA isolated from ΔfmtA and fmtA-CM 
strains   ....................................................................................................................... 62 
2.3.9 Inorganic phosphate assay for WTA  ............................................................. 64 
2.3.10 Determination of whole-cell surface charge .................................................. 65 
2.3.11 Investigation of Esterase activity of FmtA on LTAby NMR ......................... 67 
2.3.12 Esterase activity of PBP4 or PBP2a on WTA by NMR ................................. 68 
2.4 Discussion ............................................................................................................ 70 
References......................................................................................................................79 
 
Chapter three: Interactions of FmtA with S aureus surface proteins 
involved in autolysin AtlA 
3.1 Introduction......................................................................................................... 83 
3.2 Materials and Methods ....................................................................................... 90 
3.2.1 Materials and chemicals ................................................................................. 90 
3.2.2 Cloning of atlAM gene ..................................................................................... 90 
3.2.3 Expression and purifications of Atl-AM ........................................................ 91 
3.2.4 Theoretical PI, MW calculation and Structural prediction of Atl-AM .......... 92 
4.2.5 Expression and purifications of Atl-GL ......................................................... 92 
4.2.6 Circular Dichroism (CD) spectroscopic studies ............................................. 93 
4.2.7 Enzymatic activity of Atl-AM and Atl-GL by zymography .......................... 93 
 
 
vi 
3.2.8 Investigation of Atl-AM or Atl-GL and WTA interaction by acidic 
nPAGE/H+ .................................................................................................................. 94 
3.2.9 Investigation of FmtAΔ27 and Atl-AM or Atl-GL interaction with by  
acidic nPAGE/H+ ....................................................................................................... 95 
3.2.10 Investigation of FmtAΔ27 and Atl-AM interaction with by Isothermal 
Titration Calorimetry (ITC) ....................................................................................... 95 
3.2.11 Investigation of FmtAΔ27 and Atl-GL interaction with by HPLC .................. 96 
3.3 Results .................................................................................................................. 96 
3.3.1 Expression and purifications of Atl-AM ........................................................ 96 
3.3.2 Expression and purifications of Atl-GL ......................................................... 97 
3.3.3 Zymographic detection of the autolytic activity of Atl-AM and Atl-GL ....... 98 
3.3.4 Circular Dichroism (CD) spectroscopic studies for Atl-AM ......................... 99 
3.3.5 Investigation of Atl and WTA interaction by acidic nPAGE/H+ ................. 101 
3.3.6 Investigation of potential FmtAΔ27 and Atl interaction by  
 acidic nPAGE/H+ ......................................................................................... 103 
3.3.7 Investigation of FmtAΔ27 and Atl interaction by gel filtration (HPLC) ...... 105 
3.3.8 Investigation of FmtAΔ27 and Atl interaction by Isothermal Titration 
Calorimetry (ITC) ......................................................................................... 107 
3.4 Discussion .......................................................................................................... 109 
References....................................................................................................................112 
 
Chapter four: Summary and future directions 
5.1 Summary and futute directions ....................................................................... 117 
References....................................................................................................................122 
 
 
Appendices: 
Appendix A  ................................................................................................................. 123 
Appendix B  ................................................................................................................. 124 
Appendix C  ................................................................................................................. 124 
Appendix D  ................................................................................................................. 125 
Appendix E  ................................................................................................................. 126 
Appendix F .................................................................................................................. 127 
Appendix G  ................................................................................................................. 128 
Appendix H  ................................................................................................................. 129 
Appendix I  .................................................................................................................. 130 
Appendix J  .................................................................................................................. 132 
 
vii 
Appendix K  ................................................................................................................. 134 
Appendix L  ................................................................................................................. 135 
Appendix M  ................................................................................................................ 139 
Appendix N .................................................................................................................. 140 
Appendix O  ................................................................................................................. 141 
Appendix P .................................................................................................................. 143 
Appendix Q  ................................................................................................................. 144 
Appendix R  ................................................................................................................. 145 
 
viii 
LIST OF TABLES 
Table 1: catalytic residues (highlighted red) identified in the active sites of PBP/β 
lactamse fold enzymes ……………………………………………..................................15 
Table 2: Inorganic phosphate assay for WTA ………….................................................64 
Table 3: Determination of whole-cell surface charge using cyt c ....................................66 
 
ix 
LIST OF FIGURES 
Chapter one 
Figure 1.3   Schematic representation of S. aureus cell envelope of gram positive   
bacteria .................................................................................................................................4 
Figure 1.3.1.1  Chemical structure of S. aureus peptidoglycan .......................................5 
Figure 1.3.1.2  Diagram of the biosynthetic pathway of cell wall assembly ......................7 
 
Figure 1.3.3   Reactions catalyzed by D-aminopeptidase; carboxypeptidase DD; β-
lactamase and esterase .......................................................................................................12 
Figure 1.3.4.1 Path ways of S. aureus wall teichoic acid (WTA) biosynthesis ................20 
Figure 1.3.4.2  Schematic presentation of S. aureus wall teichoic acid (WTA) and 
lipoteichoic acid (LTA)......................................................................................................21 
Figure 1.4 Induction of PBP2a and penicillinase ..............................................................24 
 
Chapter two 
Figure 2.3.1.1 Activity of FmtA against PG analogue (L-Lys-D-Ala-D-Ala) by DD-
Carboxypeptidase assay in presence of WTA as an activator ...........................................47 
Figure 2.3.1.2 Investigation of potential role of WTA as an activating ligand on FmtA Δ27 
activity................................................................................................................................47 
Figure 2.3.1.3 Investigation of potential role of WTA as an activating ligand on PBP2a 
activity (control for FmtA).................................................................................................48 
Figure 2.3.1.4 Investigation of potential role of WTA as an activating ligand on PBP2a 
activity (negative control) ..................................................................................................49 
Figure 2.3.1.5 Investigation of potential role of WTA as an activating ligand on PBP4 
activity................................................................................................................................49 
Figure 2.3.1.6 Investigation of potential esterase activity of FmtA Δ27 on WTA .............50 
Figure 2.3.1.7 Investigation of potential esterase activity of FmtA Δ27 on WTA (control 
experiments) .......................................................................................................................50 
Figure 2.3.2.1 Removal of D-Ala of WTA by FmtAΔ27  ..................................................51 
 
x 
Figure 2.3.2.2 Catalytic function of FmtAΔ27 on WTA  ...................................................52 
Figure 2.3.3.1 The effect of enzyme concentration in the rate of removals of D-Ala from 
WTA ..................................................................................................................................53 
Figure 2.3.3.2 The effect of  WTA concentration in the rate of removals of D-Ala from 
WTA  .................................................................................................................................53 
Figure 2.3.4.1 Chemical structure of p-Nitrophenyl acetate (p-NPA) and p-Nitrophenyl 
butyrate (p-NPB)  ...............................................................................................................54 
Figure 2.3.4.2  Esterase activity of FmtAΔ27 against p-NPA and p-NPB by continuous 
spectrophotometric assay  ..................................................................................................55 
Figure 2.3.5.1Chemical structures of D-Ala methyl ester, L-Ala p-Nitroanilide, 
Ceforxitin and Cephalothin ................................................................................................57 
Figure 2.3.5.2 Assessment of esterase activity of FmtAΔ27 by NMR ...............................58 
Figure 2.3.5.3 Screening for potential esterase activity of FmtAΔ27on cephalothin .........59 
Figure 2.3.6 Active site (SXXK motif ) of FmtAΔ27 WT for esterase activity .................60 
Figure 2.3.7 Inhibitors studies for esterase activity of FmtAΔ27 WT ................................69 
Figure 2.3.8 1H NMR spectrum of purified WTAs of different S. aureus strains ............63 
Figure 2.3.10 Determination of whole-cell surface charge ...............................................66 
Figure 2.3.11.1 Removal of D-Ala of LTA by FmtAΔ27  ..................................................67 
Figure 2.3.11.2 Catalytic function of FmtAΔ27 on LTA ....................................................68 
Figure 2.3.12 Esterase activity of PBP4 or PBp2a on WTA by NMR .............................69 
 
Chapter Three 
Figure 3.1.1 Cleavage site of the Atl amidase (AM) and glucosaminidase (GL) .............86 
Figure 3.1.2 Genomic location of atl and domain arrangement of the bifunctional 
precursor protein ................................................................................................................87 
Figure 3.3.1 Purifications of Atl-AM ................................................................................97 
Figure 3.3.2 Purifications of Atl-GL .................................................................................98 
Figure 3.3.3 Zymographic detection of the autolytic activity of Atl-AM.........................99 
 
xi 
Figure 3.3.4 Circular Dichroism (CD) spectroscopic studies for Atl .............................100 
Figure 3.3.5.1 Investigation of Atl-AM and WTA interaction by acidic nPAGE/H+ .....102 
Figure 3.3.5.2 Investigation of Atl-GL and WTA interaction by acidic nPAGE/H+ ......103 
Figure 3.3.6  Investigation of FmtAΔ27 and Atl AM/ Atl GL interaction by acidic 
nPAGE/H+ ........................................................................................................................104 
Figure 3.3.7 Investigation of FmtAΔ27 and Atl interaction with by gel filtration  ...........106 
Figure 3.3.8 ITC analysis of the interaction between FmtAΔ27 and Atl AM ..................108 
 
 
 
xii 
LIST OF ABBREVIATIONS 
Ala – Alanine 
Asp – Aspartic acid 
Da – Daltons 
DTT – Dithiothreitol 
FPLC – Fast protein liquid chromatography 
GlcNAc – N-Acetylglucosamine 
His – Histidine 
HPLC- High performance liquid chromatography 
IPTG –Isopropyl ß-D-thiogalactopyranoside 
LB– Luria Broth 
LTA– Lipoteichoic acid 
MES – 2-(N-morpholino)ethanesulfonic acid 
MIC – Minimum inhibitory concentration 
Ni-NTA – Nickel-nitrilotriacetic acid 
NMR – Nuclear magnetic resonance 
PBS – Phosphate buffered saline 
PCR – Polymerase chain reaction 
PG – Peptidoglycan 
poly-RboP – polyribitol phosphate 
polyGroP– polyglycerol phosphate 
RPM – rotations per minute 
SDS – Sodium dodecyl sulfate 
SDS-PAGE – Sodium dodecyl sulfate-polyacrylamide gel electrophoresis  
TA – Teichoic acid 
TB–Terrific broth 
TCA – Trichloroacetic acid 
TCS – Two-component system 
TSB – Tryptic soy broth 
WT – Wild type 
WTA – Wall teichoic acid 
 
xiii 
CHAPTER ONE 
INTRODUCTION 
1.1 Staphylococcus aureus  
Staphylococcus aureus is a Gram-positive facultative anaerobic bacterium that 
causes hospital and community acquired infections which can lead to death (Diekema et 
al., 2001). This opportunistic pathogen is the leading cause of bloodstream, lower 
respiratory tract and skin/soft tissues infections. It can also cause central venous catheter-
associated bacteremia, ventilator-assisted pneumonia and serious deep-seated infections, 
such as endocarditis and osteomyelitis (Diekema et al., 2001; Schito, 2006). S. aureus is 
often responsible for toxin-mediated diseases, such as toxic shock syndrome, scalded skin 
syndrome and staphylococcal foodborne diseases (SFD). In addition to its ability to cause 
life-threatening infections in human and animal pathogen, it has a remarkable potential to 
develop antimicrobial resistance (Lindsay & Holden, 2004). 
1.2 Antibiotics and Multi drug resistance 
Penicillin G (benzylpenicillin), a β-lactam antibiotic was discovered by Sir 
Alexander Fleming, a Scottish microbiologist in 1928. Penicillin was first introduced into 
clinical practice in the early 1940s; however, resistance against penicillin in staphylococci 
was discovered in 1942. In next two decades, almost 80% of staphylococcal isolates from 
hospital and community were resistant to penicillin (Lowy, 2003; Klein et al., 2007). 
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Typically, these resistant strains produce an enzyme, known as β-lactamase which is 
responsible for inactivation of β-lactams. 
In 1959 a semisynthetic, narrow spectrum, antibiotic named methicillin was 
introduced to treat penicillin-resistant S. aureus. Unfortunately, methicillin-resistant S. 
aureus (MRSA) was identified immediately upon the introduction of methicillin into 
clinical practice (Jevons et al., 1963). Soon after the isolation of MRSA strain, several 
other countries also reported the resistance to this antibiotic where methicillin or other 
penicillinase-resistant penicillins were not yet available (Ayliffe, 1997). Resistance in 
MRSA strain was not associated with β-lactamase production but due to the expression of 
an additional penicillin-binding protein (proteins that are involve in the final stage of 
peptidiglycan synthesis), known as PBP2a or PBP2', which is imported from another 
species S. fleurettii (Tsubakishita et al., 2010). In MRSA strain, PBP2a was encoded by 
mecA gene which is a part of cassette chromosome mec (SCCmec). This protein shows 
low affinity for all β-lactam antibiotics. 
Although S. aureus strains harboring mecA are referred to MRSA, in reality, they 
are resistant to all β-lactam antibiotics (Berger-Bachi, 1994). It has been observed that in 
heterogeneous population of MRSA, expression level of PBP2a doesn’t correlate with the 
level of resistance.  As a result, other genes known as fem (factors essential for methicillin 
resistance) or aux (auxiliary factors) are proposed and identified as high level resistance 
in MRSA (Fuda et al, 2005).  Over the year, extensive use of different types of antibiotics 
has led to emergence of multidrug-resistant MRSA strains which are also referred as 
multidrug resistant strains (MDR). MDRs result from mutations in genes encoding for 
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drug target proteins and through acquisition and accumulation of many other 
determinants of resistance into the sequence of SCCmec (staphylococcal cassette 
chromosome mec, responsible for PBP2a) such as plasmids, transposons, and insertion 
sequences (Stefani and Goglio, 2010). 
Initially, MRSA strains were limited to hospital settings and are referred to 
Hospital  Acquired MRSA strains (HA-MRSA), later, a new group of MRSA strain was 
identified in community called community-acquired MRSA(CA-MRSA) and livestock 
associated MRSA (LA-MRSA) (Otter et al., 2012). HA-MRSA often lead to severe and 
life-threatening infections; however, CA-MRSA is responsible for superficial skin 
infections (Chambers and DeLeo 2009). According to recent data, more than 50% 
infections in the hospitals are caused by MRSA and this has resulted increased mortality 
and morbidity in patients with bacterial infections (Taiwo, 2009). Currently, HA –MRSA 
and CA-MRSA have outspread all over the world and are a great concern in clinical 
settings. In 2005, there were aproximately 11,406 S. aureus–related deaths reported, of 
which 6,639 were MRSA-related (Klein et al., 2007). In the recent years from 1999 to 
2005, hospitalization due S. aureus increased by 62 % and mortality related to these 
infections is very significant (Klein et al., 2007). Due to rapid increase of staphylococci 
resistant to many antibiotics, it is very important to understand the factors and signal 
mechanism related to antibiotic resistance. 
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1.3 The cell walls  
Cell wall of Staphylococcus aureus is a dynamic, semi-rigid structure (Scheffers 
et al., 2005). The composition of staphylococcal cell wall includes three major 
components: peptidoglycan, teichoic acids and surface proteins. 
Cell
 
Wall
Peptido-
glycan
 
(PG)
Surface
 
proteins
WTA
LTA
Cell
 membrane
 
Figure 1.3 Schematic representation of S aureus cell envelope of gram positive 
bacteria. 
1.3.1 Peptidoglycan  
Peptidoglycan (PG), also known as murein, is an essential and elastic component 
of the bacterial cell wall found on the outside of the cytoplasmic membrane of almost all 
bacteria.  Its main function is to resist lysis as a result of its high intracellular osmotic 
pressure. It also provides strength, relative rigidity, shape, and protection (Rogers et al., 
1980). The main structural features of peptidoglycan are linear glycan strands cross-
linked by short peptides. The glycan strands are made of repeating disaccharide units of 
N-acetylglucosamine and N-acetylmuramic acid (Rogers et al., 1980). These glycan 
chains vary in a length of 3–10 disaccharide units. A short stem peptide with the sequence 
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L-Ala-D-Glu-L-Lys-D-Ala-D-Ala is attached to the carboxyl group of each N-
acetylmuramic acid (Scheffers & Pinho, 2005). One of the characteristic features of the S. 
aureus cell wall includes attachment of a series of five L-glycine residues to the L-lysine 
component of one stem peptide to the penultimate D-Alanine of a neighboring stem 
peptide in which glycan strands are cross-linked with short peptide regions.  
O O
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H
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CH
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Figure 1.3.1.1 Chemical structure of S. aureus peptidoglycan  
General peptidoglycan (PG) monomer composed of two sugars: N-acetylglucosamine and 
N-acetlymuramic acid. Polymers are linked via the pentaglycineinterbridge from L-Lys to 
D-Ala.  
 
PG biosynthesis is a complex process which can be divided into three stages. 
Initially, water soluble precursor’s formation starts in the cytoplasm where formation of 
UDP-Mur-L-Ala-D-Glu-L-Lys-D-Ala-D-Ala (UDP-MurNAc-Penta) through a series of 
steps starting from UDP-N acetylglucosamine (UDP-GlcNAc) catalyzed by Mur enzymes. 
The finished PG precursor is an insoluble polymer outside the cytoplasmic membrane. 
The water-soluble precursors must therefore cross the membrane. To do this, a carrier 
lipid is employed. In the second stage of synthesis, UDP-MurNAc-Penta is anchored to 
inner leaflet of the cell membrane catalyzed by MraY leading to formation of lipid I 
intermediate. In last step, the transfer of N-acetylglucosamine (NAM) to Lipid I to form 
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β-(1,4) linked NAG-NAM- pentapeptide (Lipid  II) catalyzes by MurF enzyme. 
Furthermore, a pentaglycine peptide of PG precursor is synthesized in a sequential 
manner by the family of FemABX (Berger-Bachi & Tschierske, 1998; Rohrer et al., 
2003). In the final step, polymerizations of PG occur with the help of enzymes 
glycosyltransferases that catalyze the formation of linear glycan chains and 
transpeptidases that catalyze the formation of peptide cross bridges. These polymerization 
steps are carried out by some enzymes known as Penicillin binding proteins. The glycan 
chain synthesis is catalyzed by glycosyltransferase domain of penicillin-binding proteins 
in which the pyrophosphate on the MurNAc moiety of one Lipid II subunit is displaced 
by a hydroxyl group on the GlcNAc moiety of a second Lipid II molecule. As a result, 
free undecaprenyl pyrophosphates are generated, which is flipped back to the cytoplasmic 
face of the cell membrane and recharged via hydrolysis to undecaprenyl phosphate 
(Macheboeuf et al., 2006). Whereas the Lipid II pentapeptides cross-linking reaction is 
catalyzed by the transpeptidation domain of penicillin-binding proteins (Van Heijenoort, 
2001).The transpeptidation (TP) reaction results in the cleavage of the C-terminal D-Ala 
in the Lipid II pentapeptide, and the formation of an amide bond between the carbonyl 
group on the remaining alanine residue and a free amino group on the pentaglycine 
crossbridge (Rohrer et al., 2003). Some PBPs can cleave the terminal D-alanine from the 
pentapeptide using water as an electron acceptor, thereby preventing cross-linking which 
is known as carboxypeptidase activity (Van Heijenoort, 2001).  
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Figure 1.3.1.2 Diagram of the biosynthetic pathway of cell wall assembly  
Generation of cell wall precursors begins in the cytoplasm, resulting in the synthesis of 
UDP-MurNAc–L-Ala–D-iGlu–L-Lys–D-Ala–D-Ala. The PG precursor subunit is 
transferred to a lipid carrier in the membrane to generate lipid I. After further 
modification, the lipid-anchored PG precursor is translocated to the extracellular face of 
the cytoplasmic membrane. The PG precursor is subsequently incorporated into the cell 
wall by transpeptidation and transglycosylation reactions with the concomitant 
displacement of the lipid carrier. The terminal D-alanine of the wall pentapeptide is 
subject to substitution by cross-linking to other wall subunits or can be removed by the 
action of a D-alanyl–D-alanine carboxypeptidase. PEP, phosphoenolpyruvate; MN-GN, 
MurNAc-GlcNAc. 
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1.3.2 Penicillin-binding proteins  
Penicillin-binding proteins (PBPs) are ubiquitous among Gram-positive and 
Gram-negative bacteria. They are involved in the latter steps of PG biosynthesis where 
they recognize the terminal D-Ala-D-Ala unit (Van Heijenoort, 2001). Based on the 
molecular weight, PBPs are classified into two classes: high molecular mass (HMM) 
PBPs (20-120 kDa) and low molecular mass (LMM) PBPs (20-50 kDa). Both HMM and 
LMM PBPs are further categorized based on their catalytic activity. HMM PBPs are 
broadly divided into Class A (bifunctional, having both transglycosylase and peptidase 
activity) or Class B (monofunctional, only transpeptidase PBPs); whereas, LMM PBPs 
are generally DD- carboxypeptidases (monofunctional) (Ghuysen, 1991). 
HMM PBPs play a vital role in cell elongation, cell morphology, and cell division, 
thus are essential for S. aureus viability; as a result they are the lethal targets for β- lactam 
antibiotics. On the other hand, LMM PBPs are nonessential for cell viability; they often 
play important roles in S. aureus cell morphology (Macheboeuf et al., 2006). Inhibitors of 
transpeptidase (TP) interfere with cell wall synthesis by weakening the cell wall and 
eventually lead to cell death. Currently, TP inhibitors (e.g. β-lactams and glycopeptides) 
are in use as chemo-therapeutics due to low toxicity. 
All PBPs contain a common domain which uses the D-alanyl-D-alanine dipeptide 
on the C-terminal end of the Lipid II pentapeptide as a substrate for peptidation reactions. 
They harbor three highly conserved active site sequence motifs (SXXK, S/YDN, and 
K(T/S)G) (where X  resembles any variable amino acid) (Goffin & Ghuysen, 1998). The 
serine residue of the motif SXXK is central to catalysis and is involved in enzyme 
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acylation by the C-terminal alanine. For transpeptidation, an amino group from the 
pentaglycine bridge serves as the proton acceptor of the reaction, resulting in the cross-
linking of two stem peptides from PG strands. On the other hand, carboxypeptidation can 
further results in a permanently shortened stem peptide (4 amino acids) that is unable to 
be cross-linked. Finally, the proton is back-donated to the active site, breaking the acyl-
enzyme bond and recharging the PBP for a new reaction (Ghuysen, 1991) (Figure 1.3.1). 
Though PBPs are named based on their binding and catalytic hydrolyzing activity 
on β-lactam along with in-vitro transpeptidation/carboxypeptidation activity with 
synthetic dipeptides, independently of its function in the cell; no concrete evidence for 
direct PG biosynthesis participation has been reported for some PBPs (e.g. Streptomyces 
K15 and R61 transpeptidases). Moreover, precise cellular functions of Streptomyces K15 
and R61 transpeptidases are still unknown (Macheboeuf et al 2006). 
1.3.3 Penicillin-recognizing enzymes  
PBPs are a large family of cell wall biosynthetic enzymes which are ubiquitous 
among all gram-positive and gram-negative bacteria with the exception of mycoplasmal 
species due to lacking of PG (Macheboeuf et al., 2006).  PG is a major constituent of the 
bacterial cell wall where D-amino acids are found and these D-residues are synthesized 
by the help of a racemase that converts L-amino acids to D-amino acids. β-Lactam 
antibiotics interfere with PG biosynthesis by inhibiting the D-ala-D-ala transpeptidation 
reaction to form a penicilloyl- enzyme complex with a long half-life, this results in cell 
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lysis by preventing the synthesis of PG. The active site serine residue plays a key role for 
this catalysis.  
However, aside from D,D-carboxypeptidases/transpeptidse, a large group of 
structurally similar protein family with an active-site serine at SXXK motif can recognize 
penicillin. These proteins are known as “penicillin-recognizing active-site serine enzymes 
(PRPs)” (Asano et al., 1996). These active-site serine proteins have been shown to 
catalyse a wide variety of substrates and reactions. They include  β-lactamases  which 
hydrolyze amide bond of β-lactam antibiotics, DD carboxypeptidase/transpeptidase which 
catalyze the removal of last D-Ala from the PG precursor),  esterase which hydrolysis of 
esterase bond,  D,L-endopeptidases which eleave DL bonds in stem peptides,  D-
aminopeptidases  hydrolyze the removal of D-Ala from N-terminus of peptide (Asano et 
al., 1989; Bourne et al., 2001; Ghuysen, 1991; Komeda and Asano, 2000, Wagner et al., 
2002). A brief description of above enzymes is provided below. 
DD-Carboxypeptidase (EC 3.4.17.14) catalyzes a step in cell wall biosynthesis by 
hydrolyzing D-Ala- D-Ala bonds using a reactive site serine residue (Asano et al., 1989). 
Acting on pentapeptide muropeptides, it thus controls the extent of crosslinking between 
adjacent PG macromolecules. Most of the low molecular weight PBP’s are referred to 
DD-carboxypeptidase. Representative substrate for these carboxypeptidase 
/transpeptidase (PBPs) is Nα,Nε-Diacetyl-Lys-D-Ala-D-Ala which is an analogue of short 
stem peptide with the sequence: L-alanyl-D-isoglutaminyl-L-Lysyl-D-Alanyl-D-alanine 
which is attached to each N-acetylmuramic acid in PG (Scheffers & Pinho, 2005) (Fig 
1.3.1).  
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D-aminopeptidase (DAP) (EC 3.4.11.19) purified from Ochrobactrum anthropi 
which can hydrolyse peptides with a free N-terminal D-amino acid has shown various β-
lactam inhibition and share ∼25% sequence identity with the R61 DD-carboxypeptidase 
and the class C β-lactamases. The sequence motif SXXK which is conserved among all 
penicillin-recognizing proteins is also essential for D-aminopeptidase activity (Asano et 
al., 2000). Delmarcelle et al. has illustrated a specificity inversion of D-aminopeptidase to 
D,D-carboxypeptidase via a loop deletion (the 476–486 γ-loop of domain C was replaced 
by a single glycyl residue) along with site-directed mutagenesis (Asn275Arg mutation), 
which is an unique example of drastic specificity change in the serine penicillin-
recognizing proteins (Delmarcelle et al., 2005). DAP is very specific to peptides with free 
D-amino acid at NH2 terminus D-Ala-L-Ala-LAla (Asano et al. 1992); However, D-Ala- 
paranitroanilide can be used as a substrate to assess the D-aminopeptidase activity. As yet, 
biological role of these enzymes are still not clear (Remaut et al., 2001).  
β-Lactamases (EC 3.5.2.6) are members of penicillin-recognizing active-site 
serine enzymes. They hydrolyze all classes of β-lactam antibiotics (Asano et al., 2000). 
These enzyme catalyses the irreversible hydrolysis of the amide bond of the β-lactam ring, 
thus yielding biologically inactive products. All β-lactamases harbor the active-site 
SXXK motif and follow a catalytic pathway similar to DD-peptidases where active-site 
serine resides close to the amino terminus of the protein. However, the deacylation step of 
the penicilloyl-enzyme complex formed after a nucleophilic attack of the active-site Ser 
of β-lactamases to the carbonyl carbon of the amide linkage is much faster than DD-
carboxypeptidase (Davies et al., 1994). 
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Figure 1.3.3 Reactions catalyzed by A. transpeptidase and DD-carboxypeptidase; B. 
D-aminopeptidase;  C. β-lactamase and D. Esterase; Modified from Asano et al.1992. 
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Esterases (EC 3.1.1.) represent a diverse group of hydrolases ubiquitous in 
animals, plants, insects and microorganisms (Wagner et al., 2002). The esterases 
hydrolyse ester bonds and generate an acid and an alcohol as metabolites. The 
physiological role of a large number of esterases form a diverse sources is unknown. 
Esterases have a diversified preference for substrates and specificity; these include 
carboxylic, thio, phospho and other types of esters. Esterases are responsible for 
metabolism of several classes of exogenous and endogenous compounds (e.g hydrolysis 
of acetylcholine) (Isabela Reis Montella et al. 2012). Carboxylesterases catalyze the 
hydrolysis of short chain aliphatic and aromatic carboxylic ester compounds. Based on 
the catalytic activity on substrates of different acyl chain lengths, carboxylester 
hydrolases are classified as esterases or lipases. Esterases act preferentially on water-
soluble short-chain fatty acids; on the other hand lipases display utmost activity towards 
water-insoluble long chain triglycerides (Tsujita et al., 1990). Based on the sequence 
homology, carboxylesterases are classified into eight families (families I–VIII) (Arpigny 
JL et al., 1999) . Superfamily VIII esterases have very high sequence similarity to class C 
β- lactamase and penicillin binding proteins (PBP). Family VIII esterases also represent a 
poorly characterized esterase family (Rashamuse et al., 2009). Family VIII 
carboxylesterases are structurally dissimilar from other carboxylesterases. Their modular 
structure is composed of a small helical domain and a α/β hydrolase domain that is similar 
of class C β-lactamases (Nacke et al., 2011). The nucleophilic serine residue in family 
VIII carboxylesterases occurs in the S-X-X-K motif, similar to class β-lactamases, rather 
13 
 
than the G-X-S-X-G motif. These enzymes have approximately 337 to 443 amino acids 
and a molecular mass of 36.9 to 48.6 kDa (Nacke et al., 2011).  
Carboxylesterases, β-lactamases and PBPs share a two-step serine hydrolase 
mechanism that consists of two successive nucleophilic attacks by the serine residue and 
a water molecule. Due to the fact that family VIII of carboxylesterases have features 
similar to β-lactamases and PBPs, these enzymes might be expected to exhibit β-
lactamase activity or DD-peptidase activity. Indeed few carboxylesterases have been 
reported to show β-lactamase activity (Wagner et al., 2002, Cha et al., 2013); however, as 
per my knowledge, no literature review in DD-carboxypeptidase activity has been 
reported. 
According to Wagner et al. Esterases, D-alanyl-D-alanine-peptidases (DD-
peptidases) and β-lactamases can be grouped into two distinct classes of hydrolases - one 
class comprised of esterases and the other one comprised of β-lactamases and DD-
peptidases based on different folds and topologically unrelated catalytic residues. Due to 
similar chemical reactivity of esters and β-lactams towards hydrolysis scientists are 
interested to know the structural features that prevent esterases from displaying β-
lactamase or PBP activity and vice versa (Wagner et al., 2002). Prediction studies indicate 
that proteins of the same family of penicillin-recognizing active-site serine enzymes may 
have evolved from a common ancestor (Ghuysen, 1991; Valegard et al., 2013). Based on 
their evolutionary distance, they may have acquired different amino acid sequences along 
with distinct functionalities and specificities while conserving the same polypeptide 
scaffolding (Ghuysen, 1991). 
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 Table 1: catalytic residues (highlighted red) identified in the active sites of PBP/β-
lactamase-fold enzymes. Classification based on Sauvage et al. (modified from 
Valegard et al. 2013) 
Class/Type/ Subtype  Representative Protein  
PDB 
code  
Motif one  Motif two  Motif three  
(SXXK)  ([S/Y]DN)  KTG   
β-Lactamase Class A  TEM-1  1M40   Ser70/ Lys73  Ser130  Lys234  
β-Lactamase Class D  OXA10  1E3U   Ser67/ Lys70  Ser119  Lys214  
β-Lactamase Class C  P99  1BLS   Ser64/ Lys67  Tyr150  Lys315  
PBP Class C / Type-5  PBP5  1Z6F  Ser44/Lys47  Ser110  Lys213  
PBP Class C / Type-4  R39 DD-peptidase  1W79  Ser
49/Lys52  Ser298  Lys410  
PBP Class B / Type-B1  PBP2a  1VQQ   Ser403/Lys406  Ser462  Lys597  
PBP Class A / Type-A3  PBP1a  2C6W   Ser370/Lys373  Ser428  Lys557  
PBP Class C /Type-7  K15 DD-peptidase  1SKF   Ser
25/Lys38  Ser96  Lys213  
PBP Class C / Type-
AmpH  
R61 DD-
peptidase/ 
transpeptidase 
3PTE   Ser62/Lys65  Tyr159  His298  
D-Aminopeptidase  DAP  1EI5   Ser62/Lys65  Tyr153  His287  
D-Amino acid amidase  DAA  2DRW   Ser60/Lys63  Tyr149  His307  
Esterase family VIII  EstB  1CI8  Ser75/ Lys78  Tyr133  Tyr181  
Nylon amidase  NylC  1WYC   Ser112/Lys115  Ser217  Tyr215  
Esterase family X  ORF12  2XEP  Ser173/ Lys176  Ser234  Lys375  
Unknown FmtA    Ser 
63/ Lys 65 & 
Ser 127/ Lys130 Tyr
211   
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1.3.4 Teichoic acids 
Teichoic acids are an important component of cell wall in Gram-positive bacteria. 
They play vital roles in bacterial survival under unfavorable conditions and in other basic 
cellular processes (Weidenmaier and Peschel, 2008). In S. aureus, these constitutively 
produced anionic glycopolymers can be classified into two types: wall teichoic acids, 
(WTA); which are usually covalently connected to PG and extend through and beyond 
cell wall and lipoteichoic acids (LTA); which are usually connected to cytoplasmic 
membrane and extend from cell surface into PG layers. Most of the Gram-positive 
bacteria produce both teichoic acids (Swoboda et al., 2010). 
S. aureus WTAs consist of 1, 5-linked repetitive poly ribitol phosphate attached to 
N-Acetylmuramic acid (MurNAc) of PG via a disaccharide linkage unit to consisting of 
N-Acetylglucosamine (GlcNAc), MurNAc and two to three glycerol phosphate residues. 
WTA repeating polymer is composed of 11–40 poly ribitol phosphate (PolyRboP) 
repeating units in most S. aureus strains (Brown et al., 2008). S. aureus produces 
polyRboP WTAs whereas B. subtilis produces either polyRboP or polyGroP (poly 
glycerol phosphate) depending on strains (Brown et al., 2012). On the other hand, LTAs 
consist of 1,3-linked repetitive polyol (glycerol) phosphate repeating units attached to the 
cytoplasmic membrane via a glycol lipid anchor (diacylglycerol). LTA repeating 
backbone is composed of repeating units of polyGroP (Figure 1.3.4.2). 
Teichoic acids structural diversity exhibit due to tailoring modifications on the 
repeating polymers. The hydroxyls groups from repetitive polyol (ribitol or glycerol) 
phosphate in teichoic acids can be modified. In WTA, cationic D-alanine esters 
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modifications are found at the second position of ribitol where as sugars, mono- or 
oligosaccharides, mainly glucose or GlcNAc are incorporated at the fourth position of 
ribitol (Brown et al., 2013). These modifications are commonly observed in all S. aureus 
strains. Recently, it has been reported that modification of WTA by GlcNAc could be 
fully α-glycosylated, fully β-glycosylated or mixture of both. However, anomeric 
configuration of the glycosidic linkage to the repeat unit of ribitol varies, sometimes in 
the same cell (Brown et al., 2013). Recently, it has been demonstrated that glycosylation 
of WTA may contribute to methicillin resitance (Brown et al., 2012). Although there is 
structural similarity between WTA and LTA, most of their biosynthesis follows different 
pathways and precursors (Xia and Peschel, 2008). Usually, modifications of LTA are 
observed at the second position of the glycerol, where hydroxyl group is substituted with 
D-alanyl ester or a-GlcNAc (Fischer, 1988). 
Characterization of the WTA biosynthetic pathway was challenging due to the 
attachement of the precursor undecaprenyl phosphate (C55-P) lipid chains in the substrate 
which is difficult to handle. Biosynthesis of WTA starts in the cytoplasm catalyzed by tag 
family of enzymes in S. aureus. Genes involved in conserved steps like poly-Gro-P and 
poly-Rbo-P WTA biosynthetic pathways are referred as ‘tag’ while ‘tar’ is used only for 
those genes that are additionally required for incorporation of Ribitol phosphate units 
(Xia and Peschel,2008). WTA biosynthetic pathway can be divided into five steps and 
uses an undecaprenyl phosphate (C55-P) which is also known as bactoprenyl phosphate 
(Xia and Peschel, 2008). The first step of WTA biosynthesis is initiated by disaccharide 
linkage unit by the enzymes TagO and TagA which transferr GlcNAc-1-phosphate and a 
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ManNAc, respectively, from UDP-activated precursor to C55-P. Further, 
phosphoglycerol units are attached to the WTA precursors with the help of TagB and 
TarF. Incorporation of repeating units of poly ribitol phosphate into WTA is mediated by 
a group of polymerizing enzymes (Xia and Peschel, 2008). With the help of the 
transporter TagGH, it is flipped to the external surface of the cytoplasmic membrane 
(Brown et al., 2008; D’Ellia et al., 2009) (Figure 1.3.4.1).  
Prior to the WTA export to the cell surface, WTA glycosylation occurs, where 
RboP WTA α-O-GlcNAc modifications are installed by TarM and β-O-GlcNAc 
modifications are installed by TarS. Another major modification of WTA, D-alanylation 
occurs in the cell surface. Four enzymes encoded by the dltABCD operon participate in 
the esterification of hydroxyl group of ribitol with D-Ala. D-Ala biosynthesis starts in the 
cytoplasm where DltA activates D-alanine as an AMP ester and then transfer the 
aminoacyl adenylate to DltC. It is believed that this is transported to the cell surface and 
attached to WTA with the help of DltB and DltD. Though it has been shown that both 
LTAs and WTAs require the same enzymes (DltABCD) for incorporation of D-alanine, 
the enzymology of these biosynthetic process remains to be elucidated (Xia et al., 2010; 
Brown et al., 2013; Reichmann et al., 2013). 
Teichoic acids play an important role in cell wall based on their location, 
abundance and nature. However, the actual cellular functions are poorly understood. 
Generally, TAs are known to protect Gram-positive bacteria against harmful molecules 
and environmental stresses, control enzyme activities in the cell surface, control cation 
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concentrations in the cell envelope and  bind to receptors (toll-like receptors 2 and 4) and 
assist bacteria to attach to the surfaces (Weidenmaier et al.,2003; D’Elia et al., 2009). 
Due to teichoic acids anionic nature, they bind cations and thus play a role in 
cation homeostasis (Marquis et al. 1976). However, most TAs display zwitterionic 
properties because of the presence of negatively charged phosphate groups and tailoring 
D-alanine residues on the repeating units, which have a positively charged amino group 
(Weidenmaier and Peschel, 2008). The dltA gene deletion removes D-alanine esters from 
both LTAs and WTAs. Recent studies on dltA deletion mutant have shown that absence 
of D-alanyl esters increases the overall negative cell surface charge.  Controlling cell 
surface charges by altering the amount of teichoic acid D-alanylation is a very important 
mechanism by which Gram-positive bacteria can protect themselves against host-defense 
mechanism (Kristian et al., 2005).  
D-alanine deficient S. aureus has shown an increased susceptibility to 
endopeptides: lysostaphin and lysozyme, to phagocytes and to neutrophil killing (Collins 
et al., 2002). Furthermore, a reduction of D-alanylation in teichoic acid resulted in 
increased susceptibility to glycopeptide antibiotics and to certain cationic antimicrobial 
peptides (CAMPs) (Collins et al., 2002). The amount of D-alanyl esters and the presence 
of WTAs influence bacterial interactions with various surfaces (Neuhaus et al., 2003). 
WTA-lacking cells have shown reduced capability to form biofilms (Gross et al., 2001). 
Moreover, strains lacking D-alanine showed decreases biofilm formation and bacterial 
adhesion to plastic and glass surfaces. A decreased in D-alanine content in WTA could 
result in an increased of negative cell surface charge creating an increased repulsive force 
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between bacteria and a surface which could result in reduced adherence (Holland et al., 
2011). Reduced cationic binding capacity of WTA could result due to the masking of 
negative charge of WTA by D-alanylation.  
It has been hypothesized that ion binding to WTAs could help prevent fluctuations 
in osmotic pressure between the inside and the outside of the cell (Heptinstall et al., 1970). 
It has been demonstrated that the dlt operon could be a target for antivirulence agents as 
strains lacking teichoic acid or D-alanine esters are strongly attenuated in animal infection 
models (Weidenmaier et al., 2003). Given the importance of D-alanylation in teichoic 
acids they remain a potential target for prospective drug development. 
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Figure 1.3.4.1 Path ways of S. aureus wall teichoic acid (WTA) biosynthesis  
CDP, cytidyldiphosphate; Glc, glucose; GlcNAc, N- acetylglucosamine;; ManNAc, N-
acetylmannosamine; MurNAc, N-acetylmuramicacid; UDP-Glc, uridine-5’-diphosphate-
glucose; UDP-GlcNAc, uridine-5’-diphosphate-N-acetyl-glucosamine; UDP-ManNAc, 
uridine-5’diphosphate-N-acetyl-mannosamine. 
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Figure 1.3.4.2 Chemical structure of S. aureus wall teichoic acid (WTA) and 
lipoteichoic acid (LTA) 
A) Wall teichoic acid (WTA) linkage unit is composed of N-acetylglucosamine (GlcNAc) 
and N-acetlymuramic acid (MurNAc) followed by two to three D-alanylated glycerol 
phosphate residues. The WTA backbone on average ranges from 15 - 40 units of ribitol 
phosphates (substituted with D-Ala and/or α- or β- GlcNAc). B) Lipoteichoic acid (LTA) 
linkage unit is composed of a diacylglycerolconnected to disaccharide. The LTA 
backbone on average is 18 to 50 units of glycerolphosphates (substituted mainly with D-
Ala). 
 
1.4 Methicillin resistance S. aureus (MRSA)  
S. aureus has four major penicillin-binding proteins (PBPs): PBP1, PBP2, PBP3 
and PBP4 (Machebouf et al., 2006). Out of these, PBP1, PBP3 and PBP4 show 
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monofuctional transpeptidase activity, which can cross link the pentaglycine bridge to 
other stem peptide containing terminal D-ala-D-ala (Atilano et al., 2010). β-lactam 
antibiotic inhibits penicillin-binding proteins (PBPs), specifically transpeptidase activity 
that are involved in the synthesis of PG, an essential mesh-like polymer that surrounds the 
cell. This then leads to death of the bacterial cell due to osmotic instability or autolysis 
(Stapleton, 2002). After penicillin resistance by β-lactamase in S. aureus was observed, a 
new β-lactam antibiotic name Methicillin was introduced. However, S. aureus became 
resistant to methicillin and other β-lactam antibiotics through the expression of a foreign 
PBP, PBP2a that shows low affinity for methicillin. 
Methicillin resistant Staphylococcus aureus (MRSA) harbour a large mobile 
genetic element called staphylococcal cassette chromosome, mec (SCCmec) which was 
acquired through the horizontal transfer. It carries the mecA gene that encodes for an 
alternative penicillin binding protein, PBP2a that has reduced affinity for β-lactams. This 
allows MRSA strains to grow in antibiotic concentrations when all native PBPs are 
inactivated (Ito et al., 1999). Expression of PBP2a is inducible through a signal 
transduction system encoded by genes mecRI and mecI on the SCCmec genetic element, 
and involves an integral membrane protein sensor (MecR1) and a transcriptional 
repressor (MecI). MecRI, a receptor protein contains an extracellular penicillin-binding 
domain that undergoes a conformational change inducing autocleavage of the intracellular 
protease domain upon the binding of β-lactams. Further, de-repression of mecA 
transcription as well as the mecI-mecRI operon starts by the cleavage of MecI by active 
MecRI (Mallorqui-Fernandez et al., 2004). Besides the regulation of mecA expression by 
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its cognate MecI and MecRI regulators, it can also be regulated structurally and 
functionally by β-lactamase regulators, BlaI and BlaRI (champbers, 1997) (Figure 1.4).  
Apart from methichillin resistance, S. aureus has developed resistance to other 
class of semisynthetic β-lactamase-insensitive β-lactams: oxacillin and nafcillin by using 
the same mechanism of acquired mecA gene described above. The expressed PBP2a has a 
molecular mass of 78 kDa enzyme and consists of a transpeptidase domain and a non-
penicillin binding domain (Goffin & Ghuysen, 1998). Compare to other native PBPs that 
synthesize highly cross-linked peptidoglycan, PBP2a, emerged to be a rather poor active 
enzyme in-vitro (de Jonge et al., 1993). It has been shown that the cooperative 
functioning of PBP2A and the penicillin-insensitive transglycosylase (TGase) domain of 
PBP2 is required for high-level of resistance (Pinho et al., 2001). Recent crystallographic 
studies have revealed that PBP2a has an allosteric binding domain which can control the 
substrate entry to active site by conformational changes (Otero et al., 2013). 
To treat MRSA associated infections, Vancomycin, a glycopeptide was introduced 
in hospitals. Unfortunately, it didn’t take long for S. aureus to exhibit resistance or 
reduced susceptibility to glycopeptides. Vancomycin resistant strains follow an 
alternative pathway for PG biosynthesis where these strains synthesize D-Ala-D-Lac 
instead of D-Ala-D-Ala in the stem peptides which are the binding site for vancomycin. 
In addition to alteration of stem peptides, other mechanisms of over production of PG 
precursors also contribute to antibiotic resistance. Based on the vancomycin 
susceptibilities, vancomycin-resistant S. aureus are categorized into three classes: 
vancomycin-intermediate S. aureus (VISA), heterogenous vancomycin-intermediate S. 
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aureus (hVISA), and high-level vancomycin-resistant S. aureus (VRSA) (Howden et al., 
2010). VRSA shows fully vancomycin-resistance due to acquisition of the vanA gene 
from vancomycin-resistant enterococci.  In case of VISA strains, abnormally thickened 
cell wall was observed. Unfortunately, it didn’t take long to spread worldwide the 
resistance phenotype after the first report of VISA and hVISA from Japan (Hiramatsu et 
al., 1997).  
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Figure 1.4 Induction of PBP2a and penicillinase  
Two pathways regulate PBP2a (mecA) and penicillinase (blaZ) production. MecI 
represses transcription of mecA and mecR1-mecI. Upon binding of an inducer to the 
sensor domain of MecR1, the sensor transducer is autocatalytically cleaved, activating the 
intracellular zinc peptidase domain, which in turn cleaves the MecI repressor, thereby 
relieving mecA and mecR1-mecI repression. In analogy, BlaI represses blaZ, and 
induction occurs through BlaR1. While the repressors are interchangeable and can 
recognize both the mec and bla regulatory regions, cleavage of the repressors by BlaR1 or 
MecR1 is specific. 
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1.5 Factors affecting methicillin resistance levels 
In MRSA, PBP2a plays a major role for resistance. Methicillin resistance in S. 
aureus is classified into two categories: homogeneous and heterogeneous. The level of 
resistance varies extremely among strains. Non-consistency in the phenotypic expression 
of antibiotic resistance is known as heteroresistance (Tomasz et al., 1991). The ability of 
heterogeneous S. aureus population to produce PBP2a is essential for their methicillin 
resistance but there is no correlation between cellular concentration of PBP2a and the 
observed difference in resistance levels (Berger-Bachi & Rohrer, 2002). Hence, 
involvement of additional factors from chromosomal genes is proposed for optimal 
methicillin resistance. In addition to mecA, several other accessory factors were identified 
for high level of methicillin resistance in S aureus which were named fem genes (for 
factor essential for methicillin resistance) or aux genes (for auxiliary genes) (Chambers, 
1997). These series of fem and aux genes: llm, fmt, pbpD, lytH, dlt operon, VraSR and 
sigB were identified as factors which are independent of the mec locus and affect the 
methicillin resistance level. Most of these factors are considered to be associated with PG 
biosynthesis directly or indirectly (Schneider, 2004). However, precise functions of most 
of these genes are still not well understood.  
1.5.1 FmtA (a factor which affects methicillin resistance and autolysis in presence 
of Triton X-100)  
FmtA was first identified as a methicillin resistance factor by Komatsuzawa’s 
research group in Japan in 1997.  Inactivation of fmtA has been shown to affect the 
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sensitivity of MRSA strains result in decreased level of highly cross-linked PG in the 
presence of Triton X100 (Komatsuzawa et al., 1999). Transcriptomics studies of fmtA 
have reported to be involved in cell wall stress stimulon. Cell wall stress stimulon is a 
group of genes that is commonly induced when treated with cell wall active antibiotics, 
such as β–lactams. Transposon insertions (Tn551) in fmtA resulted in decreased biofilm 
formation and reduced attachment of wall teichoic acids to cell wall (Boles et al., 2010). 
Dr.Golemi-Kotra’s lab showed that FmtA is capable of biding with fluroscent 
labeled penicillin and can form stable acylenzyme species; however, the interaction is 
weak (Fan et al, 2007). Recently, this group reported that SarA, a global regulatory 
transcription factor is responsible for regulation of fmtA. SarA is also known to be 
involved in methicillin resistance and regulation of many virulence factors (Zhao et al., 
2012). In another study by a former PhD graduate student, Dr.Aneela Qamar revealed that 
FmtA interacts with WTA and localizes in cell division septum (Qamar and Golemi-kotra, 
2012). However, the biological functions of FmtA remain to be elucidated.  
  
26 
 
1.6 Aims of Research 
S. aureus is one of the major reasons for mortality and morbidity due to hospital- 
and community-acquired infections. Due to extensive use of antibiotics, S. aureus has 
acquired resistance to β-lactams. Methicillin, a β-lactam antibiotic was introduced to 
overcome the penicillin-resistance of S. aureus, but subsequently resulted in resistant 
strains soon after its introduction into therapeutics. Moreover, Methicillin-resistant S. 
aureus (MRSA) strains have become resistant to almost all the clinically used antibiotics 
and this is a serious threat to all over the world.  Besides mecA gene, which encodes 
PBP2a, many other genes are recognized for phenotypic expression of methicillin 
resistance. FmtA is one of the methicillin resistance factors, connected to biofilm 
formation and cell wall synthesis. To date, the biological function of FmtA is not well 
understood. It has been shown in-vitro that FmtA has very low carboxypeptidase activity 
and can interact with WTA. Understanding of FmtA’s functional role and mechanism 
towards methicillin resistance would provide insights into development of novel 
antibacterial molecules. Hence the aim of my thesis research work was to characterize the 
functions of FmtA by investigating potential role of WTA as an activator ligand for low 
carboxypeptidase activity of FmtA, which is described in chapter two. Moreover, 
potential protein-protein interaction activity of FmtA and cell wall associated protein such 
as AtlA are addressed in chapter 3.  
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CHAPTER TWO 
INTERACTION OF FMTAΔ27 WITH WTA 
2.1 Introduction 
The peptidoglycan (PG) is composed of repeating units of the glycan chains made 
up of the alternating amino sugars N-acetylglucosamine and N-acetylmuramic acid. Stem 
pentapeptides (L-Ala-D-Glu-L-Lys-D-Ala-D-Ala) are attached to the carboxyl group of 
each N-acetylmuramic acid, and interpeptide bridges (pentaglycines, made up of glycine 
residues) connect the lysine component of one stem peptide to the penultimate D-Ala of a 
neighboring stem peptide where the glycan strands are cross-linked with short peptide 
bridges (Vollmer et al. 2008). 
Gram-positive bacteria synthesize peptidoglycan at the interface of the membrane 
and the inner layer of the cell wall, where new peptidoglycan strands are assembled and 
cross-linked by PBPs (Silhavy et al., 2010). PBPs can exhibit transglycosylase,   
transpeptidase or DD-Carboxypeptidases activity (Sauvage et al., 2008). Both 
transpeptidase and carboxypeptidase activities of PBPs occur at the D-Ala-D-Ala 
terminus of a murein precursor. Antibiotics having β-lactam ring inactivate 
transpeptidases by reacting with the active site nucleophile of transpeptidases. S. aureus 
has four native PBPs and based on their molecular weight they are named as PBP1, PBP2, 
PBP3 and PBP4, which differ in their cell wall biosynthetic functions and affinity to β-
lactam antibiotics. In addition, a non native PBP2a is observed in methicillin resistance S. 
aureus (MRSA). PBP1 and PBP3 are mono-functional transpeptidase whose function is 
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primarily related to cell division (Wada et al., 1998). PBP2 is the only bifunctional PBP 
in S. aureus shows transpeptidase as well as trasglycosylase activity and important for 
viability in S. aureus (Pinho et al., 2001). PBP4 is responsible for higly cross linked 
peptidoglycans (Leski et al., 2005). PBP2a in methicillin resistance strain shows 
transpeptidase activity and low affinity towards β-lactams (Pratt, 2008; Sauvage et al., 
2008). Beside PBP2a, other factors named as fem (factor essential for methicillin 
resistance) and aux (auxilary) can affect methicillin resistance level in S. aureus 
(Komatsuzawa et al., 1999). 
Teichoic acids are long anionic polymer composed of ribitol or glycerol 
phosphates appear to extend to the layers of the peptidoglycan. Teichoic acid that are 
covalently attached to peptidoglycan are known as the Wall Teichoic Acids (WTA) where 
as teichoic acids that are anchored to the head groups of membrane lipids are referred as 
Lipoteichoic Acids (LTA) (Neuhaus et al., 2003). 
It is believed that attachment of WTA to peptidoglycan occur during septum 
formation of the cell division cycle (Formstone et al., 2008; Atilano et al., 2010). In gram-
positive bacteria, WTAs are highly abundant in the cell walls (Matias and Beveridge, 
2007). The structures of WTA vary widely between bacterial to bacteria and often even 
between species. Teichoic acid biosynthesis in S. aureus is discussed in chapter one. In S. 
aureus, WTA D-alanyl residues are attached to second position of ribitol contribute 
positive charge to WTA (Swoboda et al., 2010). The amount of D-Ala ester in ribitol 
phosphate varies a lot and depends on environmental conditions such as pH, salt 
concentrations and temperature (Paschel et al., 1999). On the other hand, WTA sugar 
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substituents are generally enclosed at the fourth position of ribitol and do not appear to 
alter with changes in the cellular environment (Brown et al., 2012). Both WTA and LTA 
show zwitterionic properties because of the presence of negatively charged phosphate 
groups and additional positively charged amino groups of D-Ala residues on the repeating 
units (Neuhaus and Baddiley, 2003).  
The FmtA protein was first identified in a methicillin resistant S. aureus (MRSA) 
by using a transposon mutagenesis (Tn551 insertion of COL strain) screening technique 
by Komatsuzawa et al. It has been identified as a part of the core cell wall stimulon and is 
known to be involved in methicillin resistance of S. aureus (Komatsuzawa, et al. 1997; 
Komatsuzawa, et al. 1999). Inactivation of fmtA in MRSA resulted in enhanced autolysis, 
increased sensitivity to β-lactams and decreased level of highly cross-linked 
peptidoglycans. Expression of fmtA was found to be upregulated in the presence of cell 
wall inhibitors (Komatsuzawa, et al. 1997; McAleese F, et al. 2006, Utaida et al., 2003). 
It has been speculated that FmtA might be involved in peptidoglycan biosynthesis under 
antibiotic-induced cell wall stress conditions (Xin et al., 2007). Analysis of the primary 
structure of FmtA reveals that of carries two of the three conserved motifs of PBPs, 
SXXK and S(Y)XN and absence of the third conserved motif KTG. Dr. Golemi-Kotr’s 
group showed that FmtA binds to β-lactams and forms a covalent species. However, this 
interaction is vey weak (Xin et al., 2007). 
Recently, Dr. Golemi-Kotra and co-worker demonstrated that FmtA has very low 
DD carboxypeptidase activity on Nα,Nε-diacetyl-L-Lys-D-Ala-D-Ala peptide, which is a 
surrogate of peptidic moiety of PG precursor. FmtA interacts with WTA and localizes in 
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the cell division septum, most likely by binding to the cross wall. Furthermore, FmtA can 
alter the autolysis and biofilm formation which requires the presence of WTA and 
depends on the concentration of FmtA (Qamar and Golemi-kotra, 2012). 
Although, it was proposed that FmtA could be a novel penicillin binding protein, 
its precise function was not demonstrated. Several hypotheses were raised for FmtA’s low 
DD carboxypeptidase activity. It was proposed that FmtA may require a ligand to become 
active in the periplasmic space of S. aureus. Here in, we probed whether WTA could 
serve as an activator of FmtA activity. 
2.2 MATERIALS AND METHODS 
2.2.1 Materials and chemical  
Growth media were purchased from EMD Bioscience. Enzymes (trypsine, DNase, 
RNase, horseradish peroxidase, D-amino acid oxidase) and chemicals (Tris, Cytochrome 
C, LTA) were purchased from Sigma (Oakville, Canada) and Thermo-Fisher (whitby, 
Canada); unless otherwise stated.  Amplex Red (AR) was purchased from Molecular 
Probes, Inc. 
2.2.2 Expressions and purifications of FmtA Δ27 wild type and mutant proteins 
Expressions of FmtAΔ27 wild type and mutant proteins were performed as 
described by Xin Fan and Dr. Aneela Qamar (Fan, 2006; Qamar, 2011). Briefly, 1 ml of 
overnight seed culture of E. coli BL21 (DE3) containing pET24a (+):: fmtAΔ27 or the 
mutant variants were used to inoculate 800 mL of terrific Broth medium supplemented 
with kanamycin (30 µg/mL). A glycerol stock of BL21(DE3), containing pET24a (+):: 
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fmtAΔ27 or the mutant variants, was used to start a seed culture which was grown 
overnight at 37°C in 5 mL Luria Bertani medium supplemented with kanamycin (30 
µg/mL). A 1 mL overnight seed culture was used to inoculate 800 mL of Terrific Broth 
medium supplemented with kanamycin (30 µg/mL), 0.4 M D-sorbitol; and 2.5 mM β-
betaine. The inoculated medium was grown at 37°C, 180 rpm, until OD600nm reached 0.6 
to 0.8, at which time protein expression was induced by addition of Isopropyl β-D-
thiogalactopyranoside at a final concentration of 1 mM. Expression of protein was carried 
out for 16 hours at 25°C, 120 rpm and the cells were harvested at 7000 x g for 20 min at 
4°C. Resulting pellets were frozen at -80°C if subsequent purification steps were not 
carried out on same day. 
Purifications of FmtAΔ27 wild type and mutant proteins were performed as 
described by Xin Fan and Dr. Aneela Qamar with few modifications (Fan, 2006; Qamar, 
2011). All purification steps were carried out at 4°C. Harvested cells were resuspended in 
50 mM sodium phosphate buffer, pH 7.2. Sonication (5 cycles of 1 min; 30% power, 60% 
pulse) was used to liberate the protein and centrifugation at 21000 x g for 60 min was 
carried out to remove cell debris. The resulting supernatant was applied to a Sp-Sepharose 
column (80 mL column volumes) pre-equilibrated with sodium phosphate buffer, pH 7.2. 
The target protein (FmtAΔ27 or mutants) was eluted at 60-70% of a liniear gradient of 0 to 
1 M sodium chloride in 50 mM sodium phosphate buffer, pH 7.2. The fractions 
containing the target protein were combined and concentrated to 4 mL and loaded to a gel 
filtration column (HiPrep 26/60 Sephacryl, 320 ml) washed and pre-equilibrated with 
sodium phosphate buffer, pH 7.2. Protein fractions containing pure protein were 
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concentrated using centrifugal filter Ultracel-3K (Amicon, Millipore). The purified 
protein concentration was determined BSA method. 
2.2.3 Construction of fmtA conditional mutant and fmtA Deletion strains 
To investigate the FmtAΔ27 biological function, two mutant strains (fmtA 
conditional mutant and fmtA deletion strain) were constructed by Dr. Vidhu Verma.   
2.2.4 Isolations of wall teichoic acid 
Wall teichoic acid was isolated according to Former graduate student Michale 
Fridman from Dr.Golemi-Kotra’s Lab (Fridman, 2013). Briefly, S. aureus (RN4220, 
FmtA Del, FmtA CM2, DltA) Cultures were incubated at 37°C in an orbital incubator 
(180 rpm) and harvested by centrifugation (5300 x g for 15 min, RT) once the OD660 had 
reached 0.6–0.7. Cells were suspended in 10 mL of 2 M NaCl and disrupted with 
sonicator((1 sec ON, 9 sec OFF, 2 min total, 35% amplitude) at RT. Cell wall fragments 
were recovered by centrifugation (14 100 x g; 5 min at 4°C), the pellet suspended in 
phosphate-buffered saline (PBS) (prepared in the Lab) and recovered by centrifugation 
(14 100 x g; 5 min at 4°C). Recovered wall materials were incubated with 20 mL of 4% 
w/v sodium dodecyl sulphate at 37°C for 4 h.  Cell walls were recovered by 
centrifugation (14 100 x g; 5 min at 25°C), washed three times by resuspending in water 
(10 mL each time) to remove non-covalently bound components by incubation at 37°C 
with 4 mL trypsin (0.2 mg/mL), RNase (0.1 mg/mL) and DNase (0.1 mg/mL) in 50 mM 
Tris-HCl, pH 7.0, 5 mM MgCl2 for 18 h with stirring. After recovery by 
centrifugation(14 100 x g; 5 min at 4°C), wall material was washed with  1 M Tris–HCl 
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(pH 7.0) containing 1 M NaCl and then again with 1 M Tris–HCl (pH 7.0), recovered by 
centrifugation (14 100 x g; 5 min at 4°C) and finally washed three times by resuspending 
in water (5 mL each time) (14 100 x g; 5 min at 4°C) . WTA was released from 
peptidoglycan using 10% w/v aqueous trichloroacetic acid (TCA) at 4°C for 48 h. 
Peptidoglycan was removed by centrifugation (5300 x g; 45 min; 20°C) and WTA 
precipitated from the supernatant with 95% ice-cold ethanol and held 5 days at 4°C. After 
centrifugation (5000 x g; 30 min; RT), the pellet was washed two times with 95% 5 mL 
ethanol (5000 x g; 30 min; RT); after the final ethanol wash, the solvent was allowed to 
evaporate, purified WTA was lyophilized and stored at -20°C. 
2.2.5 DD-Carboxypeptidase assay 
This was carried out as described previously (Gutheil, Stefanova, and Nicholas et 
al., 2000) and modified by Dr. Aneela Qamar (Qamar, 2011). Briefly,  Purified  FmtAΔ27 
(10 µM ) was incubated in 0.1 M Tris (pH 8.5) buffer with 6 mM  Nα,Nε-Diacetyl-Lys-
D-Ala-D-Ala for 60 min at 37°C in a total volume of 100 µL . In another reaction, 
different concentrations of WTA (10 µg/100 µL , 20 µg/100 µL, 30 µg/100 µL ) and 
purified FmtAΔ27 (10 µM) was incubated in 0.1 M Tris (pH 8.5) buffer (100 µL).  At this 
time, 40 μM of Amplex Red (Molecular Probes, Inc) (in DMSO) and 2.5 μg/ml of flavin 
adenine dinucleotide (FAD), 0.75 units of horseradish peroxidase (HRP), and 0.05 units 
of D-amino acid oxidase (DAO) in a total volume of 200 µl were added to each sample 
(100 µL) and samples were incubated for another 30 min. D-Ala released from the 
tripeptide or WTA was determined by fluorescence spectrophotometer at excitation 563 
nm and emissions 584 nm.  
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2.2.6 Nuclear Magnetic Resonance Spectroscopy (NMR) Experiments 
WTA was isolated from various strains (RN4220, ΔfmtA, fmtA CM2) using 
trichloroacetic acid as described earlier. LTA (S. aureus) was purchased from Sigma. 
NMR experiments were performed with the help of Dr. Hunter (Manager NMR facilities, 
York University). The isolated WTAs were lyophilized and resuspended in 100% D2O to 
a 5−10 mg/mL concentration and placed in a 3 mm NMR tube. LTAs were resuspended 
in 100% D2O to a 5 mg/mL concentration and placed in a 3 mm NMR tube. One-
dimensional 1H NMR spectra were collected at 25 °C on a Bruker AV III 700 MHz 
spectrometer (operating frequencies of 700.28 MHz for 1H NMR and 176.096 MHz for 
13C NMR). The spectrometer was controlled with TOSPIN version 3.2 software and 
equipped with a 5 mm 1H/13C/15N cryoprobe. For quantitative 1D 1H spectra, 1D 1H T1 
analysis was completed using the inversion recovery experiment.  
2.2.7 Enzymatic activity of FmtA Δ27 by NMR 
The isolated lyophilized WTA or LTA (Sigma) was dissolved in 100% D2O to a 
0.25–10 mg/mL concentration and mixed with FmtAΔ27 (10 µM, unless or otherwise 
mentioned) placed in a 3 mm NMR tube. LTA was resuspended in 100% D2O to a 5 
mg/mL concentration and mixed with FmtAΔ27 (10 µM) placed in a 3 mm NMR tube. 
Enzymatic reaction (formation of D-Ala from wall teichoic acid) was observed at 
different time intervals (25°C).  
To check the activity on FmtAΔ27 in presence of common esterase inhibitors, e.g. 
Sodium fluoride, Eserine, PMSF (1 mM) was added in the enzymatic reaction mixture. 
Briefly, FmtAΔ27 at 10 µM was incubated with WTA at 5 mg/mL and the inhibitor (1 mM) 
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was added and the enzymatic reaction was checked over time at (25°C). In some cases, 
FmtA Δ27 at 10 µM was pre-incubated with one of PMSF (1mM) for 24 hrs and the WTA 
at 5 mg/mL was added and the activity was monitored.    
2.2.8 Investigation of the substrate specificity of FmtAΔ27 by NMR 
Esterase substrates, e.g p-nitro phenyl butyrate (p-NPB), p-nitro phenyl acetate (p-
NPA), D-Ala methyl ester (1 mM) in 300 µL of sodium phosphate buffer, pH 7.0 was 
incubated  with FmtA Δ27 (10 µM) along with 300 µL of deuterium oxide. The reaction 
was monitored by NMR at different time intervals at 25°C for appearance of peaks 
around 8.15 ppm with disappearance of peaks around 8.35 ppm  for p-NPA and p-NPB 
and appearance of peaks around 1.46 pp with disappearance of peaks at 1.53 ppm for D-
Ala methyl ester. 
2.2.9 Enzymatic activity of FmtA Δ27 by continuous spectrophotometric assay 
Esterase activity of FmtA was investigated by a continuous spectrophotometric 
assay using p-Nitrophenyl butyrate (p-NPB) or p-nitrophenyl acetate (p-NPA) as the 
substrate. DMSO was used to dissolve these substrates. The standard assay was measured 
in a final volume of 0.5 mL containing p-NPB or p-NPA (1mM), the enzyme FmtAΔ27 
WT or PBP4 or PBP2a (5 µM), and the assay buffer (50 mM sodium phosphate buffer, 
pH 7.0) at room temperature. The reaction was initiated by the addition of substrate. The 
hydrolysis of p-NPB or p-NPA was spectrophotometrically monitored for the formation 
of the p-nitrophenol at 405 nm (ε = 0.2 mM-1 cm-1). 
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2.2.10 Determination of whole-cell surface charge  
To estimate the relative surface charge of cell envelope, cationic protein 
cytochrome C (Sigma) was used according to previously described method (Peschel et al., 
1999). Briefly, cells were grown for overnight in 5 ml Tryptic Soy Broth (TSB) at 37°C 
200 rpm.  Overnight culture was diluted to 200 fold in 50 mL TSB (in a 250 mL flask) 
and further inoculated for 3 hours at 37°C 200 rpm. Cell densities were measured at 
Absorbance 650 nm, and an amount equivalent to 15 absorbance units (e.g., 15 ml of a 
culture with an A650 of 1.0) were pelleted by centrifugation (5000 x g for 5 min at 4°C) 
and washed twice by resuspending the pellet with 20 mM morpholinepropanesulfonic 
acid (MOPS), pH 7 (5000 x g for 5 min at 4°C). Washed cells were resuspend in 0.5 
mg/ml cytochrome c and incubated for 10 min at room temperature. The mixture was 
centrifuged twice (5000 x g for 5 min at 4°C), and the amount of cytochrome C in the 
supernatant fraction was determined at A530 using standard Cyt C as a reference. Cyt C 
protein concentration in the supernatant was calculated as, % of applied protein = (A530 
of sample / A530 of Std Cyt C) x 100. 
2.2.11 Phosphate assay 
The WTA phosphate content was determined by using QuantiChrom™ Phosphate 
Assay kit (BioAssay systems, USA). In a typical reaction, 50 µL of 30 µg /mL to 50 µg 
/mL WTA sample was transferred in a clean dry glass tube. WTA samples were dried at 
150°C (Dr. Yousaf  lab, LSB, 4th Floor) for 10 min. Samples were hydrolyzed for 
inorganic phosphate release by addition of 40 µL HClO4 (70-72%) and incubated  for 2 
hr at 150°C. 500 µL distilled water was added into the incubated samples and analyzed by 
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QuantiChrom™ Phosphate Kit’s instruction. Briefly, 50 µL blank (distilled water from 
kit), 50 µL standard (30 µM Pi) and 50 µL samples were transferred into clear flat bottom 
96 well plate. 100 µL developing solution from the Kit was added into each sample, 
mixed gently and incubated for 30 min at room temperature. Change in color was 
determined by using the Synergy H4 Hybrid plate reader (BioTek, USA) at optical 
density at 620 nm. All the experiments were done in triplicates. 
2.3 Results  
2.3.1 Activity of FmtAΔ27 WT against PG analogue (L-Lys-D-Ala-D-Ala) and WTA 
by DD-Carboxypeptidase assays  
Previously, Dr.Golemi-Kotra’s research group showed that FmtAΔ27 has very 
weak D,D-carboxypeptidase activity. It was hypothesized that FmtAΔ27 may require 
interaction with a ligand in the periplasmic space to become active (Qamar and Golemi-
Kotra, 2012).  In lieu of earlier findings that FmtAΔ27 interacts with WTA, we raised the 
question whether this interaction has any effect on the activity of FmtAΔ27 as a D,D-
Carboxypeptidase. For this purpose we used the D,D-carboxypeptidase assay (based on 
Fluorescent coupled enzyme assays for D-Ala) to monitor the amount of D-Ala released 
from the tripeptide Nα,Nε-Diacetyl-Lys-D-Ala-D-Ala by FmtAΔ27 in the presence and 
absence of WTA. Incubation of the tripeptide with FmtA Δ27 resulted in very low amount 
of D-Ala release, which was comparable to the background levels. However, in the 
presence of WTA (0.1 µg/µL, 0.2 µg/µL, 0.3 µg/µL) the amount of D-Ala release 
increased 3 to 4 fold (Figure 2.3.1.1). We used PBP4 (1µM) and PBP2a (10 µM) as a 
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control, in these cases no significant free D-Ala formation was observed in the presence 
of WTA and substrate Nα,Nε-Diacetyl-Lys-D-Ala-D-Ala (6 mM) (Figure 2.3.1.3 and 
Figure 2.3.1.5). WTA contain D-Ala on its second position of ribitol phosphate polymer. 
To exclude the possible source of D-Ala from WTA, we performed another experiment 
using WTA isolated from dltA mutant S. aureus which lacks D-Ala in WTA. In this case 
no significant release of D-Ala was observed in the presence of WTA. In light of these 
results, we suspect that FmtAΔ27 removes the D-Ala from WTA and that was the reason 
behind the observed significant increase in D-Ala in the reaction. To confirm this, we 
repeated the experiment without the tripeptide Nα,Nε-Diacetyl-Lys-D-Ala-D-Ala and 
observed the same trend for the increased signal in comparison to the  experiment that 
was done in the presence of Nα,Nε-Diacetyl-Lys-D-Ala-D-Ala and WTA . Furthermore, 
we repeated this experiment with boiled FmtA Δ27 protein and no significant amount of D-
Ala was detected.  These results strongly suggest that FmtAΔ27 has a catalytic activity to 
release D-Ala from WTA, which is connected through ester bond with ribitol. 
Furthermore, FmtA Δ27 S127A (mutation of serine at 127 poition of fmtA) showed less 
catalytic activity towards WTA which indicates the potential involvement of serine 
residue (Figure 2.3.1.6). 
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 Figure 2.3.1.1 Activity of FmtAΔ27 against PG analogue (L-Lys-D-Ala-D-Ala) by DD-
Carboxypeptidase assay in presence of WTA as an activator 
A reaction mixture containing FmtA Δ27 (10 µM),Nα,Nε-Diacetyl-Lys-D-Ala-D-Ala (6 
mM), and various concentrations of WTA (0.1 µg/µL, 0.2 µg/µL, 0.3 µg/µL) isolated 
from RN4220 was incubated at 37° C for 1 hr. Conversion of amplex red to resorufin 
which depend the presence of free D-Ala in the reaction mixture was detected by 
fluorescence signal at 584 nm. Reaction mixture without FmtA Δ27 or substrate was used 
as a blank. Reactions with FmtA Δ27 alone or WTA from RN4220 with Lys-D-Ala-D-Ala 
were used as controls. 
 
 
Figure 2.3.1.2 Investigation of the potential role of WTA as an activating ligand of 
FmtA Δ27 activity (negative control) 
A reaction mixture containing FmtAΔ27 (10 µM), Nα,Nε-Diacetyl-Lys-D-Ala-D-Ala (6 
mM), and various concentrations of WTA (0.1µg/µL, 0.2µg/µL, 0.3µg/µL) isolated from 
ΔdltA strain (no D-Ala in WTA) was incubated at 37° C for 1 hr. Conversion of amplex 
red to resorufin which depend on the presence of free D-Ala in the reaction mixture was 
detected by fluorescence signal 584 nm. Reaction mixture without FmtAΔ27 or substrate 
was used as a blank. Reactions with FmtA Δ27alone or WTA from ΔdltA strain were used 
as negative controls. 
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 Figure 2.3.1.3 Investigation of the potential role of WTA as an activating ligand on 
PBP2a activity (Control for FmtAΔ27) 
A reaction mixture containing PBP2a (10 µM), Nα,Nε-Diacetyl-Lys-D-Ala-D-Ala (6 
mM), and various concentrations of WTA (0.1µg/µL, 0.2µg/µL, 0.3µg/µL) isolated from 
RN4220 was incubated at 37° C for 1 hr. Conversion of amplex red to resorufin which 
depend the presence of free D-Ala in the reaction mixture was detected by fluorescence 
signal at 584 nm. Reaction mixture without PBP2a or substrate was used as a blank. 
Reactions with PBP2a alone or WTA from RN4220 with Lys-D-Ala-D-Ala were used as 
negative controls. 
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Figure 2.3.1.4 Investigation of the potential role of WTA as an activating ligand on 
PBP2a activity (negative control) 
A reaction mixture containing PBP2a (10 µM), Nα,Nε-Diacetyl-Lys-D-Ala-D-Ala (6 
mM), and various concentrations of WTA (0.1µg/µL, 0.2µg/µL, 0.3µg/µL) isolated from 
ΔdltA strain (no D-Ala in WTA) was incubated at 37° C for 1 hr. Conversion of amplex 
red to resorufin which depend on the presence of free D-Ala in the reaction mixture was 
detected by fluorescence signal 584 nm. Reaction mixture without PBP2a or substrate 
was used as a blank. Reactions with PBP2a alone or WTA from ΔdltA strain were used as 
negative controls. 
 
 
 
Figure 2.3.1.5 Investigation of the potential role of WTA as an activating ligand on 
PBP4 activity 
A reaction mixture containing PBP4 (1 µM), Nα,Nε-Diacetyl-Lys-D-Ala-D-Ala (6 mM), 
and various concentrations of WTA (0.1µg/µL, 0.2µg/µL, 0.3µg/µL) isolated from 
RN4220 was incubated at 37° C for 1 hr. Conversion of amplex red to resorufin which 
depend the presence of free D-Ala in the reaction mixture was detected by fluorescence 
signal at 584 nm. Reaction mixture without PBP4 or substrate was used as a blank. 
Reactions with PBP4 alone or WTA from RN4220 with Lys-D-Ala-D-Ala were used as 
controls. 
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. 
Figure 2.3.1.6 Investigation of the potential esterase activity of FmtA Δ27 on WTA  
A reaction mixture containing FmtAΔ27 WT or FmtAΔ27 S127 or PBP2a (10 µM) and 
various concentrations of WTA (0.1µg/µL, 0.2µg/µL, 0.3µg/µL) isolated from RN4220 
was incubated at 37° C for 1 hr. Conversion of amplex red to resorufin which depend the 
presence of free D-Ala in the reaction mixture was detected by fluorescence signal at 584 
nm. Reaction mixture without protein and substrate was used as a blank. Reaction with 
FmtAΔ27, FmtAΔ27S127, PBP2a alone or WTA from RN4220 was used as a control. 
 
Figure 2.3.1.7 Investigation of the potential esterase activity of FmtA Δ27 on WTA 
(control experiments) 
A reaction mixture containing boiled FmtAΔ27 WT or FmtAΔ27 S127 or PBP2a (10 µM) 
and various concentrations of WTA (0.1µg/µL, 0.2µg/µL, 0.3µg/µL) isolated from 
RN4220 was incubated at 37° C for 1 hr. Conversion of amplex red to resorufin which 
depend the presence of free D-Ala in the reaction mixture was detected by fluorescence 
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signal at 584 nm. Reaction mixture without protein and substrate was used as a blank. 
Reaction with FmtAΔ27, FmtAΔ27S127, PBP2a alone or WTA from RN4220 was used as a 
control.  (B): Boilled 
2.3.2 Investigation of the esterase activity of FmtAΔ27 on WTA by NMR  
We observed that in the presence of WTA, the amount of free D-Ala increased in 
the reaction mixtures. To probe whether WTA solutions with FmtA Δ27 contained free D-
Ala, we have analyzed wall teichoic acid and furthermore monitored the changes in WTA 
in presence of FmtA Δ27 by 1H NMR. Results showed that indeed FmtAΔ27 can remove D-
Ala from wall teichoic acid. The cleavage of D-Ala ester from WTA was observed by the 
disappearance of the resonance at 1.65 ppm and the appearance of the free D-Ala 
resonance at 1.45 ppm. In another experiment, we included a control, which was only 
wall teichoic acid in deuterium oxide. In absence of FmtAΔ27 there was no removal of D-
Ala from WTA (Figure 2.3.2.1).  
A B  
Figure 2.3.2.1 Removal of D-Ala of WTA by FmtA  
1H-NMR spectrum of WTAs (RN4220) in the absence or presence of FmtAΔ27 (10 µM). 
A: WTA (5 mg/ml) in deuterium oxide (control); B: Reaction mixture containing 
FmtAΔ27 (10 µM) and WTA (5 mg/ml) in deuterium oxide. Formation of free D-Ala was 
monitored as appearance of a resonance around 1.45 ppm. 
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Figure 2.3.2.2 Catalytic function of FmtAΔ27 on WTA. 
A: Chemical structure of WTA B: In presence of water, FmtA removes D-Ala from WTA 
and produces free D-Ala. 
2.3.3 Investigating the specificity of D-esterase activity of FmtAΔ27 by NMR 
Our NMR experiments confirmed that FmtAΔ27 can remove D-Ala from WTA. 
Furthermore, I checked the effects of various enzyme and substrate concentrations on 
removal of D-Ala from WTA. The increase in FmtAΔ27 concentration in the reaction 
mixture resulted in the increased in the D-Ala removal. The increase in substrate 
concentrations had a double effect and showed reaction rate chages as substrate 
concentaion chages. Interestingly, no reaction was observed in the presence of  high 
substrate conecntration of WTA (10 mg/mL). This effect may be possible due to substrate 
inhibition. 
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 Figure 2.3.3.1 The effect of enzyme concentration in the rate of removals of D-Ala 
from WTA 
FmtA Δ27 WT enzymatic activity on WTA (RN4220) by 1H NMR was monitored for 
reaction mixture containing different concentration of  FmtA Δ27 WT (5 µM,  10 µM, 20 
µM) and WTA (5 mg/mL) isolated from RN4220. Release of free D-Ala was monitored 
as appearance of a resonance around 1.45 ppm over time. 
 
 
Figure 2.3.3.2 The effect of WTA concentrations in the rate of removals of D-Ala 
from WTA 
FmtAΔ27 WT enzymatic activity on WTA (RN4220) by 1H NMR was monitored for 
reaction mixture containing  FmtAΔ27 WT ( 10 µM) and different concentration of WTA 
(0.5 mg/mL , 1 mg/mL, 2.5 mg/mL, 5mg/mL) isolated from RN4220. Release of free D-
Ala was monitored as appearance of a resonance around 1.45 ppm over time.  
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2.3.4 Screening for esterase activity of FmtAΔ27 by continuous spectrophotometric 
assay using small molecules 
To check the substrate specificity for FmtAΔ27, we tried several carboxylesterase 
substrates, e.g p-nitrophenyl butyrate (p-NPB) and p-nitrophenyl acetate (p-NPA). 
FmtAΔ27 showed very poor esterase activity of p-nitrophenyl butyrate and p-nitrophenyl 
acetate by continuous spectrophotometric assay. Two control proteins (PBP4 and PBP2a) 
were included to compare esterase activity of FmtAΔ27. The hydrolysis of pNPB or pNA 
was spectrophotometrically monitored for the formation of the p-nitrophenol at 405 nm. 
Due to high background hydrolysis of carboxylesterase substrates, we couldn’t conclude 
any esterase activity of FmtAΔ27 for pNPB or pNA. Therefore, we moved to NMR to 
investigate enzymatic esterase hydrolysis of pNPB or pNA by FmtAΔ27. 
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Figure 2.3.4.1 Chemical structure of p-Nitrophenyl acetate and p-Nitrophenyl 
butyrate 
  
54 
 
A    
 
B    
 
Figure 2.3.4.2 Esterase activity of FmtAΔ27 against p-NPA and p-NPB by continuous 
spectrophotometric assay 
p-NPB or p-NPA at 1mM was mixed with  FmtAΔ27 , PBP4 or PBP2a at 5 µM in buffer 
(50 mM sodium phosphate buffer, pH 7.0) at room temperature. The hydrolysis of pNPB 
or pNA was spectrophotometrically monitored at 405 nm, which correspond to the 
formation of p-nitrophenol.  
A: continuous spectrophotometric assay for p-NPB; B: continuous spectrophotometric 
assay for p-NPA 
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2.3.5 Assessment of esterase activity of FmtAΔ27 by NMR 
Due to high background hydrolysis of carboxylesterase substrates, we explored 
the catalytic activity of FmtAΔ27 on pNPB and pNPA by NMR. Hydrolysis of these 
substrates was monitored as disappearance of a resonance around 8.35 ppm with 
appearance of new peak round 8.15 ppm which was observed due to the ortho protons on 
the benzene ring of the ester. Hydrolysis results from NMR revealed very poor activity of 
p-nitrophenyl butyrate and almost no activity on p-nitrophenyl acetate. Furthermore, we 
tried D-Alanine methyl ester and L-Alanine p-Nitroanilide for α-amino-acid esterase and 
alanine aminopeptidase activity, respectively. However, we couldn’t see any catalytic 
activity against these substrates. Carboxylesterases catalyze the hydrolysis of short chain 
aliphatic and aromatic carboxylic ester compounds and all the carboxylesterase in family 
VIII are active towards nitrophenyl esters or triglycerides with short chain acyl moieties 
(Chahiniana et al., 2009). These results suggest that FmtAΔ27 may be specific to D-Ala 
ester connected with ribitol polymer of WTA compare to synthetic substrate. Moreover, 
FmtAΔ27 doesn’t have any carboxylesterase or α-amino-acid esterase or aminopeptidase 
activity (Figure 2.3.5.2). 
Most of the cephalosporins contain an ester bond (acetyl group) which might be 
susceptible to FmtAΔ27 hydrolysis. Considering cephalosporin as a potential substrate for 
FmtAΔ27, we explored esterolytic activity on cephalosporin derivatives by NMR. To study 
any potential esterase hydrolytic activity of cephalosporin, we used cephalothin (first 
generation cephalosporin) and cefoxitin (second generation cephalosporin) as a substrate 
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(Figure 2.3.5.1). However, we couldn’t see any esterase activity on cefoxitin and 
cephalothin (Figure 2.3.6.3). 
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Figure 2.3.5.1 Chemical structures of D-Alanine methyl ester, L-Alanine p-
Nitroanilide, Ceforxitin and Cephalothin. 
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Figure 2.3.5.2 Assessment of esterase activity of FmtAΔ27  by NMR 
Substrate depletion around 8.35 ppm (ortho protons on the benzene ring) for reaction 
mixture containing FmtAΔ27 (5 µM) or PBP4 (5 µM) with p-Nitrophenyl Butyrate (A) or 
p-Nitrophenyl acetate (B) or Substrate depletion around 1.53 ppm for D-alanine methyl 
ester (C) (1 mM) was monitored by NMR. A Reaction mixture containing no protein was 
included as a negative control. 
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Figure 2.3.5.3 Screening for potential esterase activity of FmtAΔ27 WT on 
cephalothin  
FmtA Δ27 WT enzymatic activity on cephalothin by 1H NMR was monitored in a Reaction 
mixture containing FmtA Δ27 WT (40 µM), cephalothin (3 mM). Any changes for acetate 
peak around 1.8 ppm were monitored.  
2.3.6 Active site of FmtAΔ27 WT for esterase activity (SXXK motif)   
Esterases hydrolyze esters to produce acid and alcohol. Based on the literature, 
super family VIII esterases have very high sequence similarity to class C β- lactamase and 
penicillin binding proteins (Wagner et al., 2002). Family VIII esterases also represent a 
poorly characterized esterase family. The nucleophilic serine residue in family VIII 
carboxylesterases occurs in the S-X-X-K motif, like those in class β-lactamases, instead 
of in the G-X-S-X-G motif. These enzymes have approximately 337 to 443 amino acid 
sequence and a 36.9 to 48.6 kDa molecular mass (Nacke et al. 2011). FmtAΔ27 has two S-
X-X-K motifs, located at the position S63KLK and S127AQK. To explore the 
significance of these two motifs in activity, I monitored the activity of FmtAΔ27 S63 and 
FmtA Δ27 S127 mutants against WTA. A mutation of serine in the S63KLK, with the other 
active site serine residue at 127 (S127AQK) intact, was associated with a significantly 
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decrease in enzymatic activity (4 fold decrease in catalytic activity). Similar result was 
obtained with the mutation of serine in the S127AQK motif. Mutation of lysine at the 
SXXK motif produced a 4 fold decrease in catalytic activity. These results indicate that 
serine at 63 and 127 positions and lysine at 130 position from SXXK motif are important 
for the catalytic activity of FmtAΔ27.  
Carboxylesterases and β-lactamases share a two-step hydrolase mechanism that 
consists of two successive nucleophilic attacks by a serine residue and a water molecule. 
Family VIII Carboxyesterase show a modular structure of a small helical domain and a 
α/β domain similar to that seen in class C β-lactamases (S.-S. Cha et al., 2013). The 
Crystal structure of EstB from Burkolderia gladioli, a representative of Family VIII 
carboxylesterases revealed that the mechanism of ester hydrolysis involves a Ser residue 
in the SXXK sequence as a catalytic nucleophile (Wagner et al., 2002).  
 
 
Figure 2.3.6 Active site (SXXK motif ) of FmtAΔ27 WT for esterase activity  
FmtA Δ27 WT enzymatic activity on WTA (RN4220) by 1H NMR was monitored for 
reaction mixture containing FmtA Δ27 WT or FmtA Δ27 S63 (10 µM) or FmtA Δ27 S127 or 
FmtA Δ27 K130(10 µM) and WTA (5mg/ml) isolated from RN4220 . Formation of free D-
Ala was monitored resonance around 1.45 ppm. 
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2.3.7 Esterase and protease inhibitors on the activity of FmtAΔ27 
Chemical compounds known to inhibit the activities of esterase and protease were 
used to investigate whether FmtAΔ27 does rely on the Serine residue for its activity. 
Eserine (physostigmine) which is a reversible acetylcholinesterase inhibitor and sodium 
fluoride which is a known inhibitor for general esterase and serine/threonine phosphatases. 
These inhibitors showed partial inhibition (20 %) on the catalytic activity of FmtAΔ27. 
Moreover, phenylmethylsulfonyl fluoride (PMSF) a protease inhibitor that reacts with 
serine residue could inhibit FmtAΔ27 activity partially. These inhibitions were observed 
after 2.5 hours of the reaction.  
  
Figure 2.3.7 Inhibitors studies for esterase activity of FmtAΔ27 WT  
FmtA Δ27 WT enzymatic activity on WTA (RN4220) by 1H NMR was monitored in 
presence of inhibitors. Reaction mixture containing FmtA Δ27 WT (10 µM), WTA 
(5mg/ml) isolated from RN4220 and inhibitors (1mM) was used for inhibitor studies. 
Formation of free D-Ala was monitored resonance around 1.45 ppm. A: Inhibitor studies 
for sodium fluoride and eserine; B: Inhibitor studies for PMSF.  
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2.3.8 Analysis of D-Ala modification of WTA isolated from ΔfmtA and fmtA-CM 
strain 
I have shown in-vitro that FmtA Δ27 can remove D-Ala from WTA. To investigate 
the in-vivo catalytic activity of FmtAΔ27, I isolated WTA from S. aureus RN4220, S. 
aureus fmtA-CM in presence of 0.5 mM IPTG (a complete functional copy of fmtA gene 
under control of IPTG inducible promoter Pspac) and S. aureus fmtA deletion mutant.  To 
quantify the amount of D-Ala in WTA, GlcNAc peak was considered as 1 to integrate D-
Ala peak. Results from 1H NMR spectrum of purified WTAs showed that under fmtA CM 
in presence of IPTG (GlcNAc:D-ala, 1:0.76) had less D-Ala attached to ribitol of WTA 
compared to WT S. aureus RN4220 (GlcNAc:D-ala, 1:0.96).The fmtA deletion mutant 
(GlcNAc:D-ala, 1:1.17) showed slightly more D-Ala attached to ribitol compare to over-
expressing fmtA conditional mutant with IPTG. S. aureus fmtA-CM has a complete 
functional copy of fmtA gene, and under the control of IPTG it induces the promoter 
Pspac, to result in expression of fmtA at levels that are higher than in RN4220 (Qamar, 
2011). This strain resulted reduction in the amount of D-Ala esterified to wall teichoic 
acids in the cell wall envelope of S. aureus. On the other hand, S. aureus fmtA deletion 
mutant has no fmtA gene, as a result more D-Ala was observed in the wall teichoic acids. 
Overall, these findings indicate that FmtAΔ27 can remove D-Ala in vivo from WTA which 
is attached to ribitol by an esterase bond.  
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E  
Figure 2.3.8 1H NMR spectrum of purified WTAs of different S. aureus strains (S. 
aureus RN4220, S. aureus fmtA conditional mutant and S. aureus ΔfmtA mutant) 
A: WTA was isolated from WT S. aureus RN4220; B: WTA was isolated from over-
expressing fmtA-CM without IPTG; C: WTA was isolated from over-expressing fmtA-CM 
in presence of 0.5 mM IPTG; D: WTA was isolated from S. aureus fmtA  deletion mutant. 
E: comparison of D-Ala attached to ribitol phosphate of WTA from S. aureus RN4220, S. 
aureus-CM with or without IPTG and S. aureus fmtA deletion mutant 
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2.3.9 Inorganic phosphate assay for WTA  
WTA of S. aureus is a zwitterionic cell wall glycopolymer composed of ~40 
ribitol phosphate repeating units modified with N-acetylglucosamine and D-Ala. Released 
inorganic phosphate from WTA was measured with a Quanti ChromTM phosphate assay 
kit (DIPI-500) upon drying and then digesting WTA in 40 μl of 70% (w/v) HClO4 at 
165°C for 2 h. Inorganic phosphate analysis of fmtA-CM strain in presence of IPTG and 
ΔfmtA strain has very less effect in terms of phosphate content compare of wild type S. 
aureus RN4220. However, fmtA-CM strain gene without induction showed a little higher 
amount of phosphate content compare to wild type RN4220. 
 
Table 2 Inorganic phosphate assay for WTA  
 
  
Name of the Strain 
Phosphate content in  
µM 
S. aureus RN4220 1101.44± 0.005 
S. aureus fmtA-CM 1280.93±0.003 
S. aureus fmtA-CM+IPTG 946.42± 0.002 
S. aureus ΔfmtA 974.16± 0.0003 
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2.3.10 Determination of whole-cell surface charge  
Cytochrome c (Sigma) is a highly positively charged protein (pI 10.0; 12 kDa) and 
can be detected absorbance at wavelength 530 nm, binding of which is dependent on the 
net negative surface charge of S. aureus cells (Peschel et al., 1999). To determine whether 
the removal of D-Ala from WTA by FmtAΔ27 caused an alteration in the overall charge of 
the cell envelope, the capacity of the wild-type and fmtA conditional mutant, over-
expressing fmtA conditional mutant, fmtA Deletion mutant cells to positively charged cyt 
c  protein were compared. dltA mutant was used as a control, where reduction in the 
amount of D-Ala esterified to teichoic acids in the cell envelope of S . aureus (brought 
about by disruption of the protein DltA) results in increased negative charge in the 
envelope and a concomitant increase in the electrostatic attraction of cationic protein cyt c 
towards the cell membrane (Peschel et al., 1999). Results revealed that fmtA-CM without 
IPTG had less positive charge in its cell envelope compare to wild type RN4220. When 
IPTG was used for in-vivo over expression of fmtA, opposite effect was observed i.e. 
overall cell surface charge was more positive compared to without induction of fmtA gene. 
The fmtA deletion mutant has no fmtA gene, hence theoretically, there should be more D-
Ala in the WTA, as a result it should be more positively charge. Interestingly, whole cell 
surface charge of fmtA deletion mutant was a little more positively charged compared to 
fmtA conditional mutant but less than wild type RN4220. S. aureus cell surface is 
composed of peptidoglycan, teichoic acids (WTA and LTA) and surface proteins. Both 
WTA and LTA show D-Ala modifications in their polyol (ribitiol for WTA and glycerol 
for LTA) repeat units. We have shown that FmtA can remove D-Ala from WTA. We 
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don’t have enough knowledge about the regulation of fmtA gene to explain the opposite 
results of over expressing fmtA gene. 
Table 3: Determination of whole-cell surface charge using cyt c 
      
Name of the strain % of applied  protein  
Cyt c 100±0 
 RN4220 64.93±4.51 
 fmtA-CM 35.15±3.3 
 fmtA-CM+IPTG100 62.49±3.68 
 fmtA-CM+IPTG 500 55.66±5.95 
 ΔfmtA  35.61±3.53 
 ΔdltA 10.18±2.19 
  
 
 
Figure 2.3.10 Determination of whole-cell surface charge using Cyt C 
Cyt C is higly positively charged protein. Cell pellets from different strains (S. aureus 
RN4220, S. aureus fmtA-CM and S. aureus ΔfmtA mutant) was incubated with Cyt C and % 
of protein content in supernant indicates the amount of neragive charges in whole cell. 
ΔdltA mutant strain( WTA lacking D-Ala) was used as a control. 
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2.3.11 Investigation of Esterase activity of FmtAΔ27 on LTA by NMR 
Previously, I showed that FmtA Δ27 can remove D-Ala from WTA. S. aureus cell 
wall has two types of teichoic acids: WTA and LTA. To investigate the effect of FmtAΔ27 
on LTA, I monitored the changes in LTA in presence of FmtA Δ27 by 1H NMR. 
Modification of LTA is observed at the second position of glycerol, where hydroxyl 
group is substituted with D-alanyl ester (Fischer, 19988). Results showed that FmtAΔ27 
can remove D-Ala from LTA. The cleavage of D-Ala ester from LTA was observed by 
the disappearance of the resonance at 1.65 ppm and the appearance of the free D-Ala 
resonance at 1.47 ppm. In another experiment, we included a control, which was only 
LTA in deuterium oxide. In absence of FmtAΔ27 there was no removal of D-Ala from 
LTA (Figure 2.3.11.1).  
A  
B  
Figure 2.3.11.1 Removal of D-Ala of LTA by FmtAΔ27  
1H-NMR spectrum of S. aureus LTA (Sigma) in the absence or presence of FmtAΔ27 (10 
µM). A: LTA (5 mg/mL) in deuterium oxide (control); B: Reaction mixture containing 
FmtAΔ27 (10 µM) and LTA (5 mg/mL) in deuterium oxide. Formation of free D-Ala was 
monitored as appearance of a resonance around 1.47 ppm. 
No Free D-Ala 
Free D-Ala 
D-Ala attached 
to glycerol 
D-Ala attached 
to glycerol 
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Figure 2.3.11.2 Catalytic function of FmtAΔ27 on LTA. 
A: LTA chemical structure; B: In presence of water, FmtA removes D-Ala from LTA and 
produces free D-Ala. 
 
2.3.12 Esterase activity of PBP4 or PBP2a on WTA by NMR  
Amino acid sequence homology comparison  revealed that FmtA has sequence 
homology with penicillin binding protein (PBP) and  β-lactamase (Fan et al., 2007). The 
sequence alignments revealed that FmtA has  two of the three conserved motifs of serine 
active-site PBPs and β-lactamases: SXXK, Y(S)XN, and H(K/R)T(S)G, where X is any 
amino acid. 
  Previously it was shown that class B high molecular mass (HMM) PBP2a, a 
penicillin-binding protein that has transpeptidase activity interacts with WTA (Qamar, 
Golemi-kotra, 2012). Furthermore, from our experiments, it was clear that class B low 
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molecular mass (LMM) PBP4, that exhibit transpeptidase, carboxypeptidase , 
penicillinase activity can also bind with WTA . We have shown that FmtA can remove D-
Ala from WTA. Furthermore, the active site serine from two SXXK motifs are indentified 
for this catalysis. In light of these facts, we were interested to see wheather PBP4 or 
PBP2a has similar esterase activiy on WTA.  
Experiments of PBP4 or PBP2a with WTA by NMR revealed very low release of 
free D-Ala over time. We have examined the possibility of WTA hydrolysis in deuterium 
oxide and no hydrolysis of WTA was observed over time. 
A  
B  
Figure 2.3.12 Esterase activity of PBP4 or PBP2a on WTA by NMR  
Reaction mixture of Protein FmtA or PBP4 or PBP2a (10 µM) and WTA isolated from S. 
aureus RN4220 (5 mg/mL) was mixed in a total volume of 400µL deuterium oxide and 
the reaction was observed by 1H NMR over time. 
A: PBP4 with WTA  
B: PBP2a with WTA  
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2.4 Discussion 
The fmtA gene was first identified by Komatsuzawa et al. which was shown to 
effect autolysis in the presence of Triton X-100. Inactivation of fmtA in methicillin-
resistant S. aureus (MRSA) strain is associated with reduced oxacillin resistance level and 
decreased level of highly cross linked peptidoglycan ( Komatsuzawa et al., 1999). The 
primary structure of FmtA harbors two of the three conserved motifs of PBPs, β –
lactamases, and acylate a serine residue of the SXXK motif but at very slow rate (Fan et 
al., 2007). 
A previous graduate student Dr. Aneela Qamar in the lab of Dr. Golemi-Kotra 
showed that FmtAΔ27 has very week D,D-carboxypeptidase activity (Qamar , 2011).  It 
has been reported that some proteins related to peptidoglycan biosynthesis or remodeling 
require a native substrate or a particular ligand to become active.   PBP1a, PBP1b of E. 
coli that are activated through interactions with membrane-bound proteins LpoA and 
LpoB (Qamar and Golemi-Kotra 2012). PBP5 of E. coli requires binding to the 
membrane to become active(Qamar and Golemi-Kotra 2012). It was hypothesized that 
FmtA may require interaction with a ligand in the periplasmic space to become active 
(Qamar and Golemi-Kotra, 2012). In lieu of our earlier finding by Dr. Aneela Qamar that 
FmtA Δ27 interacts with WTA, we raised the question whether this interaction has any 
effect on the activity of FmtA as a DD-carboxypeptidase. To test this hypothesis, we used 
the DD-carboxypeptidase assay (also known as Fluorescent coupled enzyme assays for 
D-Ala) to monitor the amount of D-Ala released from the synthetic substrate Nα,Nε-
Diacetyl-Lys-D-Ala-D-Ala by FmtA  in the presence and absence of WTAs.  
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WTA of Staphylococcus aureus is a zwitterionic cell wall glycopolymer 
composed of ~40 ribitol phosphate repeating units modified with N-acetylglucosamine 
and D-Ala. In the presence of WTA (isolated from RN4220), the reaction mixture 
containing FmtA and the tripeptide Lys-D-Ala-D-Ala showed a significant increase in the 
amount of free D-Ala which was in agreement with our hypothesis. However, we were 
not sure about the source of D-Ala in the reaction mixture as WTA also have D-Ala in its 
second position of ribitol phosphate polymer. To exclude the possibility of D-Ala coming 
from WTA, I isolated WTA from ΔdltA mutant and used it for further experiments. The 
dltABCD operon is responsible for D-Ala incorporation into WTA and the first step of 
this process is activation of D-Ala as AMP ester in cytoplasm by DltA (Brown et al., 
2013). Deletion of dltA gene in S. aureus lacks D-Ala in WTA (Peschel et al., 1999). 
Experiments containing FmtA and tripeptide Lys-D-Ala-D-Ala along with ΔdltA WTA 
(isolated from ΔdltA mutant) showed no significant release of D-Ala in the reaction 
mixture. In light of these results, we suspected that FmtAΔ27 removes the D-Ala from 
WTA and that was the reason behind the observed significant increase in D-Ala in the 
reaction. To confirm this, we repeated the experiment containing FmtAΔ27 and WTA 
(RN4220) but in the absence of tripeptide Lys-D-Ala-D-Ala; the results were the same as 
that obtained in the presence of tripeptide Lys-D-Ala-D-Ala. Furthermore, experiments of 
boiled FmtAΔ27 and WTA (RN4220) showed no free D-Ala in the reaction mixture. These 
findings strongly indicated that free D-Ala from the reaction mixture containing FmtAΔ27 
and WTA was due to the catalytic activity of FmtA on D-Ala esterified wall teichoic 
acids.  
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Additionally, we have verified catalytic activity of FmtA on WTA by 1H NMR 
where changes in WTA in the presence of FmtA showed cleavage of D-Ala ester from 
WTA by the disappearance of the resonance around 1.65 ppm and the appearance of the 
free D-Ala resonance around 1.45 ppm. Interestingly, Different enzyme concentrations 
(FmtA) and substrate concentrations (WTA) exhibited different catalytic effect of free D-
Ala formation. Surprisingly, no enzymatic reaction was observed in the presence of high 
concentration of WTA (10 mg/ml). This behaviour could be due to substrate inhibition 
phenomenon. Many enzymes are inhibited by their own substrates and this inhibition 
often has important biological functions (Reed et al., 2010). These results strongly 
suggest that WTA is not an activator ligand for FmtA, but a substrate. Moreover, 
FmtA has an esterase catalytic activity to release D-Ala from WTA, which is connected 
through ester bond in the second position of ribitol in WTA. 
A large family of penicillin-recognizing proteins with an active-site serine residue 
exhibit wide variety of activities but not limited to β-lactamases, D,D-endopeptidases, 
D,L-endopeptidases, D-amidases, D-esterases, and D-aminopeptidases ( Delmarcelle et 
al., 2005). It has been reported that some esterases exhibit high sequence identity to class 
C β-lactamases and penicillin binding proteins. These are classified as Family VIII 
esterases (microbial carboxylesterases) based on a comparison of their primary structures 
(Arpigny and Jaeger, 1999). Family VIII esterases represent a poorly characterized 
esterase family. Enzymes from this family are distinct from those of other 
carboxylesterases. The nucleophilic serine residue in family VIII carboxylesterases occurs 
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in the S-X-X-K motif, like those in class β-lactamases, instead of in the G-X-S-X-G motif 
(Wagner et al., 2002). 
The primary structure of FmtA harbors two of the three conserved motifs of PBPs 
and β–lactamase.  The serine residue present in the sequence motif S127-X-X-K (which is 
conserved among penicillin-binding proteins and β-lactamases) is the active-site 
nucleophile during the formation of acyl-enzyme species. S-X-X-K motif in FmtA is in 
duplicate, located at the positions S63KLK and S127AQK. Mutation studies of SXXK 
motif of FmtAΔ27 revealed that both SXXK motifs are involved in the esterase catalytic 
activity of FmtA Δ27. Substitution of serine in the S63KLK or S127AQK was associated 
with a significant decreased (75%) enzymatic activity. Substitution of lysine at 130 
position (SXXK130 motif) also produced a significant decrease in catalytic activity. These 
results indicate that serine (position at 63 and 127) and lysine (position at 130) are 
important for the catalytic activity of FmtA. Furthermore, both active sites of SXXK 
motif are involved in catalysis. However, no literature review was found on catalytic 
mechanisms of esterase that involve two active-site serine residues. Carboxylesterases 
and β-lactamases share a two-step hydrolase mechanism that consists of two successive 
nucleophilic attacks by the serine residue and a water molecule (Wagner et al., 2002). 
Family VIII Carboxyesterase has a modular structure of a small α-helical domain and an 
α/β domain similar to the class C β-lactamases (Cha et al., 2013). Crystal structure of 
EstB from Burkolderia gladioli, a representative of Family VIII carboxylesterases 
revealed that the mechanism of ester hydrolysis involves Ser residue of S-X-X-K 
sequence as a catalytic nucleophile (Wagner et al., 2002). 
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To check the substrate specificity for FmtAΔ27, I tried a range of carboxylesterase 
substrates, e.g p-nitrophenyl butyrate (pNPB) and p-nitrophenyl acetate (pNPA). FmtA 
showed very poor esterase activity towards p-nitrophenyl butyrate and p-nitrophenyl 
acetate by continuous spectrophotometric assay. However, due to the high background 
hydrolysis of these carboxylesterase substrates, we explored the catalytic activity of FmtA 
toward p-NPB and p-NPA by NMR, and encountered the same problem. Hydrolyse 
results from NMR revealed very poor activity toward p-nitrophenyl butyrate and almost 
no activity toward p-nitrophenyl acetate. I used D-alanine methyl ester as a potential 
substrate, but no esterase activity was observed against it. The same observations were 
made for L-Ala p-Nitroanilide and these suggested that FmtA is not a prospective α-
amino-acid esterase or aminopeptidase. Carboxylesterases catalyze the hydrolysis of short 
chain aliphatic and aromatic carboxylic ester compounds and all the carboxylesterase in 
family VIII are active towards nitrophenyl esters or triglycerides with short chain acyl 
moieties (Chahiniana et al., 2009). General esterase inhibitors (eserine, NaF) and  
phenylmethylsulfonyl fluoride (PMSF) could inhibit FmtA activity partially. These 
results clearly indicate that esterase catalytic of FmtA is very specific to D-Alanine ester 
connected with polymer of teichoic acid. Moreover, FmtA does not have any 
carboxylesterase or α-amino-acid esterase or aminopeptidase activity. 
LTA consist of 1,3 linked repetitive glycerol phosphate repeating units attached to 
cytoplasmic membrane. Modification of LTA is observed at the second position of the 
glycerol, where hydroxylgroup is substituted with D-alanyl ester. I showed that FmtA can 
remove D-Ala from LTA. It is interesting that FmtA can show esterase activity toward 
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both teichoic acids from S. aureus but can’t show any esterase activity toward synthetic 
esterase substrates. 
I investigated the in-vivo esterase activity of FmtA towards WTA. Experiments 
with WTA isolated from S. aureus RN4220, S. aureus fmtA conditional mutant (a 
complete functional copy of fmtA gene under control of IPTG inducible promoter Pspac) 
and a S. aureus fmtA deletion mutant showed that over-expression of fmtA was associated 
with reduced amount of D-Ala modification of WTA whereas loss of fmtA gene in S. 
aureus resulted in higher content of D-Ala on WTA compare to wild type strain (S. 
aureus RN4220). 
To determine whether removal of D-Ala from WTA by FmtA caused an alteration 
in the overall charge of the cell envelope, I used cytochrome C which due its positive 
charge binds to the negative charge derivatives of the cell wall. The binding capacities of 
the wild-type and mutant cells (fmtA conditional mutant and fmtA deletion mutant) to 
positively charged cyt C protein were compared. Cytochrome C (Sigma) is a highly 
positively charged protein (pI 10.0; 12 kDa) and can be detected at wavelength 530 nm, 
binding of which is dependent on the net negative surface charge of S. aureus cells 
(Peschel et al., 1999). The results of these experiments revealed that fmtA conditional 
mutant had less positive charge in its cell envelope compared to wild type RN4220. When 
IPTG was used for in-vivo over expression of fmtA (fmtA conditional mutant), the 
opposite effect was observed, i.e. the overall cell surface charge was more positive than 
that obtained without the induction of fmtA gene in the conditional mutant. The fmtA 
deletion mutant lacks a functional fmtA gene, hence theoretically, there should be more 
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D-Ala in the WTA, as a result, cell surface should be more positively charged. 
Interestingly, whole cell surface charge of fmtA deletion mutant was a little more 
positively charged compared to fmtA conditional mutant but less positively charged than 
wild type RN4220. S. auresus cell envelope is composed of peptidoglycans, teichoic 
acids (wall teichoic acids and lipoteichoic acid) and some surface proteins. Our results 
indicate that fmtA many not be solely responsible for controlling the overall cell envelope 
charge and moreover, that over-expression of fmtA gene could trigger a feedback signal. 
It has been reported that fmtA gene is a member of the core cell wall stimulon (McAleese 
et al., 2006). However, regulation of fmtA gene is not well understood.  
We have shown that FmtA and PBP4 interact with WTA. Interaction studies 
between PBP2a and WTA using native-H+/PAGE was shown by Aneela Qamar (Qamar, 
2013). Additionally, I have shown that FmtA can display esterase enzymatic activity to 
remove D-Ala from D-alanyl ester attached to ribitiol. These findings led us to investigate 
any enzymatic changes of WTA by PBP4 or PBP2a. Our NMR data showed that indeed 
PBP4 and PBP2a can remove D-Ala from WTA. However, these esterase activity was 
very low (13 fold less) compare to FmtA.  
Family VIII carboxylesterases revealed the mechanism of ester hydrolysis involve 
Ser residue of S-X-X-K sequence as a catalytic nucleophile (Wagner et al. 2002). Site 
directed mutagenesis for FmtA showed involvement of SXXK motif for esterase catalytic 
activity on WTA. Active serine and lysine from SXXK motif of PBP4 and PBP2a might 
be responsible for PBPs esterase activity on WTA. All PBPs and β-lactmases contain 
three conserved motif and they are SXXK, SXN and KTG (where X indicates any amino 
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acid. Predicted secondary structure of FmtA showed high level of similarity with D-ala-
D-Ala carboxypeptidase and β-lactamase activity. FmtA harbors 2 out of three conserved 
motifs of PBPs (SXXK and SXN).  
PBP4 is known to have DD-carboxypeptidase, where as PBP2a shows only 
transpeptidase activity. Both transpeptidase and carboxypeptidase activities of PBPs 
occur at the D-Ala-D-Ala terminus of PG. Apart from carboxypeptidase activity of 
PBP2a and PBP4, we have shown their cross functional esterase activity. Several reports 
have been noted for cross functional esterase activity for PBPs. PBP 2x in S. pneumoniae 
exhibits esterase and thiolesterase activities in-vitro, where C6H5-CO-NH-CHR1-CO-X-
CHR2-COO- (for esterase, X=O and for thiolesterase, X=S) was used as a substrate 
(Jamin et al., 1993). PBPs from Streptomyces sp. strain R61 and Actinomadura sp. strain 
R39 have reported for D, D-peptidase, esterase, and thiolesterase activities (Frere et al., 
1975, Frere 2004). This is the first time to report that PBPs from S. aureus exhibit low 
esterase activity on WTA. However, the catalytic mechanism for PBPs as an esterase is 
not known at this point. More investigations are required for the esterase activity of PBPs.  
In conclusion, WTA is not an activator ligand for FmtA and that FmtA shows 
esterase catalytic activity towards D-Alanyl ester of WTA and LTA. Both serine and 
lysine from S127XXK130 motif are involved in esterase catalysis. Mutation studies suggest 
that both the SXXK motifs in FmtA, located at position S63 and S127 are involved in 
catalysis and the enzymatic activity depends both on substrate and enzyme concentration. 
Furthermore, high WTA concentration can inhibit enzymatic reaction of FmtA. To date, 
biological functions of most esterases are unknown. To our knowledge, this is the first 
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study to report an esterase from S. aureus that has sequence similarity to PBPs and β-
lactamase and very selective to its biological substrate WTA and LTA compare to 
synthetic esterase substrate. 
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CHAPTER THREE 
INTERACTIONS OF FMTA WITH S. AUREUS SURFACE 
PROTEINS INVOLVED IN AUTOLYSIN ATLA  
3.1 Introductions 
Most bacterial cytoplasm is surrounded by an external cell wall to prevent cell 
lysis as a result of turgor pressure generated by high internal osmolality.  One of the cell 
wall components is known as murein or peptidoglycan (PG), a long polymer with stiff 
glycan strands cross linked by short peptides.  The network of glycan strands forms 
cytoplasmic cytoskeletal elements that furnish an external physical barrier, which gives 
the cell shape and functions as a permeability barrier to macromolecules. In the final 
stage of PG synthesis cross-linked PG strands are generated by the help PBPs, which 
have transglycosylase and/or peptidase activities (Beise et al., 1987). 
In order for the cell to grow and divide effectively, it is necessary to hydrolyze the 
covalent bonds of the peptidoglycan. Autolysins are enzymes that can hydrolyze the 
peptidoglycan, by cleaving specific bonds found in PG (Typas et al., 2011). Based on 
specificities, autolysins can be categorized into three major classes: N-acetylmuramoyl-L-
alanine amidases, glycosaminidases, and endopeptidases. The N-acetylmuramoyl-L-
alanine amidases specifically cleave the bond between the carboxylate group of muramic 
acid and the N-terminal-L-alanine (Sugai et al., 1990) and N-acetylglycosaminidases 
hydrolyze the β-1,4 glycosidic bonds on the reducing  end of N-acetylglucosamine 
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(Figure 4.1.1).  The stem peptide chains in PG are specifically hydrolyzed by 
endopeptidases of which only a few have been characterized. These autolytic enzymes are 
strongly regulated and ubiquitous among bacteria. Unregulated peptidoglycan 
degradation results in damage to the integrity and protective properties of the 
peptidoglycan structure (Typas et al., 2012). However, the regulation of autolytic systems 
remains incompletely defined, and appears to be different in various species of bacteria. 
Though unregulated autolysin could be suicidal, they are involved in vital aspects of 
bacterial physiology: assembly and disassembly processes of the PG layer such as PG 
growth, PG turnover and recycling, cell separation in cell division, remodeling the PG 
sacculus to determine cell shape, assembly of cell surface organelles, autolysis, 
resuscitation of dormant cells, biofilm formation, bacterial cell lysis in interbacterial 
species competition and lysis induced by the β-lactam antibiotics (Vollmer et al., 2008; 
Typas et al., 2011).  
Staphylococcus aureus contains several peptidoglycan hydrolases. Based on their 
cleaveage site they are classified as N-acetylglucosaminidases, N-acetylmuramoyl-l-
alanineamidases, endopeptidases and transglycosidases (Strominger and Ghuysen, 1967).  
Zymograms of crude cell extracts of different S. aureus strains showed five major 
bacteriolytic bands (Sugai et al., 1990). Some of the enzymes remain uncharacterized.  
However, little is known about the regulation of staphylococcal peptidoglycan hydrolase 
system. The most prominent autolysin of Staphylococcus aureus is Atl, a bifunctional 
three-domain enzyme of aproximately 137 kDa, which undergoes proteolytic cleavage to 
yield two catalytically active proteins: N-terminal region independently exhibits N-
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acetylmuramoyl-L-alanine amidase (AM) and The C-terminal region of the protein has 
endo-β-N-acetylglucosaminidase domains (GL) (Heilmannet al., 1997; Sugai et al., 1995).  
Atl-AM is a 63.3 kDa protein that cleaves the amide bond between the N-acetyl muramic 
acid in the murein backbone and L-alanine in the stem peptide (Biswas et al., 2006). AM 
contains an enzymatic domain and two repeat domains that are involved in localization 
and substrate recognition (Biswas et al., 2006, T Baba et al.,1998). These three modules 
are separated by two linkers, L1 and L2. Two repeat domains, known as R1 and R2 are 
located at C-terminal. Studies of sequence alignments demonstrated that repeats R1 and 
R2 can each be further divided into a-type and b-type subunit (Marino et al., 2002). 
Recently M. Schlag et al has studied the role of repeat units by expressing R1 and R2 
endogenously and externally. They tried to understand the mechanism of Atl-repeat unit 
attachment to the equatorial surface ring in staphylococci. It has been shown that the 
binding of the amidase repeats (R1, 2) is based on an exclusion strategy mediated by 
WTA. 
Atl-GL is a 53.6 kDa enzyme that hydrolyzes the bond between N-acetyl-β-D-
glucosamine and N-acetyl muramic acid and contains an enzymatic domain and a single 
repeat domain (Oshida et al., 1995). The repeat domain of GL is known as R3 and located 
at its N-terminus (Heilmann et al., 1997). Its role in partitioning of daughter cells in S. 
aureus is less clear. The R3 domain showed good lytic activity in zymograms, where 
Micrococcus luteus was used as a substrate (Heilmann et al., 1997). 
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Figure 3.1.1 Cleavage site of the Atl amidase (AM) and glucosaminidase (GL). 
Shown is a section of the S. aureus peptidoglycan (PGN) structure composed of the 
glycan strand with alternating N-acetylglucosamine (GlcNAc) and N-acetylmuramic 
acid(MurNAc), the peptide subunit and the penta-glycine interpeptide bridge. The 
cleavagesites of the amidase (AM, N-acetylmuramoyl-l-alanine amidase) and the glu-
cosaminidase (GM, endo-β-N-acetylglucosaminidase) are indicated by arrows. For 
comparison the cleavage site of lysozyme (N-acetylmuramidase) and lysostaphin PGN-
endopeptidases are indicated. Also shown are the three typical PGN modifications in S. 
aureus: OAc (O-acetylation) and WTA (wall teichoic acid) both are tethered at the C6 
position of MurNAc, and the covalently cell wall bound proteins at the N-terminus of the 
pentaglycine peptide, with the conserved LPXT-motive. 
 
Regulation of the autolytic enzymes in S. aureus is controlled at various 
transcriptional and posttranslational levels such as enzyme activity, processing and 
targeting. There are several two component regulatory systems which affects 
peptidoglycan hydrolase activity and autolysis. These included: lytSR, Sar, Arg, lrgAB, 
and cidABC regulatory network that modulate murein hydrolase expression and/or 
activity. Moreover, WalK/R and GraRS regulons are also involved in autolysis control. It 
has been shown that these types of regulations evolved as a way for the bacteria to 
maximize their ability to evade host immune responses, while simultaneously reducing 
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their susceptibility to β -lactam antibiotics. These two component system are out of this 
chapter’s scope, hence not discussed here.  
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Figure 3.1.2 Genomic location of atl (A) and domain arrangement of the bifunctional 
precursor protein (B).  
In most sequenced staphylococcal genomes atl is flanked by the same orthologous genes. 
In all staphylococcal species analyzed so far the Atl homolog is organized as a 
bifunctional protein with an amidase (AM) and a glucosaminidase (GM) domain. In S. 
aureus Atl is post-translocationally processed (indicated by arrows) between the 
propeptide (PP) and amidase (AM) domain and between therepeat domains R2b and R3a 
to free AM-R1-2 and R3-GM. SP signalpeptide, PP propeptide, AM catalytic domain of 
amidase, GL catalytic domain of glucosaminidase, R1a, R1b, R2a, R2b, R3a, R3b repeat 
domains. 
 
TAs are usually constitutively produced and either connected to PG (WTA) or to 
the cytoplasmic membrane (LTA). S. aureus WTA is covalently linked to the 6-OH of N-
acetyl muramic acid (MurNAc) via a disaccharide composed of N- acetyl glucosamine 
(GlcNAc)-1-P and N-acetyl mannosamine (ManNAc) (Brown et al., 2008). Besides, 
teichoic acid and PG, cell wall has surface proteins on their outer membrane. WTAs help 
in anchoring cell surface proteins. It has been shown that Atl and PBP4 localized to the 
cell septum in presence of WTA (Atilano et al., 2010; Schlag et al 2010). This binding is 
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modulated most likely by the charge of WTA. Due to negatively charged phosphate 
groups and free positively charged amino groups D-Ala residues on the ribitol phosphate, 
teichoic acid exhibit zwitterionic properties (Weidenmaier and Peschel et al, 2008; Kohler 
et al., 2009). Reduced D-Ala in bacteria showed more negatively charged cell surface and 
this allowed increased binding of cationic proteins ( Wecke et al., 1997). In absence of D-
Ala and or less D-alanine, the cell surface charges become more negative due to less 
positive charge in WTA and that allows for increased binding of cationic proteins like Atl. 
The negatively charged bacterial surface is important for the activity of cationic 
autolysins and could direct an increased autolytic rate (Walter et al., 2007). Amidases are 
normally localized to the septum region, but in the absence of wall teichoic acids the 
amidases are delocalized and are distributed along the cell surface. It is hypothesized this 
mislocalization results in the increased autolysin activity seen in WTA deletion mutants 
(Schlag et al., 2010).  
WTAs are proposed to be temporal and spatial regulators of peptidoglycan cross-
linking that operate by mediating localization of proteins associated with PG biosynthesis 
and remodeling, such as PBP4 and AtlA (Schlag et al., 2010). Furthermore, FmtA 
localizes at the cell division septum, most likely by binding to the cross wall. More 
specifically, FmtA localizes at the division pole and moves further forward to the center 
of the bacterium as the cross-wall is synthesized. A similar localization pattern was also 
observed for PBP4 of S. aureus (Atilano et al., 2010.) In the absence of WTA, FmtA is 
delocalized throughout the cell. However, no delocalization was observed in the presence 
of cell wall inhibitors, which excluded the possibility of FmtA recruitment to the division 
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septum by PG. Like FmtA, amidase delocalize and distribute along the cell surface in the 
absence of WTA.  However, there are reports that demonstrated the absence of mature 
WTA in the cross-wall region (Schlag et al., 2010). Studies have shown that WTAs 
control the autolytic activity of AtlA most likely by modulating WTA negative charge. 
FmtA is known to have effect on autolysis in presence of triton X-100. Like FmtA, AtlA 
also interacts with WTA and localized in cell division septum. We have shown that FmtA 
interacts with WTA and removes D-Ala from ribitol (chapter 2). Binding of FmtA to 
WTAs may activate AtlA by modulating the negative charge of WTAs in cell division 
septum; however, there is a possibility of interactions between FmtA and AtlA.  
The interactions between FmtA and WTA suggest that WTA might recruit FmtA 
to cell wall. Same types of observation were noted for PBP4 and PBP2a.  However, there 
is a possibility that FmtA, PBP4 and /or PBP2a may work cooperatively (Qamar and 
Golemi-Kotra, 2012). To address these questions, we tried to explore the WTA 
interaction with FmtA, PBP4 and Atl. We designed pull down experiments to study 
potential protein-protein interactions of FmtA with PBP4 and/or PBP2a. Furthermore, we 
have cloned and purify Atl-AM and Atl-GL. we have shown the biochemical evidence of 
interactions between Atl (AM and GL) and WTA. Finally, protein-protein interactions 
between Atl and FmtA were studied by gel filtration chromatography, ITC and native 
PAGE based on their mobility. 
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3.2 Materials and Methods 
3.2.1 Materials and chemicals 
Growth media were purchased from EMD Bioscience. Enzymes and chemicals 
were purchased from Sigma (Oakville, Canada) and Thermo-Fisher (whitby, Canada) and 
New England BioLabs (Eco RI, NotI); unless otherwise stated.  All primers were 
purchased form Sigma (Oakville, Canada). The DNA polymerases PfuTurbo® was 
purchased from Agilent Technologies. 
3.2.2 Cloning of atlAM gene  
Cloning of Atl AM was done by Dr. Atul Kumar Singh. First the atlAM gene was 
amplified from genomic DNA of S. auresu strain MU50 by polymerase chain reaction 
(PCR). The Primers were:  Dir 5’ – ACG CAT ATG GCT TCA GCA CAA CCA AG-3’ 
and Rev 5’ – ACG AAG CTT TTA TTA TTT TAC AGC TGT TTT TGG TTG-3’ (Nde I 
and Hind III restriction sites are bolded and underlined). Finally the atlAM gene was 
cloned into commercial pET24a (+) vector. The resulting clones were sequenced for 
correct insert at the center for applied genomics, the hospital for sick children (Toronto, 
Canada). Finally the correct insert was transformed into E. coli BL21 (DE3) cells for 
protein expression. 
3.2.3 Expression and purifications of Atl-AM 
A single colony of BL21(DE3), containing the required expression construct in 
pET24 a(+):: atlAM  vector was used to start a seed culture which was grown overnight at 
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37°C in 5 mL Luria Bertani (LB) medium supplemented with kanamycin (30 µg/mL). A 
200 fold of overnight seed culture was used to inoculate 800 mL of Terrific Broth 
medium supplemented with kanamycin (30 µg/mL) and 0.1 M D-sorbitol. The inoculated 
medium was grown at 37°C, 180 rpm, until OD600nm reached 0.6-0.8, at which protein 
expression was induced by addition of Isopropyl β-D-thiogalactopyranoside at a final 
concentration of 0.1 mM. Expression of protein was carried out for 16 hours at 16°C, 160 
rpm and the cells were harvested at 7,000 x g for 20 min at 4°C. Resulting pellets were 
frozen at -80°C if subsequent purification steps were not carried out on same day. 
All purification steps were carried out at 4°C. Harvested cells were resuspended in 
50 mM sodium phosphate buffer, pH 7.6. Sonication (5 cycles of 1 min; 30% power, 60% 
pulse) was used to liberate the protein and centrifugation at 21000 x g for 60 min was 
carried out to remove cell debris. The resulting supernatant was applied to a S- Support 
column (Strong Cation exchange) (90-100 mL column volumes) pre-equilibrated with 
sodium phosphate buffer, pH 7.6. The target protein (AtlAM) was eluted at 40-50% of a 
liniear gradient of 0 to 1 M sodium chloride in 50 mM sodium phosphate buffer, pH 7.6. 
Protein fractions containing pure protein were concentrated using centrifugal filter 
Ultracel-3K (Amicon , Millipore). The purified protein concentration was determined 
BSA method. 
3.2.4 Theoretical PI, MW calculation and Structural prediction of Atla-AM 
Theoretical PI, MW calculation and Structural prediction of Atla-AM was 
calculated using the software Ex-pasy. For theoretical PI and MW computation, Amino 
91 
 
acid sequence was submitted to at http://web.expasy.org/compute_pi/. For Structure 
prediction, Amino Acid sequence was submitted 
to http://www.sbg.bio.ic.ac.uk/~phyre2/html/page.cgi?id=index and  
http://zhanglab.ccmb.med.umich.edu/I-TASSER/ 
3.2.5 Expression and purifications of Atl-Gl 
Atl Gl was cloned by Michael Fridman. A single colony of BL21(DE3), 
containing the required expression construct in pET24 a(+):: atlGL  vector was used to 
start a seed culture which was grown overnight at 37°C in 5 mL Luria Bertani (LB) 
medium supplemented with kanamycin (30 µg/mL). A 200 fold of overnight seed culture 
was used to inoculate 800 mL of Terrific Broth medium supplemented with kanamycin 
(30 µg/mL) and . The inoculated medium was grown at 37°C, 180 rpm, until OD600nm 
reached 0.6-0.8, at which protein expression was induced by addition of IPTG at a final 
concentration of 0.5 mM. Expression of protein was carried out for 16 hours at 16°C, 160 
rpm and the cells were harvested at 7,000 x g for 20 min at 4°C. Resulting pellets were 
frozen at -80°C if subsequent purification steps were not carried out on same day. 
All purification steps were carried out at 4°C. Harvested cells were resuspended in 
50 mM sodium phosphate buffer, pH 7.6. Sonication (5 cycles of 1 min; 30% power, 60% 
pulse) was used to liberate the protein and centrifugation at 21000 x g for 60 min was 
carried out to remove cell debris. The resulting supernatant was applied to S-Support 
column (Strong Cation exchange column) (90-100 mL column volumes) pre-equilibrated 
with sodium phosphate buffer, pH 7.6. The target protein (Atl-AM) was eluted at 40-50% 
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of a liniear gradient of 0 to 1 M sodium chloride in 50 mM sodium phosphate buffer, pH 
7.6.Protein fractions containing pure protein were concentrated using centrifugal filter 
Ultracel-3K (Amicon , Millipore). The purified protein concentration was determined 
BSA method. 
3.2.6 Circular Dichroism (CD) spectroscopic studies 
Near UV (200 nm- 260 nm) CD spectra of Atl AM and GL was recorded on a 
Jasco J-810 instrument using a cuvette with 1.0 mm light path length at 22 °C. A blank 
spectrum was recorded for buffer and subtracted from proteins spectrum.  
3.2.7 Enzymatic activity of Atl-AM and Atl-GL by zymography 
A single colony of S. aureus RN4220 was used for a seed culture which was 
grown overnight at 37°C in 5 mL Tryptic Soy Broth (TSB) medium. A 200 fold of 
overnight seed culture was used to inoculate 500 mL of TSB medium for overnight. 
Further, Cells were harvested by centrifugation at 7000 x g by using 10.5 JLA rotar and 
transferred in to 50 mL tube. Cell pellet were diluted with 2-3 mL TSB media and boiled 
for 15 min to inactivate any pathogenic factors. Second harvest was followed by 
centrifugation at 16000 x g for 15 min and supernatant was removed. Finally, cell pellet 
were lyophilized at Dr. Krylov’s lab facilities. 
Zymogram gel was prepared by using 0.6% w/v of lyophilized RN4220 in 12.5% 
SDS-PAGE gel preparation. 0.25 µg lysostaphin was used as a positive control. SDS dye 
was used for protein sample loading. For enzymatic activity on the zymogram, gel was 
washed 3 to 4 times with water to remove any SDS in the gel (1-2 hrs). Furthermore, the 
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gel was incubated in 1% triton X-100-25 mM Tris-HCL (pH-8.0) for overnight at 37°C. 
Zone of clear area showed the activity of Hydrolysis of murein on gel. Image was taken 
against light. Gel was stained with 1% w/v methylene blue in 0.01% w/v KOH (around 1 
hr) followed by destaining  with water. 
3.2.8 Investigation of Atl-AM or Atl-GL and WTA interaction by acidic 
nPAGE/H+ 
Interaction of WTA with Atl AM or Atl GL was investigated with native 
polyacrylamide gel electrophoresis (nPAGE/H+). A typical reaction mixture (15 µL) 
consisted of Atl AM or Atl GL (10 µM) and 5, 10, 15, 20 µg of WTA in 50 mM sodium 
phosphate (pH 7.0) buffers were mixed and incubated for 1 hr at room temperature. 5X 
loading dye (0.2 M acetate KOH pH-6.8, glycerol 50%, Methyl green) was added to the 
mixture prior loading onto acidic native gel. The composition of the separating gel was 
10 % Acrylamide-Bis acrylamide in 0.2 M acetate KOH pH-6.8, glycerol 50%, 1.5 M 
acetate KOH pH-4.3. The PAGE gels were stained with Coomassie blue. WTA used for 
these experiments were extracted previously by TCA method from S aureus RN4220 or 
dltA mutant (No D-alanine in WTA). 
3.2.9 Investigation of FmtAΔ27 and Atl-AM or Atl-GL interaction with by acidic 
nPAGE/H+ 
Interaction of FmtA Δ27 with Atl-AM or Atl-GL was investigated with native 
polyacrylamide gel electrophoresis (nPAGE/H+). A typical reaction mixture (15 µL) of 
FmtAΔ27 (0 to 40 µM) with Atl-AM (0 to 28 µM) or Atl-GL (0 to 30 µM) in 50 mM 
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sodium phosphate (pH 7.0) buffers were mixed and incubated for 1 hr at room 
temperature. 5X loading dye (0.2 M acetate KOH pH-6.8, glycerol 50%, Methyl green) 
was added to the mixture prior loading onto acidic native gel. The composition of the 
separating gel was 10 % Acrylamide-Bis acrylamide in 0.2 M acetate KOH pH 6.8, 
glycerol 50%, and 1.5 M acetate KOH pH 4.3 The PAGE gels were stained with 
Coomassie blue.  
3.2.10 Investigation of FmtAΔ27 and Atl AM interaction with by Isothermal 
Titration Calorimetry (ITC) 
ITC experiments were performed using a ITC200 instrument (MicroCal., Inc., 
USA). Purified proteins were dialyzed with 50 mM sodium phosphate buffer, pH 7.2. 
Titrations were performed by injecting of FmtA wild type (46 µM) into the sample cell 
containing Atl AM (4 µM) at 25°C, DP 10 and 300 rpm. The binding stoichiometry and 
binding constants were determined by fitting the data to a one-site binding model. The 
ITC data were fit using Origin 7.0 (MicroCal., Inc., USA). 
3.2.11 Investigation of FmtAΔ27 and Atl GL interaction with by size exclusion 
chromatography 
FmtA Δ27 WT 42 µM or FmtA Δ27 S127 40 µM was mixed with Atl-GL 10µM in a 
final volume of 40 µL in 50 mM Sodium phosphate buffer (pH 7.0) and incubated for 1 
hr at room temperature. The resulting mixture was analyzed by high-performance liquid 
chromatography (HPLC). FmtA Δ27 WT 42 µM or FmtAΔ27 S127 40 µM or Atl-GL 10µM 
in a final volume of 40 µL was used for reference analysis. HPLC analysis of the protein 
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mixtures was conducted on an Size exclusion column G2000SWXL for HPLC (7.8 x 300 
mm, 5 µm, TOSHOH bioscience LLC) using 50 mM Tris, 50 mM potassium Chloride, 5 
mM Magnesium Chloride (pH 7.4). The program was run for 20 min at a flow rate of 1 
mL/min.  
3.3 Results  
3.3.1 Expressions and Purifications of Atl-AM  
The pET24a (+):: atl AM  construct, containing R1 and R2 unit was cloned by Dr. 
Atul Kumar Sing. Furthermore, construct was transformed into E. coli BL21 (DE3) 
contains an IPTG inducible T7 promoter for cytoplasmic expression. The protein was best 
expressed in cytoplasm of E. coli BL21 (DE3) cells by using optimized expression 
conditions (0.1 mM IPTG in presence of 0.1M D-sorbitol at 16°C for 16 hrs). Following 
induction with IPTG sufficient amount of soluble Atl AM was obtained, as seen in the 
figure 3.3.1 for subsequent purification steps. Theoretical pI of Atl AM was calculated to 
be 9.62 with a molecular weight of 63070.80 Da. The purification strategies involve 
passing the supernatant through S-support column (strong cation exchange, due to SO3 – 
group). The desired protein was eluted between 45-60 % linear gradient of 1 M NaCl. 
The resulting fairly pure fractions were concentrated and final protein homogeneity was 
assessed by 12.5% SDS-PAGE. 
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 Figure 3.3.1 Purifications of Atl AM  
12.5 % SDS-PAGE was loaded with fractions from S support column. Lane 1: 
supernatant from E. coli BL21 (DE3) cells expressing target protein. Lane 2 to lane 8 
fractions eluted by 45-60 % linear gradient of 1 M NaCl 
3.3.2 Expressions and Purifications of Atl GL 
The pET24a (+):: atlGL construct, containing R3 unit was cloned by Michael 
Fridman. Furthermore, construct was transformed into E. coli BL21 (DE3) contains an 
IPTG inducible T7 promoter for cytoplasmic expression. The protein was best expressed 
in cytoplasm of E. coli BL21 (DE3) cells by using 0.5 mM IPTG at 16°C for 16 hrs. 
Theoretical pI of Atl GL was calculated to be 9.64 with a molecular mass of 53567.53Da. 
The purification strategies involve passing the supernatant through S-support column 
(strong cation exchange, due to SO3 – group). The desired protein was eluted between 45-
60 % linear gradient of 1 M NaCl. The resulting fairly pure fractions were concentrated 
and final protein homogeneity was assessed by 12.5% SDS-PAGE. 
       1      2     3      4      5      6      7     8     
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 Figure 3.3.2 Purifications of Atl GL 
12.5 % SDS-PAGE was loaded with fractions from S support column. Lane 1: 
supernatant from E. coli  BL21 (DE3) cells expressing target protein. Lane 2 to lane 8 
fractions eluted by 45-60 % linear gradient of 1 M NaCl 
3.3.3 Zymographic detection of the autolytic activity of Atl AM and Atl GL 
A suitable substrate (heat killed S. aureus RN4220) was embedded in the 
resolving gel during preparation of the 12.5% SDS acrylamide gel. Following 
electrophoresis, the SDS was removed from the gel (or zymogram) by incubation in water. 
Finally, the gel was incubated in a buffer containing Triton X-100 for an optimized length 
of time at 37°C. The zymogram is subsequently stained (alchene blue), and areas of 
digestion appear as clear bands against a dark background where the substrate has been 
degraded by the enzyme. Atl AM and Atl GL has a molecular weight 63 kDa and 53.5 
Kda, respectively.  Atl AM cleaves the amide bond between the N-acetyl muramic acid in 
the murein backbone and L-alanine in the stem peptide and Atl GL shows endo-β-N-
acetylglucosaminidase activity that hydrolyzes bond between N-acetyl-β-D-glucosamine 
and N-acetyl muramic acid (Biswas, R et al., 2006, Bose, J L., et al 2012).  Lysostaphin 
was used as a positive control. Clear bands in zymogram analysis showed Atl AM and Atl 
GL were active and had an enzymatic activity on substrate S. aureus RN4220 
   1      2        3      4       5      6       7       8 
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peptidoglycan cells. However, AM is more active on substrate S. aureus RN4220 
compare to GL. 
                                       
Figure 3.3.3 Zymographic detection of the autolytic activity of Atl AM. 
Atl AM Protein Purified from E. coli BL21 cells grown with IPTG were used for 
enzymatic activity. The protein extract was separated by 12.5% SDS-gel electrophoresis. 
The SDS gel was impregnated with 0.8% heat killed S. aureus RN4220 cells. Autolytic 
activity was detected by renaturing the Atl AM by incubation of the gel in 50 mM Tri-
HCl buffer, pH 8, containing 0.1% Triton X-100. Lane 1and 2: Atl AM ; lane 3: 
Lysostaphin . Lanes 4: Lysostaphin boiled, Lane 5 and 6: Atl GL 
3.3.4 Circular Dichroism (CD) spectroscopic studies for Atl AM 
Circular Dichroism is defined as the unequal absorption of left-handed and right-
handed circularly polarized light. When asymmetric molecules interact with light, they 
may absorb right and left handed circularly polarized light to different extents (hence the 
term circular dichroism). CD is an excellent method of determining the secondary 
structure of proteins. When the chromophores of the amides of the polypeptide backbone 
of proteins are aligned in arrays, their optical transitions are shifted or split into multiple 
transitions due to “exciton” interactions. The result is that different structural elements 
have characteristic CD spectra. For example, α-helical proteins have negative bands at 
 1      2      3     4        5       6 
        AM           Lysostphin             GL 
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222 nm and 208 nm and a positive band at 193 nm. Proteins with well-defined antiparallel 
β-pleated sheets (β-helices) have negative bands at 218 nm and positive bands at 195 nm, 
while disordered proteins have very low ellipticity above 210 nm and negative bands near 
195 nm.CD analysis of Atl AM showed that Atl AM has both α and β sheet.  
A  
B  
Figure 3.3.4 Circular Dichroism (CD) spectroscopic studies for Atl 
A: Atl AM 10 µM in 50 mM sodium phosphate buffer (pH 7.6) at 22°C. Data points were 
corrected for buffer signal.  
B: Atl GL 10 µM in 50 mM sodium phosphate buffer (pH 7.6) at 22°C. Data points were 
corrected for buffer signal. 
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3.3.5 Investigation of Atl and WTA interaction by acidic nPAGE/H+ 
This interaction was investigated through native acidic polyacrylamide gel 
electrophoresis (native-H+/PAGE). "Native" or "non-denaturing" gel electrophoresis is 
run in the absence of SDS. While in SDS-PAGE the electrophoretic mobility of proteins 
depends primarily on their molecular mass, in native PAGE the mobility depends on both 
the protein's charge and its hydrodynamic size. The electric charge driving the 
electrophoresis is governed by the intrinsic charge on the protein at the pH of the running 
buffer. This charge will, of course, depend on the amino acid composition of the protein. 
Since the protein retains its folded conformation, its hydrodynamic size and mobility on 
the gel will also vary with the nature of this conformation (higher mobility for more 
compact conformations, lower for larger structures like oligomers). If native PAGE is 
carried out near neutral pH to avoid acid or alkaline denaturation, then it can be used to 
study conformation, self-association or aggregation, and the binding of other proteins or 
compounds (protein-protein or protein-ligand) due to their mobility. 
The WTA-binding properties of Atl were studied using WTAs isolated from S. 
aureus RN4220 and dltA mutant (where no D-Ala is present in the WTA). Incubation of 
Atl with WTAs resulted in a lack of electrophoretic resolution of the protein by the use of 
a native acidic gel. These reported results were reproduced by Shamina Prova. When 
protein and WTA interact together the protein is prevented from entering the gel. In these 
experiments protein concentration was kept constant and varied the WTA amount in the 
assay. These experiments show both AM and GL interacts with WTA but the amount of 
WTA needed to prevent GL from entering the gel is less than AM. Furthermore, dltA 
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mutant WTA showed higher affinity for AM and GL compare to S. aureus RN4220 WTA. 
WTA extracted from dltA mutant has no D-Ala in second position of ribitol. As a result, 
WTA from dltA mutant has more negative charge, which may attract cationic autolysins 
AM and GL.  
  
A  
B  
Figure 3.3.5.1 Investigation of Atl AM and WTA interaction by acidic nPAGE/H+ 
A: Lane 1: Atl AM 10 µM, Lane 2: Atl AM 10 µM with 5 µg WTA (ΔdltA mutant), Lane 
3: Atl AM 10 µM with 10 µg WTA (ΔdltA mutant), Lane 4: Atl AM 10 µM with 15 µg 
WTA (dltA mutant), Lane 5: Atl AM 10 µM with 20 µg WTA (DltA mutant), Lane 6: Atl 
AM 10 µM with 5 µg WTA (RN4220), Lane 7: Atl AM 10 µM with 10 µg WTA 
(RN4220), Lane 8: Atl AM 10 µM with 15 µg WTA (RN4220), Lane 9: Atl AM 10 µM 
with 20 µg WTA (RN4220) 
B: Atl AM interaction comparison with RN4220 WTA and ΔdltAWTA 
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A  
B  
Figure3.3.5.2 Investigation of Atl GL and WTA interaction by acidic nPAGE/H+ 
Lane 1: Atl GL 10 µM, Lane 2: Atl GL 10 µM with 5 µg WTA (ΔdltA mutant), Lane 3: 
Atl GL 10 µM with 10 µg WTA (ΔdltA mutant), Lane 4: Atl GL 10 µM with 15 µg WTA 
(ΔdltA mutant), Lane 5: Atl GL 10 µM with 20 µg WTA (ΔdltA mutant), Lane 6: Atl GL 
10 µM with 5 µg WTA (RN4220), Lane 7: Atl GL 10 µM with 10 µg WTA (RN4220), 
Lane 8: Atl GL 10 µM with 15 µg WTA (RN4220), Lane 9: Atl GL 10 µM with 20 µg 
WTA (RN4220) 
B: Atl GL interaction comparison with RN4220 WTA and ΔdltAWTA  
3.3.6 Investigation of potential FmtAΔ27 and Atl interaction by acidic nPAGE/H+ 
Native PAGE can be used to study conformation, self-association or aggregation, 
and the binding of other proteins or compounds (protein-protein or protein-ligand) due to 
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their mobility. Acidic nPAGE/H+ was used to investigate potential FmtAΔ27 and Atl 
interactions. Different concentration of Fmta Δ27 WT and Atl AM or Atl GL mixture was 
analyzed by 10% Acidic Native-PAGE. No changes in the mobility of Fmta Δ27 WT and 
Atl AM or Atl GL from the mixed protein were observed compared to reference Fmta Δ27 
WT or AtlA-AM in the same gel. These results indicate no potential interactions between 
Fmta Δ27 WT and Atl. 
 
 
 
Figure 3.3.6 Investigation of FmtAΔ27 and Atl AM/ Atl GL interaction with by acidic 
nPAGE/H+ 
Different concentration of Fmta Δ27 WT and AtlA-AM /Atl GL was mixed and incubated 
at RT for 1 hr in a total volume of 15 µL. Native loading dye was added with protein and 
Fmta WT(µM)                0              4           4           4           4          4          10        20         30           40                        
Atla-Gl (µM)                 5            0         5       10        15      30       5         10       15        30       
Fmta WT(µM)             0             5         5         5         5        5          5       5           5            5 
Dialyzed Atl-GL                     Non Dialyzed Atl-GL 
AtlA-AM (µM)             4              0          4          10         20        28          4          4           4              4                         
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analyzed by 10% Acidic Native–PAGE. Protein bands were visualized by coomassie blue 
staining. Only Fmta Δ27 WT or AtlA-AM/ Atl GL was used as a control. 
3.3.7 Investigation of FmtAΔ27 and Atl interaction with by gel filtration (HPLC) 
Gel filtration (or size-exclusion) chromatography is a method for separating 
macromolecules on the basis of differences in Stokes’ radii (Ackers et al, 1975). The 
chromatographic resin consists of porous particles made up of cross-linked polymers. 
Separation of proteins is achieved by partitioning between the mobile phase, the solvent 
that is exterior to the chromatographic particles, and the stationary phase, consisting of 
the solution within the porous particles themselves. The volume at which a protein elutes 
from the column is a direct reflection of the amount of time it spends within the porous 
particle. Thus, larger proteins, which are less likely to penetrate the particle, elute earlier, 
and smaller proteins, which effectively spend more time in the stationary phase, elute 
later. Gel filtration chromatography has been used extensively for protein purification and 
for estimation of protein molecular weight. Because the interaction between two or more 
proteins results in the formation of a complex having a larger Stokes’ radius than its 
constituents, gel filtration chromatography can also be applied to the detection and 
characterization of protein–protein interactions. 
To study protein-protein interactions between FmtA and GL, reference FmtA and 
GL was loaded in the gel filtration column besides the mixure of FmtA and GL. Atl GL 
showed one single peak around 7.5 to 9 min when eluted with 50 mM Tris, 50mM 
potassium Chloride, 5 mM Magnesium Chloride (pH 7.4) on Size exclusion column 
G2000SWXL . On the other hand, FmtA showed two peaks, one around 9 min and other 
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one around 10 min; most likely due to their dimer nature. HPLC analysis of Atl GL and 
FmtA mixture on Size exclusion column revealed same retention time compared to 
reference Atl GL or FmtA WT protein elution. These results suggest no potential 
interactions between FmtA and Atl GL. 
A
 
B 
 
Figure 3.3.7 Investigation of FmtAΔ27 and Atl interaction with by gel filtration 
(HPLC) 
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Atl GL and FmtA were injected separately as a reference for Atl GL and FmtA mixture 
analysis. Red color line represents FmtA WT, Blue color line represents Atl GL and green 
color line represents FmtA WT or FmtA S127 and Atl GL mixture.  A: FmtA WT and Atl 
GL mixture analysis B: FmtA S127 and Atl GL analysis. 
3.3.8 Investigation of FmtAΔ27 and Atl interaction with by Isothermal Titration 
Calorimetry (ITC) 
Isothermal Titration Calorimeters (ITC) measure the heat change that occurs when 
two substances interact. Heat is liberated or absorbed as a result of the redistribution of 
noncovalent bonds, for example, when the interacting molecules go from the free to the 
bound state. An ITC mixes the binding partners and monitors these heat changes by 
measuring the power required to maintain zero temperature difference between the 
reference and sample cells. When two proteins bind, there are changes in the 
thermodynamic potentials (ΔG, ΔH, ΔS), which can be measured directly by highly 
sensitive calorimetry. Investigation of protein-protein interactions between FmtAΔ27 and 
AM by ITC showed no significant heat change. As a result, the data were not fitting well 
according to binding curve. These results suggest no potential interactions were 
FmtAΔ27 and Atl AM and GL. 
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A      B     
C   
Figure 4.3.8 ITC analysis of the interaction between FmtAΔ27 and Atl AM.  
(A) Titration by injecting of FmtA wild type (46 µM) into the sample cell containing Atl 
AM (4 µM)  (B) Titration by injecting of FmtA wild type (46 µM) into the sample cell 
containing Atl AM (28 µM) (C) Titration by injecting of FmtA wild type (63 µM) into 
the sample cell containing Atl GL (5 µM) 
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3.4 Discussion 
The major enzyme that involved in cell lysis in S. aureus is autolysin (Atl). Atl is 
processed to generate two extracellular lytic enzymes, amidase, and an endo-β-N-
acetylglucosaminidase which are noncovalently attached to the staphylococcal cell 
surface. We have cloned Atl AM with two repeat units (R1,2) and Atl GL with R3 unit 
from S. aureus Mu50. These proteins were expressed and purified to homogeneity. Atl 
AM (PI 9.62) and Atl GL (PI 9.64) are cationic proteins. These proteins were purified 
using one step purification strategy with S-support column, which is a strong cationic 
exchange column due to SO3 – group. Furthermore, zymogram was used to check the 
enzymatic activity of these proteins, where substrate (heat killed S. aureus RN4220) was 
embedded in the resolving gel during preparation of the SDS-PAGE gel and triton X-100 
was used for autolysis. Clear bands in zymogram showed Atl AM and Atl GL were active 
and had an enzymatic activity on substrate S. aureus RN4220 peptidoglycan cells. 
However, AM was enzymatically more active than GL on substrate S. aureus RN4220 
peptidoglycan cells which is in agreement with reported literature (Bose et al., 2012). 
Currently it is unknown why S. aureus cell walls have a higher sensitivity to AM when 
compared to GL.  
WTA is one of the key components of cell wall. WTA has many different 
functions: target and control of peptidoglycan biosynthetic proteins, resistance to harmful 
molecules such as antimicrobial fatty acids, antimicrobial peptides, and lysozyme. It has 
been shown that WTA plays a crucial role in targeting the Atl to the septum region. 
Recent studies have shown that presence of WTA reduces the affinity of Atl and of other 
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autolysins for S. aureus peptidoglycan. Atl binds preferentially to the cell division site 
where WTA appears to be less abundant or not yet fully matured (M Schlag et al., 2010). 
Concanavalin A (ConA) is a carbohydrate binding protein binds preferentially to teichoic 
acids. Binding studies with ConA-FITC conjugate revealed that the polymerization of 
WTA gradually increases with the distance from the cross-wall. This may explain the 
binding of AM and GL to cross wall for cell separation from daughter cell instead of 
binding to old cell wall (Götz et al., 2014).  
It is very important to understand how WTA controls autolysin activity. Teichoic 
acids exhibit zwitterionic properties Due to negatively charged phosphate groups and 
positively charged amino groups in D-Ala residues. Negatively charged bacterial surface 
is important for the activity of cationic autolysins. So far there is no biochemical evidence 
of direct interaction between autolysin Atl and WTA. We have investigated the 
biochemical interactions between Atl and WTA by acidic nPAGE/H+ and this is the first 
time to report about Atl and WTA direct biochemical interactions. WTA used for these 
experiments were extracted from well known laboratory strain S. aureus RN4220 and 
ΔdltA mutant (no D-Ala in WTA). Results from Atl and WTA experiments showed both 
AM and GL interacts with WTA, however, the amount of WTA required to prevent GL 
from entering the gel is less than AM. Moreover, WTA from ΔdltA mutant has showed 
higher affinity for AM and GL compare to wild type S. aureus RN4220 WTA. WTA 
extracted from ΔdltA mutant has no D-Ala in second position of ribitol. As a result, WTA 
from ΔdltA mutant has more negative charge, which may attract cationic autolysins AM 
and GL.  
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FmtA interacts with WTA and removes D-Ala from ribitol (Chapter 2). Therefore, 
FmtA might affect the activity of AtlA by modulating the negative charge of WTAs. 
FmtA localizes at the cell division septum, most likely by binding to the cross wall. AtlA 
also interacts with WTA and localized in cell division septum. To explore the possibility 
of interactions between FmtA and AtlA, we have examined protein-protein interactions of 
Atl and FmtA by using acidic native page, gel filtration (HPLC) and isothermal titration 
calorimetry methods. However, no potential protein-protein interactions of FmtA and Atl 
were observed from our experiments.  
In conclusion, FmtA and Atl localize in cell division septum and in absence of 
WTA they distributed along the cell surface. We have shown that in absence of D-Ala in 
WTA, Atl interacts more to WTA most likely due to more negative charge in WTA. This 
may suggest that FmtA removes D-Ala from WTA and makes zwitterionic WTA 
(Chapter two) more negatively charge to facilitate the localization of Atl at cell division 
septum. It would be interesting to investigate the localization of Atl in ΔfmtA Strain. Our 
results also suggest no potential protein-protein interactions between FmtA and Atl AM 
or GL. 
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CHAPTER FOUR 
SUMMARY AND FUTURE DIRECTIONS 
 
5.1 Summary and Future directions  
Staphylococcus aureus is a virulent pathogen that is currently the most common 
cause of infections in hospitalized patients. Over time S. aureus has evolved to acquire 
resistance against various antibiotics. Methicillin resistant S. aureus (MRSA) shows 
resistance to not only methicillin but also almost all β-actams. It has developed two 
primary strategies to combat against β-lactam antibiotics: expression of β-lactamase and 
production of additional penicillin-binding protein 2a (PBP2a). The expression level of β-
lactamase and PBP2a do not always coincide with the methicillin resistance level, which 
confers other factors are involved in methicillin resistance in MRSA (Chambers 1997; 
Rohrer and Berger-Bachi 2003). 
FmtA is one of the methicillin resistance factors that is shown to be a part of the 
cell wall stimulon, a group of genes that is commonly induced upon treatment with cell 
wall-active antibiotics. Inactivation of fmtA gene exhibited reduced peptidoglycan cross-
linking and methicillin resistance. To date, the biological function of FmtA is not well 
understood. It has been hypothesized that FmtA may participate in peptidoglycan 
biosynthesis under antibiotic-induced cell wall stress conditions (Qamar and Golemi-
kotra, 2012).  
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Studies have shown that FmtA has low affinity for binding with β-lactams and a 
very weak D,D-carboxypeptidase activity. In lieu of this finding that FmtA interacts with 
WTA, we raised the question whether this interaction has any effect on the activity of 
FmtA as a D,D carboxypeptidase. Investigation of the function of FmtA revealed that 
WTA is not an activator for FmtA and that FmtA shows esterase catalytic activity towards 
D-alanyl ester of WTA and LTA. Active site motif of this catalytic activity was found to 
be SXXK motif by mutagenesis studies, which is similar to Family VIII carboxylestease. 
Both Serine and lysine from S127XXK130 motif are involved in esterase catalysis. 
Furthermore, our mutation studies suggest that both serine from SXXK motifs (S63 and 
S127) in FmtA are involved in catalysis.  
During detail investigation of the esterase enzymatic activity of FmtA, we have 
observed that FmtA is very substrate specific (WTA or LTA) compare to synthetic 
esterase substrate and its enzymatic activity depends both on substrate and enzyme 
concentrations. Interestingly, high substrate concentration can inhibit enzymatic reaction 
of FmtA. Many enzymes are inhibited by their own substrates and this inhibition often 
has important biological functions. For example, Substrate inhibition of 
acetylcholinesterase enhances the neural signal and allows rapid signal termination 
(Shafferman et al., 1992).    
WTAs are known to protect gram positive bacteria against harmful molecules and 
environmental stresses, control enzyme activities in the cell surface, control cation 
concentrations in the cell envelope and  bind to receptors and surfaces (Weidenmaier et 
al.,2003; D’Elia et al., 2009). Most of these activities are controlled by the alteration of 
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charges in WTA. Incorporation of D-Ala in WTA is known to be an important 
mechanism by which net charge of the WTA become more positive due to free positively 
charged amino group. Studies have shown that lack of D-Ala decoration to WTA leads to 
increased susceptibility to cationic antimicrobial peptides. We have shown that FmtA can 
remove D-alanine from WTA and this could be an important mechanism of S. aureus to 
control cation homeostasis, D-alanine recycling and metabolism. 
 Besides WTA, tailoring modifications of D-alanyl esters are also observed in 
lipoteichoic acid (LTA) at the second position of glycerol. Although WTA and LTA 
follow different biosynthetic pathways and precursors, both teichoic acids use same 
biosynthetic machinery (dltABCD operon) for incorporation of D-Ala in their repetitive 
polyol (ribitol or glycerol) unit. It has been proposed that D-Ala is transferred to LTA and 
then to WTA (Reichmann et al., 2013). Recently, a new member of dlt operon named 
dltX was indentified which is a small protein with expected size of 5.9 kDa with unknown 
function (Reichmann et al., 2013). It is interesting how dlt operon incorporate D-Ala in 
WTA as well as LTA and FmtA removes it. 
So far, biological functions of most of the esterases are unknown. A putative 
esterase gene, lr1516 belonging to the COG β-lactamase family of penicillin-binding 
proteins from L. reuterish showed up-regulation while studying genome wide expression 
under acidic conditions (Wall et al., 2007). Precise function of this putative esterase is not 
known. It was postulated to be involved in changing the cell wall and thus increasing the 
tolerance of the cells towards acid (Wall et al., 2007). FmtA is considered to be a part of 
cell wall stimulon (McAleese et al., 2006); but its regulation is still unknown. 
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Amidases (AM) are normally localized to the septum region, but in the absence of 
wall teichoic acids they are delocalized and are distributed along the cell surface. 
Teichoic acids exhibit zwitterionic properties due to negatively charged phosphate groups 
and positively charged amino groups in D-Ala residues. Strains lacking D-Ala in teichoic 
acids showed more negative charge in their cell surface and control the activity of 
cationic autolysins. However, there is no biochemical evidence of direct interaction 
between autolysin Atl and WTA. We have shown that both amidase (AM) and 
glucosaminidase (GL) from S. aureus interact with WTA, however, the amount of WTA 
required to prevent GL from entering the gel is less than AM. 
FmtA interacts with WTA and removes D-alanine from ribitol. Therefore, FmtA 
might affect the activity of Atl by modulating the negative charge of WTAs. FmtA 
localizes at the cell division septum, most likely by binding to the cross wall. AtlA also 
interacts with WTA and localized in cell division septum. To explore the possibility of 
interactions between FmtA and AtlA, we have examined protein-protein interactions of 
Atl and FmtA by using acidic native page, gel filtration (HPLC) and isothermal titration 
calorimetry methods. However, no potential protein-protein interactions of FmtA and Atl 
were observed from our experiments.  
In conclusion, WTA is not an activator for FmtA Δ27 and FmtA Δ27 shows esterase 
catalytic activity towards D-alanyl ester of WTA and LTA. Active site motif of this 
catalytic activity was found to consist of SXXK motif by mutagenesis studies, which is 
similar to Family VIII carboxylesterase. Both serine and lysine from S127XXK130 motif 
are involved in esterase catalysis. Mutation studies suggest that seine located at position 
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S63 and S127 from SXXK motifs are involved in catalysis. Furthermore, esterase 
catalytic activity of FmtA Δ27 is very substrate specific (compared to synthetic substrate) 
and the enzymatic activity depends both on substrate and enzyme concentrations. High 
substrate concentration can inhibit enzymatic reaction of FmtA. We have also 
demonstrated the biochemical evidence of direct interaction of AM and GL with WTA. 
Furthermore, no potential protein-protein interactions between Atl and FmtA were 
observed from our experiments. It would be interesting to synthesize D-alanyl glycerol 
and ribitol and study the enzyme kinetics of FmtA as an esterase. To date, biological 
functions of most esterases are unknown. To our knowledge, this is the first study that 
reports an esterase from S.aureus that has sequence similarity to PBPs and β-lactmase and 
can remove D-Ala from its substrate WTA and LTA. 
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Appendix A 
Atl AM expression optimization 
                                    
 
Figure: Atl AM expression optimization 
Lane 1- pellet, 0.1 mM IPTG induced with 0.1M D-sorbitol and 2.5 mM β-Betaine at 
16°C 
Lane2- supernatant, 0.1 mM IPTG induced with 0.1M D-sorbitol and 2.5 mM β-Betaine 
at 16°C 
Lane3- pellet, 0.1 mM IPTG induced with 0.1M D-sorbitol  at 16°C 
Lane4- supernatant, 0.1 mM IPTG induced with 0.1M D-sorbitol  at 16°C 
Lane5- pellet, 0.1 mM IPTG induced at 10°C 
Lane6- supernatant, 0.1 mM IPTG induced at 10°C 
 
 
  
   1           2        3        4          5       6 
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Appendix B 
Calculation for Activity of FmtA against PG analogue (L-Lys-D-Ala-D-Ala) by DD-
Carboxypeptidase assay in presence of WTA as an activator (Figure 2.3.1.1) 
    
Fluorescence (AU) at 584 nm 
 
Avg SD 
Std 
Error Trial 1 Trail2 Trial3 
Blank 38.43567 6.913199 3.991337 39.103 44.991 31.213 
FmtA 34.613 4.387285 2.533 32.08 39.679 32.08 
 FmtA + D-Ala-D-Ala (6mM) 55.45833 2.146706 1.239401 53.329 57.622 55.424 
 D-Ala-D-Ala+WTA (0.1 µg/µL) 107.3987 13.81426 7.975666 91.917 111.812 118.467 
FmtA + D-Ala-D-Ala+ WTA (0.1 
µg/µL) 374.834 79.32415 45.79782 297.446 371.094 455.962 
 D-Ala-D-Ala+WTA (0.2µg/µL) 149.1129 111.03 64.10317 20.9457 210.453 215.94 
FmtA+  D-Ala-D-Ala+WTA 
(0.2µg/µL) 769.3447 156.7096 90.47636 633.129 734.293 940.612 
 D-Ala-D-Ala+WTA (0.3µg/µL) 238.3373 2.32564 1.342709 238.707 240.456 235.849 
FmtA+  D-Ala-D-Ala+WTA 
(0.3µg/µL) 964.8443 60.81348 35.11068 894.623 1000.008 999.902 
 
Appendix C 
Calculation for investigation of potential role of WTA as an activating ligand on FmtA 
Δ27 activity (negative control) (Figure 2.3.1.2) 
    
Fluorescence (AU) 
at 584 nm 
 
average Ave Dev error trial 1 trail 2 
Blank 44.439 0 0 44.439 44.439 
FmtA WT 42.445 0.47 0.33234 41.975 42.915 
FmtA WT  + Lys-D-Ala-D-Ala 53.014 2.73 1.930402 50.284 55.744 
FmtA WT + Lys-D-Ala-D-Ala+ Δdlt WTA (0.1 µg/µL) 58.951 6.665 4.712867 52.286 65.616 
FmtA WT + Lys-D-Ala-D-Ala+ Δdlt WTA (0.2 µg/µL) 59.644 6.172 4.364263 53.472 65.816 
FmtA WT + Lys-D-Ala-D-Ala+ Δdlt WTA (0.3 µg/µL) 58.2425 4.7845 3.383152 53.458 63.027 
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Appendix D 
Calculation for investigation of potential role of WTA as an activating ligand on PBP2a 
activity (control for FmtA) (Figure 2.3.1.3) 
    
Fluorescence (AU) at 584 nm 
 
AVG 
STD 
DEV 
std 
error Trial 1 Trial 2 Trial 3 
Blank 116.558 20.93426 12.0864 131.84 92.697 125.137 
PBP2a  118.3303 21.33699 12.31891 132.506 93.791 128.694 
PBP2a +  Lys-D-Ala-D-Ala 138.8377 25.24123 14.57303 160.551 111.143 144.819 
Lys-D-Ala-D-Ala + WTA (0.1 µg/µL) 194.1003 39.07136 22.55786 236.37 159.308 186.623 
PBP2a+Lys-D-Ala-D-Ala+ WTA (0.1 
µg/µL) 205.105 47.86551 27.63517 258.44 165.882 190.993 
D-Ala-D-Ala + WTA (0.2 µg/µL) 287.384 74.53754 43.03427 373.106 237.841 251.205 
PBP2a+Lys-D-Ala-D-Ala+WTA (0.2 
µg/µL) 306.6293 97.80576 56.46818 419.248 257.651 242.989 
Lys-D-Ala-D-Ala + WTA (0.3 µg/µL) 392.0643 89.25465 51.5312 494.413 330.404 351.376 
PBP2a+ D-Ala-D-Ala + WTA(0.3 µg/µL) 436.0113 117.1785 67.65305 571.309 367.054 369.671 
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Appendix E 
Calculation for investigation of potential role of WTA as an activating ligand on PBP2a 
activity (negative control) (Figure 2.3.1.4) 
    
Fluorescence (AU) 
at 584 nm 
 
Average Std Dev 
Std 
error trail1 trial2 
Blank 133.79 2.757716 1.95 131.84 135.74 
PBP2a  135.757 7.061168 4.993 130.764 140.75 
PBP2a +Lys-D-Ala-D-Ala 168.996 1.907774 1.349 167.647 170.345 
Lys-D-Ala-D-Ala+WTA Δ dltA (0.1 µg/µL) 168.4945 5.593922 3.9555 164.539 172.45 
PBP2a +Lys-D-Ala-D-Ala+WTA Δ dltA (0.1 
µg/µL) 168.8455 4.376284 3.0945 165.751 171.94 
Lys-D-Ala-D-Ala+WTA Δ dltA(0.2 µg/µL) 183.029 3.423811 2.421 180.608 185.45 
PBP2a+D-Ala-D-Ala+WTA Δ dltA(0.2 µg/µL) 169.579 1.359059 0.961 168.618 170.54 
Lys-D-Ala-D-Ala+WTA Δ dltA(0.3 µg/µL) 170.4555 4.277289 3.0245 167.431 173.48 
PBP2a+ Lys-D-Ala-D-Ala+WTA Δ dltA(0.3 
µg/µL) 175.3575 3.708775 2.6225 172.735 177.98 
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Appendix F 
Calculation for Investigation of potential role of WTA as an activating ligand on PBP4 
activity (Figure 2.3.1.5) 
    
Fluorescence (AU) 
at 584 nm 
 
average  std dev std eror trial 1 trial 2 
Blank 90.8655 10.90995 7.7145 83.151 98.58 
Lys-D-Ala-D-Ala 124.9705 17.4224 12.3195 112.651 137.29 
PBP4 158.363 13.55807 9.587 148.776 167.95 
WTA (0.1 µg/µL) 125.4115 4.564374 3.2275 128.639 122.184 
PBP4 + Lys-D-Ala-D-Ala 244.621 28.63782 20.25 264.871 224.371 
Lys-D-Ala-D-Ala+WTA (0.1 µg/µL) 192.275 2.58094 1.825 194.1 190.45 
PBP4 + Lys-D-Ala-D-Ala+ WTA (0.1 µg/µL) 275.1965 22.76672 16.0985 291.295 259.098 
Lys-D-Ala-D-Ala + WTA (0.3 µg/µL) 391.3215 0.959544 0.6785 392 390.643 
PBP4 +Lys-D-Ala-D-Ala + WTA (0.1 µg/µL) 432.855 71.38809 50.479 483.334 382.376 
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Appendix G 
Calculation for investigation of potential esterase activity of FmtA Δ27 on WTA (Figure 
2.3.1.6) 
    
Fluorescence (AU) 
at 584 nm 
 
Ave Std Dev 
Std 
Error trial 1 trial 2 
Blank 133.74 2.262742 1.6 132.14 135.34 
FmtA WT  131.115 4.645692 3.285 127.83 134.4 
FmtAS127  132.448 4.217185 2.982 129.466 135.43 
PBP2a  135.2345 4.476693 3.1655 132.069 138.4 
WTA (0.1 µg/µL) 174.83 5.048742 3.57 171.26 178.4 
FmtAWT+ WTA (0.1 µg/µL) 940.6135 21.51514 15.2135 955.827 925.4 
FmtAS127 + WTA (0.1 µg/µL) 773.1405 6.221833 4.3995 768.741 777.54 
PBP2a+ WTA (0.1 µg/µL) 213.244 10.23325 7.236 206.008 220.48 
WTA (0.2 µg/µL) 272.2555 10.59882 7.4945 264.761 279.75 
FmtAWT + WTA (0.2 µg/µL) 994.725 7.459977 5.275 1000 989.45 
FmtAS127 + WTA (0.2 µg/µL) 919.913 12.91601 9.133 929.046 910.78 
PBP2a + WTA (0.2 µg/µL) 276.077 5.794033 4.097 280.174 271.98 
WTA (0.3 µg/µL) 339.9575 0.880348 0.6225 339.335 340.58 
FmtAWT + WTA (0.3 µg/µL) 993.995 8.492352 6.005 1000 987.99 
FmtAS127 + WTA (0.3 µg/µL) 919.748 13.14936 9.298 929.046 910.45 
PBP2a+ WTA (0.3 µg/µL) 349.423 1.636245 1.157 348.266 350.58 
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Appendix H 
Calculation for investigation of potential esterase activity of FmtA Δ27 on WTA (control 
experiments) (Figure 2.3.1.7) 
    
Fluorescence (AU) 
at 584 nm 
 
avenge std dev 
Std 
error trial1  trial 2 
Blank 122.279 6.676502 4.721 127 117.558 
FmtA WT (Boilled) 149.2805 7.11703 5.0325 154.313 144.248 
FmtAS127 (Boilled) 122.028 15.39654 10.887 132.915 111.141 
PBP2a (Boilled) 141.2935 18.48024 13.0675 154.361 128.226 
WTA (0.1 µg/µL) 270.045 35.92385 25.402 295.447 244.643 
FmtAWT (B)+ WTA (0.1 µg/µL) 318.291 20.26851 14.332 332.623 303.959 
FmtAS127(B) + WTA (0.1 µg/µL) 341.472 31.22018 22.076 363.548 319.396 
PBP2a(B)+ WTA (0.1 µg/µL) 355.82 117.0941 82.798 438.618 273.022 
WTA (0.2 µg/µL) 479.8135 23.34513 16.5075 496.321 463.306 
FmtAWT (B)+ WTA (0.2 µg/µL) 527.1345 44.87795 31.7335 558.868 495.401 
FmtAS127(B) + WTA (0.2 µg/µL) 561.5895 107.6704 76.1345 637.724 485.455 
PBP2a (B)+ WTA (0.2 µg/µL) 586.195 180.0379 127.306 713.501 458.889 
WTA (0.3 µg/µL) 656.168 62.94947 44.512 700.68 611.656 
FmtAWT(B) + WTA (0.3 µg/µL) 713.334 89.68518 63.417 776.751 649.917 
FmtAS127(B) + WTA(0.3 µg/µL) 745.345 155.1661 109.719 855.064 635.626 
PBP2a(B)+ WTA (0.3 µg/µL) 769.899 212.3442 150.15 920.049 619.749 
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Appendix I 
The effect of enzyme concentration in the rate of removals of D-Ala from WTA by NMR 
(Figure 2.3.3.1) 
FmtA WT 10 µM +WTA RN4220 5mg/mL (integration:  CH3 of Glc-NAc,1) (Free D-
Ala peak around 1.45 ppm) 
trial 1 
 
trial 2   
 
trial 3  
time 
(hr) 
D-Ala-
Ribitol 
Free D-
Ala 
 
time 
(hr) 
D-Ala-
Ribitol 
Free D-
Ala 
 
time 
(hr) 
D-Ala-
Ribitol 
Free D-
Ala 
0.08 0.9501 0.044 
 
0.08 0.9405 0.0251 
 
0.08 0.9504 0.0349 
0.31 0.8898 0.1375 
 
0.18 0.9128 0.1148 
 
0.2 0.9121 0.1033 
0.45 0.8546 0.1698 
 
0.38 0.8732 0.1618 
 
0.4 0.8806 0.1447 
0.81 0.8261 0.2126 
 
0.58 0.8363 0.197 
 
0.6 0.8505 0.1668 
1.01 0.8014 0.2317 
 
0.78 0.7939 0.2031 
 
0.81 0.8237 0.172 
1.21 0.7848 0.2643 
 
0.98 0.7731 0.2262 
 
1.01 0.8127 0.219 
1.43 0.7568 0.2821 
 
1.2 0.7497 0.2465 
 
1.21 0.7809 0.2128 
1.63 0.7336 0.2714 
 
1.4 0.7342 0.2644 
 
1.41 0.7598 0.2319 
1.83 0.7204 0.2998 
 
1.6 0.7287 0.2824 
 
1.61 0.7471 0.2503 
2.25 0.6983 0.3358 
 
1.8 0.7116 0.2973 
 
2.23 0.7097 0.2909 
2.65 0.6793 0.3372 
 
2 0.7137 0.3315 
 
2.43 0.7028 0.3155 
3.26 0.6551 0.3638 
 
2.35 0.6931 0.3308 
 
2.85 0.696 0.3602 
19.85 0.5631 0.5043 
 
15.33 0.5734 0.5021 
 
3.66 0.6726 0.3784 
22.1 0.5488 0.5067 
 
17.9 0.564 0.5116 
 
4.06 0.6608 0.3825 
    
23.76 0.5539 0.5252 
 
4.48 0.6545 0.4017 
        
4.9 0.6448 0.4024 
        
5.3 0.6379 0.4063 
        
5.71 0.6397 0.414 
        
12.25 0.5845 0.444 
        
21.08 0.555 0.4865 
        
21.08 0.555 0.4865 
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FmtA WT 20 µM +WTA RN4220 
5mg/mL 
 
 FmtA WT 5 µM +WTA 
RN4220 5mg/mL 
time 
(hr) 
D-Ala 
Ribitiol 
Free D-
ala 
 
time 
(hr) 
D-Ala 
Ribitiol 
Free D-
Ala 
0.08 0.8953 0.0879 
 
0.03 0.9759 0.0174 
0.18 0.83 0.1182 
 
0.23 0.9647 0.054 
0.38 0.7728 0.2241 
 
0.45 0.9479 0.0369 
0.58 0.7178 0.2818 
 
0.65 0.9418 0.069 
0.78 0.6762 0.3313 
 
0.83 0.9452 0.0823 
1 0.6644 0.4066 
 
1.05 0.9295 0.0908 
1.4 0.6183 0.4359 
 
1.9 0.9038 0.1203 
2.21 0.5903 0.4847 
 
7.95 0.8252 0.1974 
2.41 0.5914 0.495 
 
8.1 0.8278 0.1989 
2.63 0.5738 0.5089 
 
23.4 0.758 0.2468 
2.83 0.5702 0.5229 
 
23.45 0.7544 0.2453 
3.03 0.558 0.5277 
    5.28 0.4811 0.5884 
    9.2 0.4252 0.652 
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Appendix J 
The effect of WTA concentration in the rate of removals of D-Ala from WTA (Figure 
2.3.3.2) (integration:  CH3 of Glc-NAc, 1) (Free D-Ala peak around 1.45 ppm) 
WTA 5 mg/ml  
 
WTA 2.5mg/ml 
 
WTA 1mg/ml 
 FmtA WT 10 µM+ WTA 
RN4220 5 mg/mL 
 
 FmtA WT 10 µM+ WTA 
RN4220 2.5 mg/mL 
 
 FmtA WT 10 µM+ WTA 
RN4220 1 mg/mL 
time 
(hr) 
D-Ala -
Ribitol 
free D-
Ala 
 
time 
(hr) 
D-Ala -
Ribitol 
free D-
Ala 
 
time 
(hr) 
D-Ala -
Ribitol 
free D-
Ala 
0 0.9505 0.0426 
 
0 0.9425 0.0631 
 
0 0.8769 0.1213 
0.5 0.8779 0.1101 
 
1.03 0.7054 0.2837 
 
0.2 0.6993 0.2811 
1 0.8312 0.1704 
 
2.51 0.5519 0.4614 
 
0.41 0.6115 0.3626 
1.5 0.7809 0.2052 
 
3.53 0.4728 0.5363 
 
0.61 0.5491 0.4445 
2.05 0.7467 0.2439 
 
4.55 0.4138 0.5603 
 
0.81 0.5007 0.4863 
2.55 0.715 0.2826 
 
5.56 0.3712 0.6205 
 
1.38 0.4116 0.5703 
3.06 0.6827 0.3079 
 
6.6 0.349 0.6551 
 
1.58 0.3782 0.5958 
3.56 0.6612 0.3351 
 
7.61 0.3254 0.6795 
 
1.78 0.3579 0.6257 
3.84 0.6526 0.3383 
 
8.63 0.3023 0.6961 
 
1.98 0.3395 0.6529 
6.5 0.58 0.42 
 
9.66 0.2816 0.7291 
 
2.2 0.3242 0.6503 
8.5 0.55 0.46 
 
10.68 0.2621 0.7368 
 
2.68 0.2914 0.6888 
12.5 0.49 0.5 
 
11.7 0.2536 0.7488 
 
4.41 0.2142 0.7486 
17.33 0.4477 0.5493 
 
12.72 0.2385 0.757 
 
5.8 0.1957 0.7709 
19.25 0.4336 0.5569 
 
13.75 0.2273 0.771 
 
7.65 0.1634 0.8099 
20.53 0.4166 0.5564 
 
17.71 0.191 0.8032 
 
9.61 0.0995 0.8864 
23.5 0.4123 0.5698 
        25.03 0.4051 0.5663 
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WTA 0.5mg/mL 
 
WTA 7.5mg/mL 
 FmtA WT 10 µM+ WTA RN4220 0.5 
mg/mL 
 
 FmtA WT 10 µM+ WTA RN4220 7.5 
mg/mL 
time (hr) D-Ala -Ribitol free D-Ala 
 
time (hr) D-Ala -Ribitol free D-Ala 
0 0.8428 0.1388 
 
0 0.939 0.0419 
0.53 0.5497 0.4465 
 
0.13 0.9156 0.0649 
0.75 0.4805 0.4995 
 
1.55 0.7703 0.2222 
0.95 0.4448 0.5251 
 
3.41 0.6451 0.3711 
1.15 0.3942 0.5731 
 
4.88 0.5733 0.4227 
1.35 0.3785 0.5918 
 
5.86 0.3475 0.4561 
3.06 0.2533 0.6775 
 
7.55 0.3331 0.4889 
4.65 0.1966 0.7233 
 
7.61 0.3336 0.6845 
5.13 0.1848 0.7321 
 
9.35 0.3151 0.6983 
5.58 0.1965 0.7338 
 
11.05 0.3002 0.7064 
5.81 0.1817 0.7577 
 
12.61 0.2853 0.7262 
6.15 0.1724 0.7635 
 
15.73 0.2681 0.7417 
7.51 0.1344 0.8074 
 
16.78 0.2178 0.8035 
9.5 0.1153 0.8337 
    11.51 0.1519 0.8699 
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Appendix K 
Esterase activity of FmtAΔ27 against p-NPA and p-NPB by continuous spectrophotometric 
assay (Figure 2.3.4.2) 
 
1mM pNPB in DMSO, 50 mM Sodium phosphate buffer pH,7.0 
 
Ave std dev std error trial1  trail2 
Blank  0.00285 0.00021213 0.00015 0.0027 0.003 
FmtA WT+ pNPB  0.00385 7.0711E-05 5E-05 0.0039 0.0038 
PBP4 + pNPB  0.0028 0.00014142 1E-04 0.0027 0.0029 
PBP2a+ pNPB  0.0029 0.00014142 0.0001 0.0028 0.003 
 
 
1mM pNA in DMSO, 50 mM Sodium phosphate buffer pH,7.0 
 
Ave Std Dev Std Error Trial1 Trail2 
Blank 0.0067 0.00014142 1E-04 0.0066 0.0068 
FmtA WT+ pNPA  0.0085 0.00014142 0.0001 0.0086 0.0084 
PBP4 5uM + pNPA  0.00695 7.0711E-05 5E-05 0.0069 0.007 
PBP2a 5uM + pNPA   0.00685 7.0711E-05 5E-05 0.0069 0.0068 
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Appendix L 
Assessment of esterase activity of FmtAΔ27 by NMR (Figure 2.3.5.2) 
1 mM P nitrophenyl acetate-
Blank 
  
p-NPA 1mM+ FmtA WT 5 
µM 
 
pNPA 1 mM + 5 µM PBP4 
time(hr) peak 8.35 ppm 
  
time(hr) peak 8.35ppm 
 
time(hr) peak 8.35ppm 
1.53 10.9 
  
0.93 9.19 
 
0.6 20.96 
2.21 10.57 
  
1.56 6.66 
 
1.11 16.56 
3.25 6.8 
  
2.25 5.61 
 
1.9 14.59 
4.06 5.09 
  
3.4 3.67 
 
2.7 12.95 
4.73 5.57 
  
4.15 3.61 
 
3.41 7.53 
5.48 4.58 
  
4.76 3.78 
 
4.3 6.24 
6.21 4.26 
  
5.53 3.66 
 
5.41 5 
6.91 5.29 
  
6.26 3.18 
 
6.31 4.62 
6.58 5.11 
  
6.96 2.98 
 
6.15 4.91 
8.83 4.5 
  
7.38 3.06 
 
8.5 4.15 
10.06 4.89 
  
8.86 2.72 
 
9.85 3.89 
12.38 3.56 
  
10.11 2.58 
 
11.26 3.73 
14.63 2.86 
  
12.43 2.25 
 
12.73 3.53 
16.88 2.71 
  
14.81 1.82 
 
14.4 2.92 
18.11 2.62 
  
16.91 1.65 
 
15.9 2.77 
19.13 2.23 
  
18.06 1.55 
 
18.38 2.48 
21.45 1.77 
  
19.16 1.47 
 
20.91 1.96 
23.73 1.91 
  
21.51 1.26 
 
23.35 2.01 
23.71 1.91 
  
23.75 1.17 
 
25.25 1.89 
27.72 1.8 
  
25.75 1 
 
26.61 1.72 
45.45 1.03 
  
27.75 1.01 
   
    
46.48 0.62 
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1 mM pNitrophenyl Butyrate-
Blank 
  
1 mM pNB+5 µM FmtA 
WT 
  
1 mM pNB + 5 µM PBP4 
time(hr) peak1 8.35 ppm 
  
time(hr) peak 8.35 ppm 
  
time(hr) peak 8.35 ppm 
2.15 17.18 
  
0.58 0.06 
  
    
3.13 10.8 
  
0.91 0.05 
  
3.33 10.73 
4.83 9.68 
  
1.78 0.08 
  
4 8.56 
6.16 7.99 
  
2.63 0.1 
  
4.68 13.12 
8.61 6.06 
  
3.61 0.1 
  
5.45 8.93 
10 5.9 
  
4.81 0.14 
  
6.18 7.04 
11.28 5.1 
  
5.83 0.23 
  
6.88 7.54 
12.61 5.09 
  
6.83 0.3 
  
7.51 6.71 
14.11 4.51 
  
7.85 0.28 
  
8.78 6.14 
15.48 4.29 
  
9.76 0.29 
  
10.03 5.8 
17.88 4.62 
  
11.66 0.41 
  
11.35 5.41 
22.65 3.91 
  
13.58 0.46 
  
14.6 4.32 
24.73 2.41 
  
15.5 0.48 
  
16.85 4.83 
26.6 2.58 
  
17.41 0.51 
  
17.96 3.76 
    
20.28 0.63 
  
19.08 3.6 
    
20.783 0.62 
  
21.41 3.83 
    
24.63 0.7 
  
23.7 3.5 
        
25.66 3.34 
        
27.7 3.18 
        
46.43 1.91 
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Trial1 :1 mM D-ala -Methyl Ester 
blank 
 
Trail 1 :1 mM D-ala ME +5 uM 
FmtA WT 
 
Trial 1:1 mM D-ala ME +5 
uM PBP4 
time(hr) peak 1.53 ppm 
 
time(hr) peak 1.53 ppm 
 
time(hr) peak 1.53 ppm 
0.25 29.9 
 
0.31 17.18 
 
0.35 23.31 
0.53 25.34 
 
0.6 20.59 
 
0.63 22.41 
1.48 15.62 
 
0.53 13.81 
 
1.56 14.51 
2.21 11.61 
 
2.3 10.45 
 
2.36 11.6 
3.16 9.63 
 
3.21 7.93 
 
2.25 9.36 
3.86 7.99 
 
3.9 7.16 
 
3.95 7.76 
4.61 7.12 
 
4.65 6.71 
 
4.68 6.91 
5.41 6.09 
 
5.45 5.36 
 
5.51 5.83 
6.2 5.47 
 
7.46 4.3 
 
6.28 5.12 
7.43 4.74 
 
6.23 4.8 
 
7.51 4.76 
8.71 3.95 
 
8.75 3.74 
 
8.8 4.11 
10.06 3.51 
 
10.11 3.11 
 
10.15 3.48 
11.4 3.06 
 
11.45 2.73 
 
11.51 3.04 
12.68 2.75 
 
12.73 2.31 
 
12.81 2.81 
14.15 2.38 
 
14.28 2.03 
 
14.38 2.44 
15.55 2.13 
 
15.58 1.99 
 
15.65 2.25 
17.96 1.88 
 
18 1.63 
 
18.08 1.99 
19.85 1.7 
 
19.9 1.52 
 
19.96 1.74 
22.71 1.43 
 
22.76 1.27 
 
21.8 1.5 
24.78 1.33 
 
24.83 1.21 
 
24.86 1.38 
26.63 1.19 
 
26.66 1.13 
 
26.71 1.27 
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Trial 2 :1 mM D-Ala -Methyl Ester 
blank 
 
Trail 2 :1 mM D-Ala ME +5 µM 
FmtA WT 
 
Trial 2:1 mM D-Ala ME +5 
µM PBP4 
time(hr) peak 1.53 ppm 
 
time(hr) peak 1.53 ppm 
 
time(hr) peak 1.53 ppm 
0.31 21.47 
 
0.38 15.95 
 
0.4 21.1 
0.66 20.16 
 
0.68 12.57 
 
0.68 18.77 
1.18 15.14 
 
1.21 10.6 
 
1.23 14.51 
1.96 12.11 
 
2.5 8.67 
 
2.01 10.37 
2.76 9.57 
 
2.8 7.76 
 
2.81 8.9 
3.53 8.21 
 
3.56 6.52 
 
3.56 7.57 
4.38 6.76 
 
4.41 5.39 
 
4.45 6.53 
5.5 5.77 
 
5.55 4.96 
 
5.58 5.62 
6.4 4.94 
 
6.43 4.16 
 
6.46 4.87 
7.21 4.38 
 
7.26 3.97 
 
8.38 3.79 
8.58 3.9 
 
8.61 3.35 
 
10.06 3.41 
9.96 3.42 
 
10.03 2.94 
 
11.5 2.94 
11.36 3.03 
 
11.41 2.64 
 
13 2.67 
12.86 2.64 
 
12.91 2.48 
 
14.58 2.37 
14.3 2.36 
 
14.55 2.17 
 
16.08 2.16 
15.98 2.13 
 
16.05 1.95 
 
18.58 1.83 
18.5 1.86 
 
18.53 1.72 
 
21.11 1.6 
21 1.59 
 
21.06 1.47 
 
23.5 1.42 
23.43 1.41 
 
23.46 1.32 
 
25.33 1.31 
25.3 1.28 
 
25.31 1.22 
 
26.7 1.23 
26.66 1.23 
 
26.68 1.12 
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Appendix M 
Screening for potential esterase activity of FmtAΔ27on cephalothin (Figure 2.3.5.3) 
 
Blank: Cephalothin 3 mM 
 
FmtA WT 40 µM+Cephalothin 3 
mM 
Time ,hr Acetate peak 1.9ppm 
 
Time ,hr Acetate peak 1.9ppm 
0 0.102 
 
    
0.2 0.1051 
 
0.2 0.1313 
0.416 0.1053 
 
0.61 0.1346 
0.6166 0.1056 
 
0.81 0.1372 
0.81 0.1071 
 
1 0.1381 
1.03 0.1073 
 
3.71 0.1472 
1.23 0.1093 
 
8.78 0.1562 
1.65 0.1101 
   1.75 0.11 
   1.81 0.112 
   4.9 0.1193 
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 Appendix N 
Active site (SXXK motif) of FmtAΔ27 WT for esterase activity (Figure 2.3.6) (integration:  
CH3 of Glc-NAc 1) (Free D-Ala peak around 1.45 ppm) 
FmtA WT 10 µM+ WTA RN4220 5 
mg/mL 
 
 FmtA S63 10 µM+ WTA RN4220 5 
mg/mL 
time (hr) D-Ala -Ribitol free D-Ala 
 
time (hr) D-Ala -Ribitol free D-Ala 
0 1.0519 0.0265 
 
0 1.0437 0.0177 
0.2 1.1035 0.0577 
 
0.61 1.0391 0.0193 
0.41 0.9995 0.0811 
 
1.23 1.041 0.0224 
0.61 1.002 0.1021 
 
2.05 1.0375 0.0298 
0.81 0.98 0.1224 
 
3.06 1.0226 0.0314 
1.2 0.9658 0.1574 
 
4.08 1.0306 0.0369 
2.23 0.9121 0.2088 
 
5.11 1.0257 0.0417 
3.75 0.8435 0.2618 
 
5.48 1.0147 0.0474 
4.61 0.8405 0.2783 
 
6.13 1.0182 0.0515 
5.36 0.8167 0.3026 
 
6.51 1.011 0.0491 
6.55 0.8064 0.3206 
 
7.53 1.012 0.0573 
8.75 0.7796 0.3564 
 
8.56 1.0108 0.06 
8.78 0.7732 0.3534 
 
9.58 1.0079 0.0609 
10.3 0.7598 0.37 
 
10.25 1.0102 0.0619 
18 0.72 0.414 
 
13.03 0.9973 0.0686 
22.66 0.7085 0.4254 
 
14.63 0.9992 0.0772 
24.31 0.7221 0.4316 
    24.38 0.6831 0.4287 
    25.13 0.6812 0.4293 
    
27.55 0.6627 0.4354 
 
FmtA K130 10 µM+ WTA RN4220 5 
mg/mL 
       FmtA S127 10 µM+ WTA RN4220 5 
mg/mL 
 
time (hr)  D-Ala Ribitol free D-Ala 
time (hr)  D-Ala Ribitol free D-Ala 
 
0 1.0699 0.0101 
0 1.0672 0.0401 
 
0.4 1.0771 0.0354 
0.91 1.0589 0.0469 
 
4.58 1.0334 0.0497 
3.6 1.0127 0.0648 
 
5.31 1.026 0.0578 
5.8 0.9806 0.0784 
 
6.79 1.0188 0.0731 
8.03 0.9551 0.0989 
 
8.7 1.0068 0.0865 
9.48 0.9535 0.1137 
 
10.58 0.9994 0.0981 
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Appendix O 
Inhibitors studies for esterase activity of FmtAΔ27 WT (Figure 2.3.7) 
FmtA WT 10 µM+ WTA 
RN4220 5 mg/mL 
 
 NaF 1 mM+ FmtA WT 10 µM+ 
WTA RN4220 5 mg/mL 
 
Eserine 1 mM+ FmtA WT 10 
µM+ WTA RN4220 5 mg/mL 
time 
(hr) 
D-Ala -
Ribitol 
free D-
Ala 
 
time 
(hr) 
D-Ala -
Ribitol 
free D-
Ala 
 
time 
(hr) 
D-Ala -
Ribitol 
free D-
Ala 
0 0.9505 0.0426 
 
0 1.0576 0.032 
 
0 1.0492 0.1894 
0.5 0.8779 0.1101 
 
0.18 1.0318 0.0578 
 
0.15 1.0235 0.2082 
1 0.8312 0.1704 
 
0.38 1.0093 0.0828 
 
0.36 1.0075 0.2488 
1.5 0.7809 0.2052 
 
0.58 0.9988 0.1086 
 
0.56 0.9837 0.2537 
2.05 0.7467 0.2439 
 
0.6 0.995 0.1053 
 
0.76 0.965 0.297 
2.55 0.715 0.2826 
 
2.4 0.8976 0.2122 
 
0.96 0.9515 0.3072 
3.06 0.6827 0.3079 
 
2.6 0.902 0.2262 
 
1 0.939 0.3156 
3.56 0.6612 0.3351 
 
3.28 0.8638 0.2574 
 
2.3 0.8664 0.3853 
3.84 0.6526 0.3383 
 
4.03 0.8372 0.2851 
 
3.03 0.8355 0.4222 
6.5 0.58 0.42 
 
5.3 0.8222 0.309 
 
4.4 0.7938 0.4713 
8.5 0.55 0.46 
 
5.38 0.8174 0.3242 
 
6.43 0.747 0.5116 
12.5 0.49 0.5 
 
7.45 0.7861 0.3512 
 
7.91 0.7253 0.537 
17.33 0.4477 0.5493 
 
8.95 0.7596 0.3635 
 
20.36 0.6437 0.6124 
19.25 0.4336 0.5569 
 
21.33 0.7061 0.4392 
 
22.81 0.6346 0.6314 
20.53 0.4166 0.5564 
 
23.75 0.6914 0.4406 
 
25.4 0.6346 0.6449 
23.5 0.4123 0.5698 
 
23.8 0.6931 0.4432 
    25.03 0.4051 0.5663 
 
26.33 0.6894 0.4514 
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Trial 1 
   
Trial 2 
  FmtA WT 10 µM+ PMSF 1mM +WTA RN4220 5 
mg/mL 
 
 FmtA WT 10 µM+ PMSF 1 mM+ WTA RN4220 5 
mg/mL 
time (hr) D-Ala -Ribitol free D-ala 
 
time (hr) D-Ala -Ribitol free D-ala 
0 0.9348 0.0347 
 
0 0.9241 0.0541 
0.5 0.8455 0.1124 
 
0.4 0.8119 0.1175 
1 0.7879 0.1514 
 
1.58 0.647 0.2373 
1.5 0.7184 0.1712 
 
2.93 0.5311 0.3235 
2 0.6872 0.2109 
 
4.95 0.4223 0.3785 
2.5 0.6601 0.2411 
 
6.03 0.3945 0.4055 
3.05 0.627 0.2549 
 
9.58 0.329 0.4599 
3.56 0.6161 0.2623 
 
9.73 0.3303 0.4652 
4.06 0.595 0.279 
 
10.9 0.321 0.474 
4.56 0.57 0.3043 
 
11.88 0.3011 0.491 
5.1 0.5529 0.3097 
 
12.88 0.3036 0.5034 
5.6 0.5425 0.3072 
 
14.86 0.2664 0.5255 
6.11 0.5228 0.3374 
 
16.85 0.2566 0.5388 
6.63 0.5183 0.3347 
 
18.81 0.254 0.5508 
7.13 0.5098 0.3508 
 
20.8 0.2295 0.5632 
7.63 0.4949 0.3468 
 
22.26 0.2121 0.5871 
8.16 0.4954 0.3624 
    8.67 0.4777 0.3674 
    9.7 0.4625 0.3722 
    10.18 0.4637 0.3721 
    13.05 0.4243 0.3903 
    16.46 0.4153 0.3973 
    18.45 0.3964 0.4066 
    19.8 0.3861 0.4282 
    21 0.3769 0.4282 
    23.13 0.3744 0.4382 
    25.1 0.3308 0.4622 
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Appendix P 
Inorganic phosphate assay for WTA (Table 2) (Absorbance at 620 nm) 
 
blank std RN4220 CM2 CM2+IPTG FmtA del 
 Num 1 2 3 4 5 6 
Sample1 0.14 0.502 0.269 0.285 0.241 0.247 
Sample2 0.123 0.496 0.26 0.286 0.242 0.248 
Sample3 0.123 0.491 0.262 0.286 0.251 0.249 
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Appendix Q 
Determination of whole-cell surface charge (Absorbance at 530 nm) (Figure 2.3.10) 
 OD 530 
 Trial1  Trial2 Trial3 Trial4 Trial5 Trial6 Trial7 Trial8 
CytC 0.4 0.402 0.44 0.481 0.43 0.45 0.421 0.429 
RN4220 0.2996 0.24 0.34 0.18 0.29 0.28 0.276 0.322 
fmtA-CM 0.1868 0.09 0.14 0.113 0.17 0.16 0.148 0.203 
fmtA-
CM+IPTG100     0.25   0.29 0.25 0.294   
fmtA-CM+IPTG 
500 0.1345 0.19 0.29 0.139 0.29 0.29 0.272 0.316 
FmtA Del 0.1398 0.16 0.09 0.1 0.18 0.18 0.155 0.212 
dltA 0.089 0.07 0.04 0.027 0.03 0.03 0.037 0.027 
 % of applied protein 
 Trial1  Trial2 Trial3 Trial4 Trial5 Trial6 Trial7 Trial8 
CytC 100 100 100 100 100 100 100 100 
RN4220 74.9 59.75 76.9 37.5 67.7 62 65.51 75.17 
fmtA-CM 46.7 22.42 31.4 23.44 39.4 35.5 35.13 47.24 
fmtA-
CM+IPTG100     56.2   67.8 56.1 69.92   
fmtA-CM+IPTG 
500 33.625 47.32 65.3 28.93 67.6 64.2 64.63 73.65 
FmtA Del 34.95 39.85 21.1 20.86 42.1 39.7 36.74 49.53 
dltA 22.25 17.43 8.58 5.51 6.9 5.87 8.69 6.25 
 
 
Mean % of applied 
protein Std dev std error 
CytC 100 0 0 
RN4220 64.93125 12.7822147 4.51919534 
fmtA-CM 35.15125 9.33708189 3.30115696 
fmtA-
CM+IPTG100 62.4975 7.37138329 3.68569165 
fmtA-CM+IPTG 
500 55.66838 16.8352611 5.95216363 
FmtA Del 35.60763 9.99944381 3.53533726 
dltA 10.185 6.20616744 2.19421154 
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Appendix R 
Removal of D-Ala of LTA by FmtAΔ27 (Figure 2.3.11.1) 
LTA from sigma 5mg/mL + FmtA WT 10 µM 
time  
peak around 1.62 
ppm 
peak around 1.46 
ppm 
0.08 1.24 0.1198 
0.7 1.31 0.1697 
1.31 1.09 0.2536 
1.93 1.02 0.2841 
2.71 1.16 0.3303 
4.56 0.914 0.4073 
6.6 0.8523 0.4704 
8.65 0.8726 0.5648 
10.68 0.762 0.5464 
12.71 0.7277 0.5673 
16.46 0.7177 0.6816 
23 0.6198 0.6539 
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